|
|
·|û¡Ghung120110149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
|
¥«³õº¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009 6634 ªYÄ£ ªÑ¥»: 3.832»õ ¥Dn·~°È: ¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo ¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤) ¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤) Ä~Äò©¹¤U¬Ý...! ============================================================================= ²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ) ¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ« 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.µL¦w¥þ©Ê°ÝÃD ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x ¬ãµo¶¥¬q: 1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á 2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ Àø®Ä¤ÀªR¡G 1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n 2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009) ============================================================================= ²£«~02¡GSNP-630 ¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE) 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~ ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡ 4.µL¦w¥þ©Ê°ÝÃD ¬ãµo¶¥¬q: 1.Á{§É«e 2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C 3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C Àø®Ä¤ÀªR¡G 1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05 ============================================================================= ²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯) ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯) ²£«~Àu¶Õ: 1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê 2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs) 3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ« 2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^ 3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O ¬ãµo¶¥¬q: 1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç 2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D 3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç ============================================================================= ²£«~04¡GSNP-830/ SNP-840 ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh) ²£«~Àu¶Õ: 1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è 2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è 2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä 3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y 4.¥i¼W¥[¤AñQÓi×ô¾¯¶q ¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î 5.¤GªÌ¾Ü¤@±ÂÅv 6.¥i¼W¥[¥«¦û²v ¬ãµo¶¥¬q: 1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ ============================================================================= ***************************************************************************** SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G 1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 ============================================================================= ***************************************************************************** ¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G 1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv 2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv 3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv ============================================================================= ***************************************************************************** ¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º §Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó ¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄÆªÑ ----------------------------------------------------------------------------- ¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×) |
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 10:11:14²Ä 2016 ½g¦^À³
|
¤À¤l¹vÂICYP2E1 ¬Ofirst-in-class!!! ¤@ª½W«ä³o¬q-[SNP-610¸gÀø®ÄÃÒ¹ê¡A¨ä¤G´Á¸ÕÅçµ²ªGÀu©ó¤wµoªí¨Ã¶i¤J¤T´Á¤§¦U°ê NASH Ô¿ïÃĪ«]ªº½t¥Ñ¡C ª½¨ì³o½g·s½×¤å¥X²{-2022.5¤ë ttps://www.sciencedirect.com/science/article/pii/S2211383522000545 ...·í CYP2E1 ¥¢¬¡®É¡A¤º·½©Ê PPAR £\¿E°Ê¾¯¥i¯à·|¼W¥[... ...¦³½ìªº¬O¡A¥þ²y¥NÁ²վǿz¿ïµo²{ CYP2E1 ªº¥\¯à³à¥¢¾ÉP¨xŦ¤¤ LysoPC 22:4 ©M¤TºØ PUFA¡BDHA¡BAA ©M LCA ÅãµÛ¼W¥[¡A³o¬O PPAR £\°ªªí¹Fªº¦P¤@²Õ´¡A¥i¥H½Õ¸`¨xŦ FGF21 ÄÀ©ñ¤@¦¸¬¡©Ê¡C³o¨Ç¥Íª«¼Ð»xª«³Q¶i¤@¨BÅçÃÒ¥i§@¬° CYP2E1 酶©³ª«©Mª½±µ PPAR £\¿E°Ê¾¯¡C¤@¥¹ CYP2E1 ³Q§í¨î¡A¨xŦ¤¶¾Éªº CYP2E1 ¤º·½©Ê¥NÁª«¡]¥]¬A LysoPC 22:4¡BDHA¡BAA ©M LCA¡^ªº¥NÁ´N·|´î®z¡A±q¦Ó¨Ï³o¨Ç¤Æ¦Xª«¦b¨x²ÓM¤¤¼W¥[¡AµM«á§@¬°ª½±µ PPAR £\¿E°Ê¾¯»¤¾Éì¦ì¨x²ÓM¬¡¤Æ. ¥Ñ©ó CYP2E1 ¥Dn¦b¥Dnµo¥Í¥NÁªº¨x²ÓM¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªº PPAR £\¿E¬¡¡A³o¥i¥HÁקKÁ{§É¤¤°¸º¸µo¥Íªº«D²Õ´¯S²§©Ê PPAR £\¿E¬¡ªº°Æ§@¥Î ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/27 ¤U¤È 04:10:48²Ä 1753 ½g¦^À³ CYP2E1? 2017-05-24ªYÄ£«Å¥¬¨ä¦b NASH ¤è±ªº«¤j¬ð¯} www.microbio.com.tw/news_detail.php?nwno=251 SNP-610¨ã¦³¦hºØ§@¥Î¾÷¨î(CYP2E1 + DGAT1)...¤À¤l¹vÂICYP2E1 ¬Ofirst-in-class¡A¤£¦P©ó¥@¬É¤W©Ò¦³¨ä¥L¦b¬ãÃĪ«¡C -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î` 108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·| mops.twse.com.tw/nas/STR/663420190724M001.pdf Phase II study: - The decreases in several clinical parameters from baseline to the end of treatment were greater in SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib treatment in literature, especially in ALT. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/24 ¤U¤È 04:41:14²Ä 2015 ½g¦^À³
|
www.vdh.virginia.gov/content/uploads/sites/110/2022/04/Youth_SelfHarm_Suicide_Report.pdf ¬ü°êºû¦{ 9-18·³¨àµ£ ±q 2016 ¦~¨ì 2020 ¦~¡A¤j¦h¼Æ«DP©R©Ê¦Û¶Ë¦í°|¬O¥Ñ©óÃĪ«¤¤¬r¡]93%¡^¡A¨ä¦¸¬O5%¥Ñ©ó³Î¶Ë¡A4%¥Ñ©ó«DÃĪ« ¤¤¬r¡A¥]¬A°sºë¡]¹Ï 7¡^.....¦b¨º¨Ç¦]ÃĪ«¾ÉPªº¦Û´Ý¦í°|¤¤ 2016-2020 ¦~¤¤¬r¡]n=2,178¡^¡A³Ì±`¥ÎªºÃĪ«¬O4-®ò°òf×ôl¥Íª«¡A¤SºÙ¹ï¤A酰®ò°ò×ô¡]28%¡^ ------------------------------------------------------------------------------------------------- 9-18·³¨àµ£ APAP¤¤¬r 2178*28%=610¤H¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/24 ¤U¤È 04:26:43²Ä 2014 ½g¦^À³
|
¬ü°ê¨àµ£¦Û±þ¨Æ¥ó¼W¥[--->¤z¹w±¹¬I--->µL¨x¬rAPAP. ¥¬¬¥ªâ¹L¶q¤]«Ü±`¨£¡A¦ýÄY«ªº¬r©Ê§@¥Î¨Ã¤£±`¨£¡AªvÀø«ü«n¤]«Ü²³æ(¤ñAPAP¹L¶q¤¤¬r¦nÂåªv¦h¤F)¡C -------------------------------------------------------------------------------------------- 2022.3.4 ¬ü°ê¬rª«¤¤¤ß³ø§iªº¨àµ£¦Û±þ¨Æ¥ó pubmed.ncbi.nlm.nih.gov/35240919/ µ²ªG¡G ¤ÀªR¤F 514,350 ¦WºÃ¦ü¦Û±þªº¨àµ£¡A¨ä¤¤ 10 ¦Ü 12 ·³¨àµ£ªººÃ¦ü¦Û±þ²v¼W´T³Ì¤j¡]109.3%¡Ap = 0.002¡^¡C13 ¦Ü 15 ·³¡]30.3%¡Ap < 0.001¡^©M 16 ¦Ü 19 ·³¡]18.1%¡Ap< 0.05)¡C³Ì±`¥Îªºª«½è¬O¥¬¬¥ªâ©M¹ï¤A酰®ò°ò×ô¡A¨ä¤¤¹ï¤A酰®ò°ò×ôªº¼ÉÅS²v¼W´T³Ì¤j¡C°Q½×¡G¸Ó¼Æ¾Úªí©ú¦Û§Ú¤¤¬r¯f¨Ò¦³©Ò¼W¥[¡A³oªí©ú¨à¬ì¤ß²z°·±d¦M¾÷¥¿¦b´c¤Æ¨Ã©µ¦ù¨ì¦~»´¤H¸s¡C¨à¬ì¤H¸s§ó®e©öÀò±o«D³B¤èÃÄ¡A³o¥i¯à¸ÑÄÀ¤F¦b¨à¬ìºÃ¦ü¦Û±þ±wªÌ¤¤¨Ï¥Î³o¨ÇÃĪ«ªº¥i¯à©Ê¡C µ²½×¡GÀ³¦Ò¼{¦b³o¨Ç¦~»´¸sÅ餤±Ò°Ê¾A·íªº¤ß²z°·±d¿z¬d©M¤z¹w±¹¬I¡A¥H¨¾¤î¦Û§Ú¤¤¬r¯f¨Ò©M¬ÛÃöµo¯f²v©M¦º¤`²v¶i¤@¨B¤W¤É¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/24 ¤U¤È 03:37:19²Ä 2013 ½g¦^À³
|
·¸Ãº¬O¦Y¤U¤pªÑªF©ñ±ó»{Áʪº³¡¦ì¡C(ú´Ú´Á®É¨S¤°®t»ù) ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/9/25 ¤U¤È 02:24:54²Ä 1428 ½g¦^À³ ¼W¸ê16000±i¡A¤pªÑªF¤j¬ù»{ÁÊ1781±i(16000-14219)¡C¦h¦h¤j«á¨Ó¦³¸Éú¦¨¥\¶Ü? ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/7/6 ¤U¤È 02:25:48²Ä 1289 ½g¦^À³ ¯S©w¤H¿ãÅD¤£¿ãÅD? 7/26«á¨£¯u¾å! ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/7/3 ¤U¤È 12:02:11²Ä 1268 ½g¦^À³ 2021¦~«×¼W¸êpµe ¦U¦ìªÑªF¡B§ë¸ê¤H¡G¤j®a¦n¡I ...¥Ñ©ó¥»¤½¥q¬ãµo¹Î¶¤¦b·sÃĶ}µo¡BÁ{§É¸gÅçÂ×´I¤§Àu¶Õ¤U¡A³°Äò¦b±M§Q¡B§Þ³N¡B¬ãµo¦¨ªG¤Î°ê»Ú¦X§@«´¬ùµ¥¼h±§¡Àò±o·¥¬°Â׺Ӥ§¬ãµo¦¨ªG¡A¥Ø«e¦V¤½¥q¥D°Êªí¹F¦³·NÄ@ªø´Á§ë¸ê¤§¯S©w¤H¬Û·í¿ãÅD¡A±©ìªÑªF¾Ö¦³ªk©wÀu¥ý»{ªÑÅv¡A¨C¥aªÑ¥i»{ÁÊ273.803ªÑ....ÁٽЪѪF̼f·Vµû¦ô¡B´x´¤§ë¸ê¥ý¾÷¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/24 ¤U¤È 02:15:38²Ä 2012 ½g¦^À³
|
4eª½¦b¿³Âd¶R¡A³o¤£ª¾nöt¥h¨º ~~~~~~~~~~~~~~~ ¼W¸ê»{ªÑ¦hú¥|»õ¡A¨S·N¥~À³¸Ó¤]¬O´I¨¹¶°¹Î |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/23 ¤W¤È 09:37:02²Ä 2011 ½g¦^À³
|
APAPÁöµM¦W¥s¤îµh¾¯¡A¦ý¬O¬G·N¤j¶qªA¥Î¡A¨Åé¤Ï¦Ó¬O¼@µh§é¿i¥B¬Oªø´Á©Ê¡A¬O³Ì¤£©ú´¼ªº¿ï¾Ü! ¥xÆW2003~2012¡A3235¦WAPAP¤¤¬r--> ¦~§¡¬ùµo¥Í323¥ó¤¤¬r¡C(«C¤Ö¦~¤×¬Æ) -------------------------------------------------------------------------------------------- 2018 ©_¬üÂå°| sjtrem.biomedcentral.com/articles/10.1186/s13049-017-0468-8 ¥xÆW¤@¶µ°ò©ó¥þ°ê¤H¤fªº¶¤¦C¬ã¨s¡A¬°´Á10¦~ªº¸ò踪½Õ¬d¹ï¤A酰®ò°ò×ô¤¤¬rªºªø´Á¦º¤`²v ¤èªk:§Ú̳q¹L¦b 2003 ¦~¦Ü 2012 ¦~¶¡¦b¥þ°ê¤¤¬r¼Æ¾Ú®w©MÁa¦V°·±d«OÀI¼Æ¾Ú®w2000¤¤¡A½T©w¥xÆW 3235 ¦W APAP ¤¤¬rªº°Ñ»PªÌ... µ²ªG:241 ¦W APAP ¤¤¬r°Ñ»PªÌ¡]7.5%¡^©M 94 ¦W¹ï·Ó²Õ¡]1.0%¡^¦bÀH³X´Á¶¡¦º¤`...APAP¤¤¬r°Ñ»PªÌªº¥þ¦]¦º¤`·ÀI§ó°ª ¤×¨ä¬O¦b20·³¤Î¥H¤U... µ²½×:APAP ¤¤¬r»Pªø´Á¦º¤`²v¼W¥[¦³Ãö¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/21 ¤U¤È 07:34:44²Ä 2010 ½g¦^À³
|
¬Ý¨ì®³´¶®³¯kÁý¦Ñ¹«¦º¤`¹êÅç«á¡AÃļtº¡Áy¨§ªá¡I¡mªYÄ£¤@©w¤£¬O¬G·Nªº¡n´¶®³¯k¯«ÃĪ±¤£¤U¥h¤F¡I¨S¦³¤Æ¼Ä¬°¤Í¤£¦æ¡AÃø©Ç²Ä¤@ӽͦX§@¡C§Ú²{¦bn¤jÁn»¡¡G¡i³o±ÂÅv®×ÅK¦¨¤F¡I¡j¤j®aµ¥¦n®ø®§§a¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/21 ¤W¤È 10:32:50²Ä 2009 ½g¦^À³
|
¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r! ¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r! ¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r! §ó¥¿:¦Û±þ¶É¦Vªº±wªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q20g (500mg *40Áû)¡A ¤£¤p¤ß·N¥~ªA¥Î¹L¶qªÌ¬O12g(500mg*24Áû). ¦³¦Û±þ¶É¦Vªº±wªÌÄá¤Jªº¹ï¤A酰®ò°ò×ô´X¥G¬O·N¥~¹L¶q²Õ±wªÌªº¨â¿¡]¤¤¦ì¼Æ:20g VS. 12 §J¡FP = 0.009¡^ www.nejm.org/doi/full/10.1056/nejm199710163371602 ...The suicidal patients had ingested almost twice as much acetaminophen as those in the accidental-overdose group (median, 20 vs. 12 g; P = 0.009). ¦³5¦W±wªÌ¡]·N¥~¹L¶q²Õ 3 ¦W¡A¦Û±þ²Õ 2 ¦W¡^¦b 24 ¤p®É¤º©úÅãÄá¤J 4 §J©Î§ó¤Öªº¹ï¤A酰®ò°ò×ô¡AÆ[¹î¨ì©úÅ㪺¬r©Ê§@¥Î¡A¥i¯à»P¸T¹¡B¹L¶q¶¼°s¦³Ãö... ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/20 ¤U¤È 09:15:05²Ä 2008 ½g¦^À³ ¥H«áªA¥ÎAPAP¦Û±þÃø¤F! (SNP-810¦Y1²~200ÁûÁÙ¤£·|¤¤¬r) §Ú¬Ý¹L¤@½gªA¥Î´¶®³¯k¦Û±þªº¸ê®Æ¡A¦Û±þªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q¦n¹³¦b25g(50Áû)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/20 ¤U¤È 09:15:05²Ä 2008 ½g¦^À³
|
¥H«áªA¥ÎAPAP¦Û±þÃø¤F! (SNP-810¦Y1²~200ÁûÁÙ¤£·|¤¤¬r) §Ú¬Ý¹L¤@½gªA¥Î´¶®³¯k¦Û±þªº¸ê®Æ¡A¦Û±þªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q¦n¹³¦b25g(50Áû)¡C ¦¨¤H³æ¦¸Äá¤J¹ï¤A酰®ò°ò×ôªº³Ì¤p¬r©Ê¾¯¶q¬° 7.5 ¦Ü 10 g¡F¦¨¤H«æ©ÊÄá¤J >150 mg/kg ©Î 12 g ¹ï¤A酰®ò°ò×ô³Q»{¬°¬O¦³¬r¾¯¶q¡A¨Ã¨ã¦³«Ü°ªªº¨x·l¶Ë·ÀI¡C 1 ¦Ü 6 ·³ªº°·±d¨àµ£¤¤¡A³æ¦¸Äá¤J¹ï¤A酰®ò°ò×ôªº³Ì¤p¬r©Ê¾¯¶q¬° 150 mg/kg¡A«æ©ÊÄá¤J≥250 mg/kg ¹ï¤A酰®ò°ò×ô¤Þ°_ªº¨x¬r©Ê¨ã¦³ÅãµÛ·ÀI¡C -------------------------------------------------------------------------------------------------- 2019.6.12 health.ettoday.net/news/1465329 17·³¤k²r§]¡u110Áû´¶®³¯k¡v¸¡µh±¾«æ¶E¡@ÂåÅå¡G14Áû´N¤¤¬r¤F (14Áû*500mg=7g) |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/20 ¤U¤È 08:51:40²Ä 2007 ½g¦^À³
|
¦~³øªÑªF«ùªÑ ¤d±i¦³15¤H¡A¦@40052±i¡A¦û58%¡C 10¤jªÑªF¡A¦@33430±i¡C ¤d±i³o2Ó¤ë¦@´î½X1%¡A§âªÑ»ù©¹¤U¥´¡C ¶°«O¤½¥q«ùªÑ ¤d±iÁÙ¬O12¤H¡A«ùªÑ4¸U1¤d¦h±i¡C ¨ì©³¬O½Ö¿ù¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/20 ¤U¤È 08:44:53²Ä 2006 ½g¦^À³
|
¬Ý¨Ó[¦Y¤@²~=100g]¤]¤£·|¤¤¬r¬O¯u¦a! ¨Ì¨C¤é«Øij¶q4g*20¿=80g ¦~³ø74¶:¥»¤½¥q©Ò¶}µo¤§µL¨x¬r¤îµh·sÃÄ¡AªA¥Î¥i¹F¦w¥þ¾¯¶qªº [20¿] ¤´¤£·|¤¤¬r¡A¥¼¨Ó¬Æ¦Ü¦³¥i¯à¥i¥H§¹¥þ¨ú¥N²{¦³ªº¤AñQÓi×ô¤îµhÃÄ¡A¬G¥Ø«e¥«³õ¤Wªº¦U¤jÃļt¥i¯à¬O¥»¤½¥q¼ç¦b¦X§@¹Ù¦ñ§í©Î¬OÄvª§ªÌ¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:28:55²Ä 1958 ½g¦^À³ 08_·sÃĬãµo¦¨¥\®×¨Ò_·s¦¨¤À(ªø®Ä¤î¼@µh¤£¦¨Å}) J¤j¯«¦b19:00¬í°_»¡:..²{¦b§ÚÌ¥i¥H[¦Y¤@²~]®@ ³£¤£·|¦³¨x¬r©Ê³á ¨ì³oºØ¦a¨B¤F ·íµM ³oÁÙ»Ýn¤@¬q®É¶¡¤~·|¤W¥« |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/20 ¤U¤È 06:22:14²Ä 2005 ½g¦^À³
|
¨L¥°¶v¬O´I¨¹´xÂd¡A¼W¸ê»{ªÑ¦hú¥|»õ¡A¨S·N¥~À³¸Ó¤]¬O´I¨¹¶°¹Î |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/20 ¤U¤È 06:18:17²Ä 2004 ½g¦^À³
|
¼öÄËÄ˪ºªÑªF·|¦~³ø¥X¨Ó¤F¡A·s¤jªÑªF¥X²{ ¥H°¨¤º§Q§ë¸ê¦³¤½¥q¡A¥Nªí¤H:½²©Ó¾§ ôù¦è¹ê·~ªÑ¥÷¦³¤½¥q¥Nªí¤H:¨L¥°¶v |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/20 ¤W¤È 11:29:09²Ä 2003 ½g¦^À³
|
´²¤áªí¹F¼¥¼©¼ÖÆ[¥¼¨Ó½}¤F¡F¤@¤Á¤j¤H»¡¤Fºâ¡A«e´ºÁö¬ü¦n¤]¤£®e©ö¹ê¦ô»ù¦ì¡FY¬O¥~°ê¨ÖÁʬü¤¸pºâ¤]¤@©w·|Åý¤j®a¯º¼H¼H¡I¨ÖÁÊ·Qªk¬O¯¸¦b¥~°ê¤jÃļt¨¤«×¦³§Q¬Ý¡F¤½¥q¤jªÑªF¸³¨Æ¤@ÂI¤]¬Ý¤£¥X·Q³Q¨ÖÁʪº·Qªk¡CÁ`»¡¤@¥y¸Ü¡Aªø´Á«ù¦³ªÑ²¼¡A·|ÁÈ¿úªº¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/20 ¤W¤È 10:47:06²Ä 2002 ½g¦^À³
|
³Q¤¤¤Ñ¿ö¤F §C¦ô ¤ß¤¤ªºµh¤S³Q´£°_ ¤Ö¤F¦Ü¤Ö¤dw ¨S«H¥Îªº¸ôxx(´N¬O©U§£)¡A«ÂI¤£¬O·¸»ù ¬O¥ý¨Ö¤F ¦A´«¦X¤@ ©ú©ú´N¦b½Í±ÂÅv/³o¤£¬O¤º½u ¤°»ò¬O¤º½u ´N·|¥h§ä¯E¹©ªº³Â·Ð ¨S¿úªº¤pªÑªF ÁÙn³Q¶Êµ| ¨S¤°»ò¤£¦P·N¦X¨Ö¡A´N¬O¥~°ê¥Xªº°÷¤£°÷ »¡Ó¤§«e¸gÅç ¬ü¤è¥X20¬ü¦¬ ¥x¹ô600 §A½æ¤£½æ ¯º¤F §Ú·í¤Uºâ¨ì¤â»Ä ÁÙµ¥Ó3`5¦~ ¤]½ü¤£¨ì§A¦P¤£¦P·N ¤jªÑªFn±j«Á§A ¹J¨ì¤Õ©ú§A¥u¯àúú ¬ë¨ì20¬ü §A´N¯º¯º +++++++++++++++++ ³Q°ê¥~Ãļt¨ÖÁʧÞÂàok¡A³Q°ê¤ºÃÄ¥ø·¸»ùÓ2-30%¦¬Áʤ£¦æ!! ²ö§Ñ¬u²±!! |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/19 ¤U¤È 02:06:51²Ä 2001 ½g¦^À³
|
¹wp 2029 ¦~¥þ²y«D°sºë©Ê¯×ªÕ©Ê¨xª¢ (NASH) ÃĪ«¥«³õ³W¼Ò±N¹F¨ì 843.4 »õ¬ü¤¸¡A¦b 2022-2031 ¦~´Á¶¡¥H 39.13% ªº½Æ¦X¦~¼Wªø²v¼Wªø www.marketwatch.com/press-release/non-alcoholic-steatohepatitis-nash-drugs-market-size-2022-2031-to-reach-at-cagr-of-3913-2022-05-17?mod=search_headline |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/19 ¤U¤È 01:48:59²Ä 2000 ½g¦^À³
|
§Ú¯uªºn¾K¤F¡I¥H³Ì¥O¤H¹Ú·Qªº°¯×ªÕ¨x¤T¦Ê»õ¬ü¤¸¡A810¤@¦Ê»õ¬ü¤¸¡Ap¥|¦Ê»õ¬ü¤¸¡A¤@¦¨¤À¼íª÷40»õ¬ü¤¸¡A1200»õ¤¸¥x¹ô¡A¨CªÑÁÈ1700¤¸¡A¥»¯q¤ñ20´N¦n¡A¤W¬Ý34000¤¸¡C¥ú¸Õºâ´N¥O¤H§Ö¼Ö¡I¥´¤@§é3000¤¸ªÑ»ù´N¬OªÑ¤ý¤F¡C¦³¿úµ{¡I |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/5/19 ¤U¤È 01:23:40²Ä 1999 ½g¦^À³
|
³Q°ê¥~Ãļt¨ÖÁʧÞÂàok¡A³Q°ê¤ºÃÄ¥ø·¸»ùÓ2-30%¦¬Áʤ£¦æ!! ²ö§Ñ¬u²±!! |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/19 ¤U¤È 01:04:27²Ä 1998 ½g¦^À³
|
½²¤j àªÕ¨xªº¥«³õ¬O±Ð±Â¦ôªº ¥L¦³«½Æ»¡ª÷ÃB ¶W¹L3¦Ê»õ¬ü¤¸ ¦pªG¦³¤j¼tÄ@·N°ª»ù¨ÖÁÊ ¦óÀ|¤£¬O¬ü¨Æ¡I ¦pªG³£°µ¨ì3´Á®É¡A»ù½X·|§ó°ª¡C ¦ý¬O¡A¬Û¹ï®É¶¡¦¨¥»·|§ó°ª¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/19 ¤U¤È 12:37:44²Ä 1997 ½g¦^À³
|
¦Ñ¹«¹êÅç¸ê°T¹ï810§ó¥[±À±R¡I¦V«e¤j°¯×ªÕ¨xÃĤG¦Ê»õ¬ü¤¸±À¦ô¡A§ó¬OÅåÆv³s³s¡I±q¦U¦ì¤j¤jªñ¤é´£¨Ñ¸ê°T¡A·P¿E¡I¤ß¤¤·Pı«¥ªYÄ£±N¨Ó·|Åý§Ú̼ƿú¼Æ¨ì»Ä¡I°í©w¤Ï¹ï³Q¨ÖÁÊ¡I |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/19 ¤W¤È 10:18:40²Ä 1996 ½g¦^À³
|
§t¤A²mÓi×ô¤îµhÃĥثe¥«³õ³W¼Ò´N¶W¹L¦Ê»õ¬ü¤¸ ¥[¤WàªÕ¨xÃĪº¹w¦ô°ª¹F3¦Ê»õ¬ü¤¸ °ê»Ú¤jÃļt®³´X¤Q»õ¬ü¤¸¨ÖÁʪYÄ£ ¥u¯à»¡¬O®³¥X¹sÀY¦Ó¤w ¥H¤W¬OÓ¤H¬Ýªk ¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/19 ¤W¤È 09:42:41²Ä 1995 ½g¦^À³
|
Ó¤Hı±o ¹ï°ê»Ú¤jÃļt¨Ó»¡ ªYÄ£ªÑ¥»«D±`¤p ¤£¶Ë¨x¤ÎàªÕ¨xªºÃĪ«¶}µo ¤w¸g¦³¬Ý¨ì®ÄªG¤Î¦¨ÁZ ¥B¦¹2ºØÃÄ¥«³õ³£«D±`¤j ¥Ø«e¤]ÁÙ¨S¦³¥ô¦ó¤@ºØÃĪ«¤W¥« ¨ú±o±ÂÅv¬Û¹ïÀ³§Q¯q¤Ï¦Ó¤£§¹¾ã ª½±µ¨ÖÁʳ̦Eºâ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 09:36:59²Ä 1994 ½g¦^À³
|
Q:½Ð°ÝSNP-810²{¦b¬ãµoªº¶i«×¦p¦ó? A:SNP-810¬°µL¨x¬r©Ê¤îµh¡u·sÀø®Ä·sÃÄ¡v....¬ü°êFDA»{¬°¡A»ÝnGLP¹êÅç«Ç¨ÓÃÒ©ú¨ä°Êª«Àø®Ä(µL¨x¬r©Ê)... -------------------------------------------------------------------------------------------------- www.facebook.com/watch/?v=3194947797458964 ³o±i¤j¹«P¦º¾¯¶q¹ÏªíÀ³¸Ó´N¬O¥ÑGLP¹êÅç«Ç§¹¦¨ªº¸ÕÅç? P2000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú / (S2000(SNP-810)6°¦¤j¹«¦Ü14¤Ñ¥þ¬¡µÛ. ... P8000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1¤p®É¤º¥þ¦º /(S8000(SNP-810)1°¦¤j¹«¦b4¤p®É¦º¥h¡A5°¦¤j¹«¨ì14¤Ñ¬¡µÛ. J³Õ»¡¦A°µ¤@¦¸¹êÅç(S8000(SNP-810)6°¦¨ì14¤Ñ¥þ¬¡µÛ. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 08:34:05²Ä 1993 ½g¦^À³
|
§Ú»¡[°ê»Ú¤j¼t¨ÖÁʪYÄ£¬°¤W¡AÅý¤pªÑªF¤@¦¸¤J³U¡C] ¥i¬O¤j¤ûJ³Õ:±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/13 ¤U¤È 08:50:10²Ä 1784 ½g¦^À³ ---°ê»Ú¤j¼t¨ÖÁʪYÄ£¬°¤W¡AÅý¤pªÑªF¤@¦¸¤J³U¡C ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/10 ¤U¤È 01:35:06²Ä 1961 ½g¦^À³ ±q³o2¥yÃöÁä¦r:[«e10¦W°ê»Ú¤jÃļt]»P[§Ú¿Ë¦Û¨ì¤Fheadquarter¥h]¡AÀ³¸Ó¬O«üªYÄ£µL»~!!! 05_·sÃĶ}µo_¿ïÃD 13.10~14:30¬í: .....³o¬O¨Æ¹ê®@ [«e10¦W°ê»Ú¤jÃļt] ........§Úɨ䤤¤@®a [§Ú¿Ë¦Û¨ì¤Fheadquarter¥h] ½Í¨ì³Ì«á ¥L»¡±z̯ण¯à ³o®a.§Ú´N¶R±z̪ºªÑ²¼°Ú.§ë¸ê±z̪ºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z....½Í¨ì³o¼Ë£²... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 08:24:44²Ä 1992 ½g¦^À³
|
SNP-610ªº2Ó¤G´ÁÁ{§É: 1.Àø®Ä±´¯Á¸ÕÅç(¤w§¹¦¨) SNP-610 [¶}©ñ¦¡]Á{§É¤G´Á¬ã¨s¤wÀò±oÅãµÛ¤HÅéÀø®ÄÃÒ¾Ú¡C¾Ú109¦~7¤ë´Á¤¤¤ÀªRµ²ªG¡A35¦ì NASH¯f¤H¡A¥]§t17¦ì°ª¾¯¶q ²Õ©M18¦ì¤¤¾¯¶q²Õ¡A¸g12¶gªvÀø«á¡A¥DnÀø®Ä«ü¼Ð¨xŦ¾¢Ói»Ä¤þ଻ÄÂà®ò°ò»Ã¯À(ALT)¦b°ª¾¯¶q²ÕÅãµÛ°§C¹F -29.5¡Ó33.0 U/L, p=0.002¡A¤¤¾¯¶q²ÕÅãµÛ°§C¹F -18.9¡Ó27.3 U/L, p=0.009¡C 2.¬dÅçµn°O¥ÎÁ{§É¸ÕÅç 2022.3.9¤½¥q¦³§ó·sFDAÁ{§É¶iµ{:2022.12.1 ~2023.12.30:SNP-610ªvÀø«D°sºë©Ê¯×ªÕ©Ê¨xª¢±wªÌÀø®Ä©M¦w¥þ©ÊªºÀH ¾÷¡B[Âùª¼]¡B¦w¼¢¾¯¹ï·Ó¬ã¨s(80¤H) clinicaltrials.gov/ct2/show/NCT03468556?term=SNP-610&draw=2&rank=1 ¥Dnµ²ªG´ú¶q¡G ¤þ®ò»Ä®ò°òÂಾ酶 [®É¶¡®Ø¬[¡G12 ¶g]: ¦å²M¤þ®ò»Ä®ò°òÂಾ酶 (ALT/GPT) ¬Û¹ï©ó°ò½uªºµ´¹ïÅÜ¤Æ ¦¸nµ²ªG´ú¶q¡G MRI ¨xŦ FF [®É¶¡½d³ò¡G12 ¶g] ¨xŦ¯×ªÕ§t¶q¬Û¹ï©ó°ò½uªºµ´¹ïÅÜ¤Æ MRI ¨xŦ FF [®É¶¡½d³ò¡G12 ¶g]¨xŦ¯×ªÕ§t¶q¬Û¹ï©ó°ò½uªºÅÜ¤Æ ... ... |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/18 ¤U¤È 07:28:24²Ä 1991 ½g¦^À³
|
µL©Ò¿×¡A¤Ï¥¿¬n°ê¤H¦³¿ú¡A¬Ý¥X¦h¤Ö¡A12eÁâ¤]¦n¡C¥_·¥³£n¤W¤F¡C ²ö«D¬O¤£¤WÂd¤F¡A³Qªü°Â°Ú¾ã¸JºÝ¨«...? ¤p§ÌJ¨¥¶Ã»y¦U¦ì¤j¤j»~»{¯u 1.2021.11.10 ½÷·ç¯{ 12.4»õ¬ü¤¸¶R°¾ÀYµhÃĪ«Rimegepant(°ß¤@¤ä¤fªACGRP药ª«) www.taiwanlab.com.tw/news/show.asp?id=24440 |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/5/18 ¤U¤È 02:06:44²Ä 1990 ½g¦^À³
|
¤£ª¾¹D¬°¦ó¨ú±o®Öã¨ç«á¿ð¿ð¨S¦³¶i®i¡A¤½¥q¨ì©³¦bµ¥¤°»ò... ²ö«D¬O¤£¤WÂd¤F¡A³Qªü°Â°Ú¾ã¸JºÝ¨«...? ¤p§ÌJ¨¥¶Ã»y¦U¦ì¤j¤j»~»{¯u |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/17 ¤U¤È 12:02:02²Ä 1989 ½g¦^À³
|
·Ç!!!!!!!! ªYÄ£´N¹³¡u³Âò¡v£¸¼Ë³n¡I ½L¤F¥b¦~¡A¤S§Ö¶^¨ì¥h¦~9¤ëªº²{¼W»ù75¤¸¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/16 ¤U¤È 02:05:08²Ä 1988 ½g¦^À³
|
§Ú³s0.1»õ³£¨S¦³¡A¤£´±²q4eªº·Qªk |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/16 ¤U¤È 12:22:31²Ä 1987 ½g¦^À³
|
¬OnÅý²{¼W75¤¸¨S¦³¶R¨ì©Ò°h¦^ªº4»õ¤¸ ³£¦³¾÷·|¤W¨®¶Ü¡H |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/16 ¤W¤È 11:59:28²Ä 1986 ½g¦^À³
|
Âà¤J¤j¾ð ¥s¦n¤£¥s®y ·|ª£¤~¬O¤ý¹D ¤£n©M¶¶n¤@¼ËªºªÑ»ù´Ngg |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/16 ¤W¤È 11:51:54²Ä 1985 ½g¦^À³
|
ªYÄ£´N¹³¡u³Âò¡v£¸¼Ë³n¡I ½L¤F¥b¦~¡A¤S§Ö¶^¨ì¥h¦~9¤ëªº²{¼W»ù75¤¸¡C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/16 ¤W¤È 06:40:15²Ä 1984 ½g¦^À³
|
½Ð°Ý¤j®a¦³ª`·N¨ì¤½¥q¥h¦~©³¦³¥Ó½Ð2ӰӼСA¤À§O¬OCEPLENITOL©MCORDYCEPLEN |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/14 ¤U¤È 01:38:49²Ä 1983 ½g¦^À³
|
TGA±N¹ï¯«ÃÄ´¶®³¯k¥X«¤â?! 2022.5.12 ¿D¤j§Q¨ÈªºÃÄ«~ºÊºÞ¾÷ºc(TGA)¥¿¦b¦Ò¼{¨î¨Ï¥Î¥@¬É¤W³Ì±`¥Îªº¤îµhÃÄ¡C ...³ø§i±N¦b 7 ¤ë«e§¹¦¨³ø§i ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/27 ¤U¤È 10:04:52²Ä 1252 ½g¦^À³ ±N¨C¤é¾¯¶q¥Ñ4g°¦¨3§J¡A¹ïÃļtªº¾P°â¶q¼vÅT´N¬O¥´¤F75§é! ¥t¥~¡A¿D¬w/¯Ã¦èÄõªººÊºÞ¾÷ºc¦³·N¹ï¥]¸Ë®e¶q¨î¡A¹ïÃļtªº¾P°â¶q¼vÅT¤]¬Û·í¤j¡C©Ò¥HSNP-810ªº[¥i¼W¥[¾¯¶q]¡A¤]ªí¥ÜÃļtªº¾P°â¶q¥i¥HÅܤj! --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:13:39²Ä 1215 ½g¦^À³ ...¤µ¦~5¤ëTylenol¦b¿D¬w¤W¬[¶}½æ¡A³Ì«Ü¤j¦]¯À´N¬OGSKªº´¶®³¯k¨ÑÀ³µu¯Ê |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/13 ¤U¤È 01:19:41²Ä 1982 ½g¦^À³
|
ªñ´ÁªYÄ£®ø®§±§ó²M·¡¤]¥¿¦V¡F¦³¤@¦ì¥Í§Þ»â°ì³Õ¤h»¡ªYÄ£¦³¨âÓ¥¥x¡A³o¥¥x¬O¬ã¨s³õ°ì¡A»ùÈ«Ü°ª¡IªÑ²¼©ñÓ¤¦~¡A¨â¤j¨t²ÎÃĦ¨ªG®i²{¡B±ÂÅv¡AµP±±È§¹«á¡A¨º®ÉªÑ»ù¤~¬O¯u¥¿¤ÏÀ³ªYÄ£»ùÈ¡Cµu®É¶¡ªÑ»ù¤£¦p¹w´Á¡A¤j®a¤£¥²®ð¾k¡A±N¨Ó·|¶¥±è¦¡¤@¶¥¤ñ¤@¶¥°ª¡C |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/5/12 ¤U¤È 05:58:06²Ä 1981 ½g¦^À³
|
¼v¤ù¤º®e¦³´£¨ì TB ªºªvÀø§xÃøÂI¤Î¥Ø«eÁ{§É¤W¤£¶Ë¨xªºªvÀø¤è¦¡¡C³oӮפl¥xÆW¦¬®× 556 ¤H¡A¦]¬°¦¬®×³t«×¤£§Ö¡AÁ{§É®É¶¡¤~·|³o»ò¤[¡A¦ý·ÓJ±Ð±Âªº»¡©ú¡A±q¥Ø«eªº¼Æ¾Ú¤w¯à©úÅã¬Ý¥X¸¨®t¡A¬Û«H¦¨¥\ªº¾÷²v·¥°ª¡C ¾ãÓºtÁ¿ªº¼v¤ù¡AÁöµM¨S¦³´£¨ì¤½¥q¦WºÙ¡A¦ý§ÚÓ¤Hı±o´X¥G´N¬O¦bÀ°ªYÄ£¦æ¾P°Ú! J±Ð±Â¦b°ê»Ú¤W¨É¦³¦WÁn¡A°µ·sÃĪºÅÞ¿è²M´·¡A¤S«á±¤j¤O«ü¾É¡BÀ°¦£ªYÄ£¡A¬Û«HªYÄ£¤é«á¤j¦³¥i¬°¡C ¼v¤ù¤¤´£¤Î¡A610/630 «D°sºë¯×ªÕ©Ê¨xª¢¤Î°sºë¯×ªÕ©Ê¨xª¢³£¬O¾A¥Îªº¡A³o¬O¤@¤j«GÂI¥B GSP Y¯à¸ò FDA °Q½×¥X¦bÁ{§ÉÀ³¥Îªº¼Ò¦¡¡A¦¬®×ªº³t«×À³¸Ó·|§Ö¤W¬Æ¦h¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤U¤È 12:39:00²Ä 1980 ½g¦^À³
|
辉·ç»¨掷116亿¬ü¤¸¡A¤@©w¤£¬O¦]为¥h¦~赚¤Ó¦h¡A¦Ó¬O¦]为BiohavenÚ̦³独¨ì¤§处¡A°£¤F产«~ºÞ线¥~¡A¬Û«H¨ä独¯Sªº°¾头µh药ª«¬ã发¥¥x¤]¬OɲȩҦb¡C ¦b¥Ø«e资¥»¥«场热«×¤U°ªº±¡úG¤U¡A拥¦³®tÉݤƪº¤½¥q¤~¯à§ó¦nªº¦s¬¡¤U来¡A¥¥x§Þ术«¬¥ø业会¦b¨ä¤¤¦³þӫܦhªºÉ¬势¡C 从¤Ñºt&赛诺µá¡A©M铂&ªü´µ§Q±d¡A¦Ê奥赛图&Àq§J¡A¨ì现¦bªºBiohaven&辉·ç¡A¥i¥H¬Ý¨ì¡A§Þ术¥¥xªºÉ²È¥¿¦bºCºC¥Y显¡C 这对¤_¤@¨ÇP¤O¤_开发§Þ术¥¥xªº¥ø业¡A©Î许¬O§ó¤jªº¿E励¡C -------------------------------------------------------------------------------------------------- ªYÄ£ªº¥Dn§Þ³N¥¥x¬O¨Ï¥Î¦w¥þªº½Æ¦Xª«¨Ó½Õ±±¨xŦ»Ã¯À¤Î°ò¦]¡A¦¹ºØ§Þ³N¥iÀ³¥Î©ó¥i¯à¾ÉP¨x¬r©Ê¤§ÃĪ«¥H¤Î¨xŦ¯e¯f(¦p¯×ªÕ¨x)¤§ªvÀø¡C µL¨x¬r§Þ³N¥¥x¦ó®Éµo¥úµo¼ö°Ú? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤U¤È 12:34:05²Ä 1979 ½g¦^À³
|
½÷·ç±q·s«aÃĪ«Áȱo¬Öº¡²Úº¡¡A°®¯Üª½±µ¦Y±¼! 2022.5.11 ½÷·ç¥H116»õ¬ü¤¸²{ª÷¦¬ÁÊ°¾ÀYµhÃÄ°ÓBiohaven(°¾ÀYµhÃĪ« Rimegepant) news.cnyes.com/news/id/4870079 ªvÀø«æ©Ê°¾ÀYµh¤@½uÃĪ«¤AñQ®ò×ô¡]acetaminophen¡^. ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/28 ¤U¤È 10:14:42²Ä 1756 ½g¦^À³ SNP-810±ÂÅv«á¦A°µ´XÓ°¾ÀYµhÁ{§É¹êÅç¡A°£¤F»´¯g¡A©Î³\¤¤«¯g¤]¯à¦¨¬°¤@½uÃĪ«! 1.2021.11.10 ½÷·ç¯{ 12.4»õ¬ü¤¸¶R°¾ÀYµhÃĪ«Rimegepant(°ß¤@¤ä¤fªACGRP药ª«) www.taiwanlab.com.tw/news/show.asp?id=24440 |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/12 ¤W¤È 10:44:35²Ä 1978 ½g¦^À³
|
±Ð±Â©Ò»¡ªº¡u¶Ë¨x¡v¦¨¥÷¬O¤°»ò ¨Ã§ä¨ì¥i¥H¥NÁ¦¨¡u¤£¶Ë¨x¡vªº²Õ¦X ¸g°Êª«¡B¤HÅé¸ÕÅç«á¡AÃÒ©ú¥\®Ä ¦p¦ó¨ú±o¬ü°êOTC¤Î¥xÆWÃÄÃÒ ³s³e¤U¨Ó¡A«üªº´N¬O810¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 10:13:54²Ä 1977 ½g¦^À³
|
2022.5.11 FDA¦P·N¤£»ÝnÃB¥~ªº¥\®Ä¬ã¨s©Î¦w¥þ¼Æ¾Ú¨Ó¤ä«ù EUA ªº½Ð¨D-Verup¹º¦b 2022 ¦~²Ä¤G©u«×´£¥æ EUA ½Ð¨D finance.yahoo.com/news/fda-states-veru-submit-request-103000648.html ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/11 ¤W¤È 06:25:36²Ä 1967 ½g¦^À³ ¥Ó½ÐFDA pre-EUA meeting¡AFDA¦P·N»P§_±oªá¦h¤[? ¥un6Ó¤u§@¤Ñ!!! Veru contacted on MAY 2 about FDA willing to meet on EUA and granted meeting MAY 10, TODAY, only 6 (SIX) BUSINESS DAYS AFTER! ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³ °ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 09:28:12²Ä 1976 ½g¦^À³
|
¶ø¥ì´µ¯S¤j¬O·~¤º¤H¤h? ¦³ªÅ½Ð¤W¨Ó¦h²á²á¡A§Ú¯à»´ÃP¦h¤F¡C HUEXC030 = HUYPS-2(mannitol¥ÌÅS¾J)´NSNP-810ªº½á§Î¾¯¦¨¤À¤§¤@ -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/28 ¤W¤È 10:56:48²Ä 617 ½g¦^À³ ±q(§Üµ²®ÖÃĪ«+HUEXC030 )-¸Ñ¨M§Üµ²®ÖÃĪ«¨x¬r©Ê »P (APAP+SNP-820)=SNP-810-¸Ñ¨M§ÜAPAP¨x¬r©Ê¡A ¦P²z½×·íµM¯àl¥Í¸Ñ¨M¨ä¥LÃĪ«ªº¨x¬r©Ê! ALF«æ©Ê¨x¥\¯à°IºÜ: 1¤äAPAPÃĪ«(46%) VS 1,036¤äÃĪ«(11%)---³Ì¤j°¦ªº·íµM¬OÀu¥ý¸Ñ¨M¡A©Ò¿×¡u®¾¤}·í®¾±j¡A¥Î½b·í¥Îªø¡C®g¤H¥ý®g°¨¡A¾à¸é¥ý¾à¤ý¡C¡v ------------------------------------------------------------------------------------------ ³o¬OªYÄ£¥ÛªF¤¸¸g²zªº³Õ¤h½×¤å (¹Á¸Õ¸Ñ¨M§Üµ²®ÖÃĪ«ªº¨x¬r©Ê) ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi?o=dnclcdr&s=id=%22101NDMC0105024%22.&searchmode=basic ...§Q¥Î¤H¨x»P¹«¨x·L²ÉÅé¿z¿ïCYP2E1§í¨î¾¯¡A¬D¿ï§í¨î²v¥i¹F60-88%ªºHUEXC030 (mannitol¥ÌÅS¾J)¶i¦æ¤p¹«ÃÄ®ÄÃİʸÕÅç.... §Üµ²®ÖÃĪ«³y¦¨¨x¬r©Ê¤§°Êª«¼Ò¦¡¡A¨Ã¦¨¥\¦Û111ºØ±`¥Î¤¤¿z¿ï¤F¦hºØCYP2E1¤Îamidase§í¨î¾¯¡A¥Ñ²ÓM¡B°Êª«©MÁ{§É ------------------------------------------------------------------------------------------------ -·|û¡GROGER588910148151 µoªí®É¶¡:2021/7/18 ¤W¤È 09:59:28²Ä 1331 ½g¦^À³ SNP-810n¥þ±¨ú¥N¥«³õ¤W«Ü«K©y¦ý¦³¨x¬r©ÊªºAPAP¡A¤W¥««á°â»ù¤]¬OÃöÁä¡C ¥ÌÅS¾J©M¤T´â½©¿}§¹¥þ²Å¦X:[¬ü°êFDA®Öã]¡B[±`¥Î¥B¦w¥þ]¡B[«K©yt¾á±o°_]¡B[¤HÅé¥i¹¥Î¦w¥þ¤Æ¦Xª«] ¥xÆWSafeTynadol ¦w®õ®³¯kªº¥é³æ¤¤½á§Î¾¯¦¨¤À file:///C:/Users/USER/Downloads/1.6.1+%E4%BB%BF%E5%96%AE-110-07-16.pdf ...HUYPS-2(Mannitol)¡BHUYPS-4(Sucralose)... |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/5/12 ¤W¤È 09:04:29²Ä 1975 ½g¦^À³
|
¼v¤ù¤¤J±Ð±Â´£¨ìªºÁ{§É¤T´Áªñ§ÀÁn¡A¬O«üªÍµ²®Ö TB ¥ÎÃÄ¡A³o¬O¤ÍÀM¥Í§Þ¦b°µªºÁ{§É¡A¤£¬OªYÄ£¡C¦ý¨ä¤¤ªº HUEXC030 ¦¨¥÷¡A¥i¯à¸ò 810 / 610 / 630 ¦³¤@ÂIÃö«Y¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 09:03:09²Ä 1974 ½g¦^À³
|
¨S²Ó¨s¤¤°êÁ{§É¸ÕÅç(ª`®gªø®Ä¯Ç¯k¸Ñ)¡A¤£¦n»¡¡C¦ý±qÀÙ¥Á¥i«H±N³z¹L«·s³]pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C ±ÀÂ_¬O°_©lªºÁ{§É¸ÕÅç³]p¤£¬¢·í¡A¤wºØ¤U«¤j°ÝÃD¡A¸ÕÅçª`©wµLªk¦³®Ä¡C §Ú¯d·NÃö¤ßªº¬O©³¤U:SNP-810+ (¤fªAªø®Ä¯Ç¯k¸Ñ)ªº½Æ¤è¤îµhÃĸÕÅç¡C ------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/13 ¤U¤È 09:35:49²Ä 784 ½g¦^À³ ²Ä 3 ²ÕAAP 1000 mg+¯Ç¯k¸Ñ 20 mg??? [«·s§Q¥Î]SNP-810 1000mg+¯Ç¯k¸Ñ20mgªº(½Æ¤è)¤îµhÃÄ¡An¥´¯}2014¦~FDA¤½§i°Ç¥O°±¤î»s³yAcetaminophen§t¶q¶W¹L325 mgªº [½Æ¤è] ¤îµhÃĸT¥O??? -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/25 ¤U¤È 10:28:31²Ä 574 ½g¦^À³ »O¥_ºa¥ÁÁ`Âå°|¤HÅé¸ÕÅç©eû·|(¤@)²Ä 131 ¦¸·|ij¬ö¿ý ¤½§iª© ¶}·|®É¶¡¡G109 ¦~ 11 ¤ë 2 ¤é¤U¤È 2 ®É¥¿ pµe¥D«ù¤H¡G³¯¥¿Â× pµe¦WºÙ¡G·s±j®Ä¤£¦¨Å}¤îµh²Õ¦XÃÄ Sebacoyl Dinalbuphine Ester ¤Î [µL¨x¬r¤AñQÓi×ô]¥Î©óÂù °¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/12 ¤W¤È 08:39:28²Ä 1973 ½g¦^À³
|
R¤j ²³øªº2¤p®É26¤À-31¤À ³£¦b½Í¡u¶Ë¨x¡v¡A¨Ã¤£¬O¤îµh¡C ³o¬q®É¶¡ªº¤º®e±z¥i¥H¦AÅ¥¤@¦¸¡A§Ú¤]¤£ª¾¹D±Ð±Â«ü¨ººØÃÄ¡H ¦pªG¬O3´Á¡H¬O§_¬O¼Ï¶s¡H |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/12 ¤W¤È 08:13:12²Ä 1972 ½g¦^À³
|
¥xÆW®õ°ê·s¥[¬Á³£¤W¥«¡A´N¤¤°ê¨S¹L¡A¬Oµû¦ô«ü¼Ð³]p¤£¦P¶Ü?? ===================== 1.08 ==>20¤À ¬Ý¬ÝPÈ---³o¬O¶¶ÃĪø®Ä¤îµh°w¾¯LT1001(¯Ç¯k¸Ñ)¼Æ¾Ú==>À³¸Ó¨S¿ù =====================b.¸ÕÅçpµe¨ü¸ÕªÌ¤H¼Æ¡G120¤H¡]¹ê»Ú¦¬®×¤H¼Æ: 124¤H¡^ c.¥Dnµû¦ô«ü¼Ð¡G¸ÕÅçµ²ªGÅã¥Ü³N«á48¤p®É¤º¶Ü°Ø·í¶q¦b±µ¨üLT1001ªø®Äª`®g²G²Õ¬°21.76¡A¦b±µ¨ü¦w¼¢¾¯ªº¹ï·Ó²Õ¬°18.36¡A¥¼¹F¨ì²Îp¤WÅãµÛ®t²§(p=0.86)¡C d.¦¸nÀø®Ä«ü¼Ð¡G 1.³N«á48¤p®É¤º¯kµhµ{«×µøı¼ÒÀÀµû¤À¦±½u¤U±¿n¡A¦b±µ¨üLT1001ªø®Äª`®g²G²Õ¬°1164.56¡A¦w¼¢¾¯¹ï·Ó²Õ¬°1124.25¡A¥¼¹F¨ì²Îp¤WÅãµÛ®t²§(p=0.76)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 06:55:16²Ä 1971 ½g¦^À³
|
1.08 ==>20¤À ¬Ý¬ÝPÈ---³o¬O¶¶ÃĪø®Ä¤îµh°w¾¯LT1001(¯Ç¯k¸Ñ)¼Æ¾Ú 2.¤j®aÀ³¸Ó¦³¬Ý¨ìJ±Ð±Â´£¤w§Ö±µªñ3´Á¸Ñª¼(§Ú¨SÅ¥¨ì³o¬q¸Ü!)--- ªYÄ£ÁÙ¨S¶i¤J¤T´ÁÁ{§É¡A¦p¦ó±µªñ3´Á¸Ñª¼? ±q®É§Ç¤W§Ú²qJ´£ªº¬OLT1001: 2022.2.25¶¶ÃÄLT1001ªø®Ä¤îµh°w¾¯©ó¤¤°ê¤T´ÁÁ{§É¸Ñª¼¤ÀªRµ²ªG¡G¥Dnµû¦ô«ü¼Ð¥¼¹F²Îp¤WÅãµÛ®t²§ www.moneydj.com/kmdj/news/newsviewer.aspx?a=5753e28c-53cf-4517-b95d-ca74d807e4dc ...LT1001©ó¤¤°ê¦a°Ï¤§¶}µo¤Î°Ó·~¤ÆÅv§Q±ÂÅv¤©¦¿¦èÀÙ¥Á¥i«H¡A¥Ñ¨ät³d¦b¤¤°ê¤W¥««e¥²n¤§Á{§É¸ÕÅç.. ÀÙ¥Á¥i«H±N¤ÀªR¥¼¹F¼Ðì¦]¡A¥Ø¼Ð³z¹L«·s³]pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C [ÀÙ¥Á¥i«H±N¤ÀªR¥¼¹F¼Ðì¦]¡A¥Ø¼Ð³z¹L«·s³]pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C] |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/11 ¤U¤È 07:03:47²Ä 1970 ½g¦^À³
|
Ó¤H¥HªÑªF·|ij¨Æ¿ýµ¥¤å¥ó±À¦ô קï«Ü¦h³W©w¡A¥i¯àn²Å¦X¡u¤º±±¡vªºªk¥O³W©w¡C ¤j®aÀ³¸Ó¦³¬Ý¨ìJ±Ð±Â´£¤w§Ö±µªñ3´Á¸Ñª¼¡H ®É¶¡¤w¦A¹L¥b¦~¤F¡AÁÙ¬O¨S¦³®ø®§¡H |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/11 ¤U¤È 06:54:41²Ä 1969 ½g¦^À³
|
To ¤p¨k¤H¤j 3/15¤½§i¥»¤½¥q¨ú±o¸gÀÙ³¡¤u·~§½¥X¨ã¤§¡u«YÄݬì§Þ¨Æ·~¥B¨ã¥« ³õ©Ê¡v¤§·N¨£®Ñ¡C 6.¦]À³±¹¬I:¥»¤½¥q±N¨Ì³W¹º®Éµ{´£¥XªÑ²¼¤WÂd¤§¥Ó½Ð§@·~¡C ²ö«D¤SÅܧópµe¡A§ï¬°¥Ó½Ð¤W¥«¡A©Ò¥HÁÙ¨S´£¥X¤º±±¼f¬d? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/11 ¤U¤È 04:06:57²Ä 1968 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:41:53²Ä 1959 ½g¦^À³ 10_·sÃĬãµo¦¨¥\®×¨Ò_GSP¨x¥\¯à©w¶qªk 1:18 avalon hepaPOC ¤z¯à¿}---GSP¦X§@¼t??? --------------------------------------------------------------------------------------------- 2018.6.29 ATHENEX THERAPEUTICS LIMITED»PAVALON HEPAPOC LIMITED ñ±ÂÅv¬ù ¹w¥I¶O¥Î¡Cñ¸p¥»¨óij«á¡AAthenex À³¥ß§Y¦V Avalon ¤ä¥I 500,000 ¬ü¤¸¡C 5.2¨½µ{¸O¥I´Ú¡C (a) Athenex ±N¦bµo¥Í¥H¤U¨Æ¥ó®É¡]¦pªG¦³¡^¦V Avalon ¤ä¥I¥H¤Uª÷ÃB¡G (i) ¦b Avalon ¦¬¨ì¦b¥xÆW¾P°â°Ó«~¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§åã«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F (ii) ¦b Avalon ¦¬¨ì¦b¬ü°ê¾P°â³fª«¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§åã«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F (iii) ¦b Avalon ¦¬¨ì¦b¼Ú·ù¾P°â³fª«¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§åã«á¤T¤Q (30) ¤Ñ¤º¬ü¤¸***¡F (iv) ¦b Avalon ¦¬¨ì¦b¤¤µØ¤H¥Á¦@©M°ê¡]¬°²M·¡°_¨£¤£¥]¬A»´ä¡B¥xÆW©M¿Dªù¡^¥Î©ó¦b³õ¦a; (v) ¦b Athenex ¦b¬ü°êº¦¸°Ó·~¾P°â³\¥iªA°È«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F©M (vi) ¦b Athenex ¦b¼Ú·ùº¦¸°Ó·~¾P°â³\¥iªA°È«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F©M ©Ò¥H¬O¥ÑATHENEX THERAPEUTICSt³d¥þ²y¦æ¾P! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/11 ¤W¤È 06:25:36²Ä 1967 ½g¦^À³
|
¥Ó½ÐFDA pre-EUA meeting¡AFDA¦P·N»P§_±oªá¦h¤[? ¥un6Ó¤u§@¤Ñ!!! Veru contacted on MAY 2 about FDA willing to meet on EUA and granted meeting MAY 10, TODAY, only 6 (SIX) BUSINESS DAYS AFTER! ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³ °ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting. ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤W¤È 07:44:08²Ä 1896 ½g¦^À³ ..±q¸Ñª¼¼Æ¾Ú¥ÎÃIJջP¹ï·Ó²Õ¨S¦³®t²§¡A§Ú±ÀÂ_°ê¹©¨S¦³Pre-eua meeting! |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/10 ¤U¤È 08:55:13²Ä 1966 ½g¦^À³
|
ªYÄ£¹ê¦¬¸ê¥»ÃB¬O6e9,Ãø¹D¬O«áªÌ¡H ------------------------- ¡´À³¥Ó³ø^¤åª© ¡¹¡uªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R ¸ê®Æ¡v ¡¹¡uªÑªF·|¦~³ø¡v ¡¹¡u¦~«×°]°È³ø§i¡v ¡´¡u110¦~©³¹ê¦¬¸ê¥»ÃB¹F20»õ¤¸¥H¤W¡v ©Î ¡u110¦~¥l¶}ªÑªF±`·|®ÉªÑªF¦Wï¥~(³°)¸ê«ùªÑ¤ñ²v¦Xp¹F 30%¥H¤W¡v |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/10 ¤U¤È 08:45:11²Ä 1965 ½g¦^À³
|
¦Û©ú¡]108¡^¦~«×°_¡A²Å¦X¤@©w±ø¥ó¤§¤W¥«¤½¥qÀ³¥Ó³ø^¤åª©ªÑªF·|ij¨Æ¤â¥U¡B¦~³ø¤Î¦~«×°]°È³ø§i µo¥¬®É¶¡¡G¥Á°ê107¦~08¤ë29¤é (ÃÒ¥æ©Ò·s»D½Z) ¬°°t¦X¥DºÞ¾÷Ãö·sª©¤½¥qªv²zÂŹϬFµ¦¡AÃÒ¥æ©Ò¤w·s¼W³W©w¡A¦Û©ú¡]108¡^¦~«×°_²Å¦X¤@©w±ø¥ó¤§¤W¥«¤½¥qÀ³¥Ó³ø^¤åª©ªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡BªÑªF·|¦~³ø¤Î¦~«×°]°È³ø§i¡C ÃÒ¥æ©Òªí¥Ü¡A¬°´£ª@¸ê°T´¦ÅS«~½è¤Î³Ð³y°ê»Ú¤Æ¤§§ë¸êÀô¹Ò¡A¤Z¹ê¦¬¸ê¥»ÃB¹F·s¥x¹ô¤@¦Ê»õ¤¸©Î¥~¸ê«ùªÑ¤ñ²v¹F¦Ê¤À¤§¤T¤Q¥H¤W¤§¤W¥«¤½¥q¡A§¡À³©ó¦¸¤@·|p¦~«×¤º¥Ó³ø^¤åª©ªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡BªÑªF·|¦~³ø¤Î¦~«×°]°È³ø§i¡C¥H¾ä¦~¨î¤§¤W¥«¤½¥q¬°¨Ò¡A107¦~12¤ë31¤é¤§¹ê¦¬¸ê¥»ÃB¹F·s¥x¹ô¤@¦Ê»õ¤¸©Î107¦~¥l¶}ªÑªF±`·|¤§ªÑªF¦Wï°O¸ü¤§¥~¸ê«ùªÑ¤ñ²v¹F¦Ê¤À¤§¤T¤Q¥H¤WªÌ¡AÀ³©ó108¦~¥l¶}ªÑªF±`·|«e¡A¥Ó³ø«ez¸ê°T¤§^¤åª©¹q¤lÀÉ¡FYªÑªFÁ{®É·|©ó108¦~«×´Á¶¡¥l¶}ªÌ¡A¥çÀ³¤ñ·Ó¿ì²z¡C ÃÒ¥æ©Ò¥tªí¥Ü¡A¸g²ÎpºI¦Ü107¦~6¤ë¤î¡A¥~¸ê«ù¦³§Ú°ê¤W¥«¤½¥q¤§ªÑ¥÷¥«È¤wªñ¥|¦¨¡A±©¤W¥«¤½¥q´¦ÅS^¤å°]°È·~°È¸ê°T¤´¥¼´¶¹M¡]106¦~«×¥Ó³ø^¤åª©Ä³¨Æ¤â¥Up¦³267®a¡B^¤åª©ªÑªF·|¦~³øp¦³193®a¡^¡AÃÒ¥æ©Ò·~¤w×¥¿¡u¹ï¦³»ùÃÒ¨é¤W¥«¤½¥q¤Î¹Ò¥~«ü¼ÆªÑ²¼«¬°òª÷¤W¥«¤§¹Ò¥~°òª÷¾÷ºc¸ê°T¥Ó³ø§@·~¿ìªk¡v¬ÛÃö³W©w¡A½Ð²Å¦X±ø¥ó¤§¤W¥«¤½¥q¤Î¦¦]À³¡A¥H´£ª@¸ê°T´¦ÅS«~½è¤Î±j¤Æ§ë¸ê¤HÃö«Y¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/10 ¤U¤È 08:28:05²Ä 1964 ½g¦^À³
|
©_©Ç¤F §Ú³£¨S¦¬¨ì³qª¾ ^¤å¬Oµ¹n±ÂÅvªº¦Ñ¥~¬Ýªº¶Ü?©ú¤Ñ¨Óº²Â_¤U |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/10 ¤U¤È 04:45:28²Ä 1963 ½g¦^À³
|
½Ð±Ð¤j®a¡A§Úª`·N¨ì¤@¥ó¨Æ¤£ª¾ì¦]¥i¯à¬°¦ó: ¶}©l¥X²{^¤åª©ªº¶}·|³qª¾¤Îij¨Æ¤â¥U¡A¬O§_¬°¤WÂd»Ýn? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/10 ¤U¤È 02:54:15²Ä 1962 ½g¦^À³
|
08 ==>20¤À ¬Ý¬ÝPÈ «¢«¢ ªÑ»ù§Ö¶W¹L¨SPȪº§r Åܤdª÷ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/10 ¤U¤È 01:35:06²Ä 1961 ½g¦^À³
|
±q³o2¥yÃöÁä¦r:[«e10¦W°ê»Ú¤jÃļt]»P[§Ú¿Ë¦Û¨ì¤Fheadquarter¥h]¡AÀ³¸Ó¬O«üªYÄ£µL»~!!! 05_·sÃĶ}µo_¿ïÃD 13.10~14:30¬í: .....³o¬O¨Æ¹ê®@ [«e10¦W°ê»Ú¤jÃļt] ........§Úɨ䤤¤@®a [§Ú¿Ë¦Û¨ì¤Fheadquarter¥h] ½Í¨ì³Ì«á ¥L»¡±z̯ण¯à ³o®a.§Ú´N¶R±z̪ºªÑ²¼°Ú.§ë¸ê±z̪ºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z....½Í¨ì³o¼Ë£²... --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 09:21:39²Ä 1957 ½g¦^À³ J¤j¯«¬OªYÄ£ªºSAB¡A«ö²z·|¥X®u¤U¦Cªº¦X§@¬¢½Í¡A©Ò¥H±z·Q¶R[¤½¥q]¡A©Ò¿×ªº[¤½¥q]8¦¨´N¬OªYÄ£¡C --------------------------------------------------------------------------------------------- ·|û¡G«ä¦Ò¤¤10147262 µoªí®É¶¡:2020/7/23 ¤U¤È 09:36:18²Ä 195 ½g¦^À³ 2019/04 »P¸ó°ê«e¤¦W¤§»sÃĤ½¥q¡A¬ãµo¹Î¶¤¦@¤E¦ì¤£¦P³æ¦ì°ÆÁ`µô¤Î¨Mµ¦¤H¤h¡A¦b¬ü°êÁ`³¡³sÄò¤K¤p®É¡A 2019/04 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ãµo¹Î¶¤¡A¦b¬ü°êÁ`³¡¡A¬¢½Íªø¹F¥|¤p®É¦³Ãö¤îµhÃÄSNP-810¦X§@¨Æ©y¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/10 ¤W¤È 11:49:25²Ä 1960 ½g¦^À³
|
¹Ú«Ü¬ü ¥i±¤ªÑ»ù¤£¶R±b |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:41:53²Ä 1959 ½g¦^À³
|
10_·sÃĬãµo¦¨¥\®×¨Ò_GSP¨x¥\¯à©w¶qªk 1:18 avalon hepaPOC ¤z¯à¿}---GSP¦X§@¼t??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:28:55²Ä 1958 ½g¦^À³
|
08_·sÃĬãµo¦¨¥\®×¨Ò_·s¦¨¤À(ªø®Ä¤î¼@µh¤£¦¨Å}) J¤j¯«¦b19:00¬í°_»¡:..¦ý¬O§Ú¦Û¤v³£¦b¦Y°Ú §Ú¤£¦Y¨ºÓ¦³¨x¬r©Êªºpanadol ´N¬O´¶®³¯k §Ú¤]¤£¦Y¦³¨x¬r©Êªºtylenol ²{¦b§ÚÌ¥i¥H[¦Y¤@²~]®@ ³£¤£·|¦³¨x¬r©Ê³á ¨ì³oºØ¦a¨B¤F ·íµM ³oÁÙ»Ýn¤@¬q®É¶¡¤~·|¤W¥« ¦ý¬O... ----------------------------------------------------------------------------------------------------- J¤j¯«²{¦b¥u¦YªYÄ£ªºSAFETYNADOL¡A[¦Y¤@²~=100g]¨S¤¤¬r³o»ò¸Ø±i??? dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=b956d527-7ea7-e084-e053-2a95a90a866d&type=display 500mg *200Áû/²~=100g |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 09:21:39²Ä 1957 ½g¦^À³
|
J¤j¯«¬OªYÄ£ªºSAB¡A«ö²z·|¥X®u¤U¦Cªº¦X§@¬¢½Í¡A©Ò¥H±z·Q¶R[¤½¥q]¡A©Ò¿×ªº[¤½¥q]8¦¨´N¬OªYÄ£¡C --------------------------------------------------------------------------------------------- ·|û¡G«ä¦Ò¤¤10147262 µoªí®É¶¡:2020/7/23 ¤U¤È 09:36:18²Ä 195 ½g¦^À³ 2019/02 »P¸ó°ê«e¤Q¦W»sÃĤ½¥qñ¸p¦³Äv·~¸T¤î¤§«O±K¨ó©w¡A°Ó°QSNP-810¦X§@¨Æ©y¡C 2019/04 »P¸ó°ê«e¤¦W¤§»sÃĤ½¥q¡A¬ãµo¹Î¶¤¦@¤E¦ì¤£¦P³æ¦ì°ÆÁ`µô¤Î¨Mµ¦¤H¤h¡A¦b¬ü°êÁ`³¡³sÄò¤K¤p®É¡A 2019/04 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ãµo¹Î¶¤¡A¦b¬ü°êÁ`³¡¡A¬¢½Íªø¹F¥|¤p®É¦³Ãö¤îµhÃÄSNP-810¦X§@¨Æ©y¡C 2019/07 »P¸ó°ê«e¤Q¦W»sÃĬü°ê¤½¥q¹Î¶¤Á|¦æ²Ä¤G¦¸¹q¸Ü·|ij¡A²`¤J°Q½×¥þ²yº¨ÒµL¨x¬r¤îµhSNP-810¤§¬ì§Þ¡B¬ãµo¶i«×¤Î¦X§@¨Æ©y¡C 2019/12 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ü°ê¡B¼Ú¬w¡B·ç¤h¤§°Ó·~µo®i¡B¬ãµo³¡¤Î±M§Q«ß®v¡AÄ~«e¤T¦¸§¹¦¨¬ì§Þ¤Î¬ãµo¶i«×«á¡A²Ä¥|¦¸Á|¦æ¦¸¹q¸Ü·|ij¬¢½ÍSNP-810¦X§@¡B±ÂÅv¡B°Ó·~µo®i¨Æ©y¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 08:52:57²Ä 1956 ½g¦^À³
|
05_·sÃĶ}µo_¿ïÃD J¤j¯«¦b14:15¬í°_:...½Í¨ì³Ì«á ¥L»¡±z̯ण¯à ³o®a.§Ú´N¶R±z̪ºªÑ²¼°Ú.§ë¸ê±z̪ºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z....½Í¨ì³o¼Ë£²... ±z·Q¶R[¤½¥q]ªº[¤½¥q]¤£¾å±o¬O¤£¬OªYÄ£??? ªYÄ£³oºØ¤p¤½¥q¡A¤jÃļt¬O¥Î¦¬ÁÊÂX¤j²£«~½uÅý¦Û¤vÅܧó¤j¡A¦Ó¤£¬O¤JªÑ¡C --------------------------------------------------------------------------------------------------- ·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/9 ¤U¤È 05:41:54²Ä 1951 ½g¦^À³ §ä¨ì¤@ÓLinkingPros³X½ÍJ¤j¯«ªº¤½¶}¼v¤ù»P¤j®a¤À¨É: www.facebook.com/watch/108155710567674/1041370163073318 ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 11:37:52²Ä 1835 ½g¦^À³ ªYÄ£³oºØ¤p¤½¥q¡A¤jÃļt¬O¥Î¦¬ÁÊÂX¤j²£«~½uÅý¦Û¤vÅܧó¤j¡A¦Ó¤£¬O¤JªÑ¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/9 ¤U¤È 08:49:36²Ä 1955 ½g¦^À³
|
°¨¤W§ó·s?? ¤½¥q¬ãµo¤Hûªº¬ãµo¸gÅç¦Xp306/¤H¦~¡AªYÄ£®Ö¤ß§Þ³N¨Ó¦Û¥]§t¬ì§Þ³¡µ¥¬ã¨s¾÷ºc±MÄݱÂÅv¡A¤½¥q¬ãµo¹Î¶¤«h¥ÑÀò±o¡u¬ü°ê°ê®aµo©ú®a¾Ç°|¡v°|¤h³Ì°ªºaÅA¡B²{¾»O¥_Âå¾Ç¤j¾ÇÁ¿®y¡B¤¤¬ã°|«È®yÁ¿®y±Ð±ÂªºJ¥®®E³Õ¤h«ü¾É¤U¡A¦Û¦æ«Ø¸m¥H¡u¨xŦ¥NÁȕÀ¬¡©Ê¡v¤Î¡u°ò¦]½Õ±±¡v¤G§Þ³N¥¥x¡A¶}µo¥X¤»¶µ®Ö¤ß²£«~¡C¥»¤½¥q±Mª`¥H¤HÅé¥NÁȕÀ¬¡©Ê½Õ±±µ¥¬ÛÃö±M§Q§Þ³N¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/9 ¤U¤È 08:36:42²Ä 1954 ½g¦^À³
|
R¤j ¤w°µ200¤H¡H¬O¯uªº¶Ü¡H °µ¥X¨Óªºµ²ªG·Ç½T¶Ü¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 07:43:27²Ä 1953 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:28:41²Ä 1948 ½g¦^À³ ¨xŦ¬ï¨ë¬¡²Õ´À˹ï¶}µoNASHÃĪ«ªºÃļt¨Ó»¡¬O¤jÅ]¤ýÃö¥d! -------------------------------------------------------------------------------------------- «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)---¥Ø«e¤w°µ§¹200Ó¯f¤H..... Æg°Õ!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 07:01:02²Ä 1952 ½g¦^À³
|
¤p¨k¤H¤jµ¹±z«öÆg°Õ!!! |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/9 ¤U¤È 05:41:54²Ä 1951 ½g¦^À³
|
©ÓR¤j©Ò»¡ªº¤j¯«¡A§ä¨ì¤@ÓLinkingPros³X½ÍJ¤j¯«ªº¤½¶}¼v¤ù»P¤j®a¤À¨É: www.facebook.com/watch/108155710567674/1041370163073318 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 12:56:37²Ä 1950 ½g¦^À³
|
108¦~«×¡u½ÃºÖ³¡¡P¸gÀÙ³¡ ÃĪ«¬ì§Þ¬ã¨sµo®i¼ú¡v±o¼ú¦W³æ ¥Ó½Ð¤H:J¥®®E ¼ú¶µ:»É½è¼ú ²£«~¦WºÙ:§Ö³tºë·Ç´ú¶q(Point-of-Care, POC)¨x¥\¯à¤§·s¥b¨Å¿}ÀË´ú¨t²Î Point-of-Care Determination System for Quantitative Liver Function Test ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:23:14²Ä 1947 ½g¦^À³ (¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)³o¬O¤j¤û¾ÇªÌJ¥®®E³Õ¤hªºµo©ú |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:48:18²Ä 1949 ½g¦^À³
|
2019.4.12 ¡m2019¼Ú¬w¨xŦ¦~·|¡nNASH¤j¼tGileadµoªí«D«I¤J©Ê¶EÂ_¨ú¥N¶Ç²Î¤Á¤ù www.genetinfo.com/investment/featured/item/25302.html ----------------------------------------------------------------------------------------------- §Ú°O±oFDA©|¥¼®ÖãGileadªº«D«I¤J©Ê¶EÂ_ªk! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:28:41²Ä 1948 ½g¦^À³
|
¨xŦ¬ï¨ë¬¡²Õ´À˹ï¶}µoNASHÃĪ«ªºÃļt¨Ó»¡¬O¤jÅ]¤ýÃö¥d! ¥Ø«eÁ{§É¶EÂ_¤W¡A¨ã[«I¤J©Ê]¥B [ªá¶O°ª]ªº¨xŦ¬ï¨ë¬¡²Õ´Àˬd¬°FDA°ß¤@®Ö㪺ÀËÅç¤èªk¡A¤]¬Oµû»ù·sÃĸÕÅ禳®Ä©Êªº¡§ª÷¼Ð·Ç¡¨¡C ¦³¨Ç±wªÌ¤£Ä@·N¶i¦æ¤Á¤ùÀˬd¡A©Ò¥HNASHÃĪ«Á{§É¤£¦n©Û¦¬±wªÌ¡C ¦]¦¹ÃļtÄv¬Û§ë¤J¶}µo[«D«I¤J]©Ê¥Íª«¶Ç·P¾¹¨ÓºÊ´ú©M°lÂÜNASH¡A§Æ±æ¯àÀò±oFDA®Ö㬰NASHÀø®ÄÀËÅç¼Ð·Ç!!! 2020.11.17(¬ü°ê¨x¯f¬ã¨s¨ó·|¦~·|) Glympse Bio¶}µoNASH«D«I¤J¦¡¶EÂ_13ºØ¥Íª«¼Ð°O¥i±æ¨ú¥N¬ï¨ëÀˬdnews.gbimonthly.com/tw/article/show.php?num=34577 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:23:14²Ä 1947 ½g¦^À³
|
(¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)³o¬O¤j¤û¾ÇªÌJ¥®®E³Õ¤hªºµo©ú ªYÄ£©|¦³¦¬¿ý¦bUSFDA«ü¤Þ¤¤¡A¥H«D«Iŧ©Êªº©w¶q´ú©w³Ñ¾l¨x¥\¯àªº¤èªk¡u¥b¨Å¿}³æÂIªkGSP (galactose single point)¡v¡A¥¿µo®i¬°¶EÂ_ªvÀøNASHªº¥Íª«¼Ð°O(biomarker)¡A¦p¦¹¥i±æ¸Ñ¨M¨ä¥LNASHÃÄn¥Î¨x¬ï¨ë¤~¯à¨Ï¥ÎNASH ÃĨӪvÀøªº§x¹Ò¡CSNP-6¨t¦C²£«~¦]¦³¨}¦nªº¦w¥þ©Ê¤ÎÅãµÛÀø®Ä¡A¤wÀò°ê»Ú¤j¼tÆf¥Ø¡A²`«×°Q½×¨Ã±K¤ÁÁpôµû¦ô°Q½×¤¤¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/11 ¤W¤È 06:03:29²Ä 112 ½g¦^À³ ...ªYÄ£SNP6/SNP8--J¥®®E³Õ¤h(2016¦~Àò¿ï¬°¬ü°êÃľǬì¾Ç®a¾Ç·|°|¤h¤Îµo©ú®a³Ì°ªºaÅA¤§¬ü°ê°ê®aµo©ú®a¾Ç°|Âù°|¤h) www.microbio.com.tw/tw/news_detail.php?nwno=264 J¥®®E³Õ¤hµo©úªº¥b¨Å¿}³æÂIªk¤w³Q¦¬¿ý¦bUSFDA«ü¤Þ¤¤...¥¿µo®i¬°¶EÂ_ªvÀøNASHªº¥Íª«¼Ð°O(biomarker)¡A¦p¦¹¥i±æ¸Ñ¨M¨ä¥LNASHÃÄn¥Î¨x¬ï¨ë¤~¯à¨Ï¥ÎNASH ÃĨӪvÀøªº§x¹Ò¡C 1.www.sinewpharma.com/news_detail.php?nwno=35 2.www.cna.com.tw/news/ahel/201911130336.aspx |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/8 ¤U¤È 06:19:08²Ä 1946 ½g¦^À³
|
¦V¤j¡A¥t¥~µo²{ ¨Î®mªºªL¡¯·ìݶ겻¥Í§Þ¸³¨Æ ¶ê²»¦n¹³¤S¬O¯E¹©ªº¤l¤½¥q |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/8 ¤U¤È 06:04:12²Ä 1945 ½g¦^À³
|
Page19,³o¬q¤]ÆZ¦³½ìªº¡G¤£¾å±o¬O¤£¬O¸ò110/12¤ëñ¬ùªº¦³Ãö (¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP)¡G ¥¼¨Ó¤]³W¹º¦X§@¶}µo GSP¡A¥H¨ó§UÁ{§É¶Eªv¯×ªÕ¨xª¢¡C³Ñ¾l¨x¥\ ¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP)¤w©ó 2003 ¦~¯Ç¤J¬ü°ê FDA ¶EÂ_«ü¤Þ¤Î±Ð¬ì ®Ñ¡A²{¤w¦³¦b±Ä¼Ë²{³õ§Q¥Î¥iÄ⦡ªº¤ÀªR»ö¾¹¤Î®M²Õ§Ö³t±o¨ìÀË´úµ² ªG(point-of-care)¡A¤w³q¹L¤W¥«¡A¥¿»P¥»¤½¥q³W¹º¦X§@¤¤¡C¯×ªÕ¨xª¢¨t ¦C·sÃÄ¡A¥¼¨Ó±N¦¹²£«~ÂX®i¨ì¡u°sºë©Ê¯×ªÕ¨xª¢¡v¤Î¡u¯×ªÕ¨x¡v¡A¦p ¦¹¥«³õ¦û¦³®É¶¡¥i©µªø¡A©Ôªø¾P°â¾Ô½u |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/8 ¤U¤È 04:59:09²Ä 1944 ½g¦^À³
|
111¦~«×Àç¹Bp¹º (¤T)»P°ê»Ú¤j«¬Ãļt¬¢½Í§Þ³N±ÂÅv¤§¦X§@pµe ¤½¥q¦³©ú½T¼g¤W¡A§Æ±æ¯à¦pÄ@ |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/8 ¤U¤È 04:33:22²Ä 1943 ½g¦^À³
|
¤p¨k¤H¤j Ó¤H¤]ı±o¸ê®Æ«Ü©_©Ç¡H Áp¹©»P¨Î¯C³£¤£¬O¸³¨Æ¡A«o¦C¡u¸³¨Æ±Æ°£Äv·~¡v¡C Áp¹©ªº¥Nªí¤H¡G°¨XµY¬O§_¬°´I¨¹ªº¤H°¨¡H ±©¤@«GÂI¡A75¤¸²{¼W¦³¶WÃB·Q»{5¤d¦h±i¡A |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 01:12:45²Ä 1942 ½g¦^À³
|
20200415 ¼¶½Z¢¬¯Î©s·O¡]»O¤jÂå¾Ç°|Âå¾Ç¨t§U²z±Ð±Â¡^ ...ÄY«ªº°sºë©Ê¨xª¢¬Æ¦Ü¦b¶EÂ_«á90¤Ñ¤º¡A¦³°ª¹F75%ªº¦º¤`²v¡C¥Ø«eÄY««æ©Ê°sºë©Ê¨xª¢ªºªvÀø¥u¦³¥Ö½èÃþ©T¾J«j±j³Q»{¬°¥i¯à¦³®Ä¡C¨xŦ²¾´Ó¬O°ß¤@¥i¥Hªv¡ªºÀøªk¡A¦ýµ¥«Ý´«¨xªº¤H¤Ó¦h¡A¥u¦³¤Ö¼ÆÂå¾Ç¤¤¤ß¤Î¦³ªº±wªÌ¦³¾÷·|±µ¨ü¨xŦ²¾´Ó¡C www.liver.org.tw/journalView.php?cat=65&sid=878&page=1 ------------------------------------------------------------------------------------------------- ¥x¤jªº75%¦º¤`²v»P·s¥[©Y30%¦º¤`²v¡A2²Õ¼Æ¾Ú®t¶Z¦n¤j¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 01:03:58²Ä 1941 ½g¦^À³
|
§Ú¤§«e»´µø¤FSNP-630ªº[°sºë©Ê]¨xª¢¥«³õ!!! ·s¥[©YSZN-043¥HÄY«°sºë©Ê¨xª¢¬°ªvÀø¯f¯g( ¤£°µAPAP¤¤¬r¸ÑÃÄ) www.surrozen.com/programs/pipeline ¬ü°ê¨C¦~¬ù¦³ 100,000 ¤H¦][ÄY«°sºë©Ê] ¨xª¢¦í°|¡A³o¨Ç±wªÌ¦b 90 ¤Ñ¤ºªº¦º¤`²v¬ù¬° 30%¡AªvÀø¿ï¾Ü«Ü¤Ö¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 11:04:17²Ä 1660 ½g¦^À³ ªYÄ£ºô¶: ²£«~¶i«×SNP-630:·sªvÀø¾AÀ³¯g±´°Q-°£¤F¹ï«D°sºë©Ê¯×ªÕ¨xª¢(NASH)¦³®Ä¡A¤]¦P®É¶i¦æ°Êª«¹êÅç¡A±´°QªvÀø°sºë©Ê¯×ªÕ¨xª¢(ASH)¤§Àø®Ä ................................................................................................ ¦³½ì¤F! µn¿ý¦b®×ªºASHÁ{§É©tªù¿W¥«´N1¥ó 1¥ó 1¥ó(ÁÙºM®ø¨S°õ¦æ)---³oªí¥ÜASHÀ³¸Ó¨S¥«³õ§a¡A¤£¸ÑªYÄ£·F¹À±´°Q??? clinicaltrials.gov/ct2/results?cond=ASH+alcoholic+Steatohepatitis&term=&cntry=&state=&city=&dist= ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/30 ¤U¤È 03:40:36²Ä 1257 ½g¦^À³ ...2021.6.25 (2021¦~°ê»Ú¨xŦ¤j·|™ 2021 (ILC)) Surrozen ¦b 2021 ¦~ Wnt ½Õ¸`§ÜÅé SZN-043 °ê»Ú¨xŦ·|ij¤W¤½§G¼Æ¾Ú¡¨ ¡§§ÚÌ´Á«Ý¦b 2022 ¦~±N¨ä±À¦VÁ{§É¬ã¨s®ÉÄ~Äòµû¦ô SZN-043¡C¡¨¦bÃD¬°¡§SZN-043¡A¤@ºØ¹v¦V R-spondin ªº¨x²ÓM¼ÒÀÀª«¡A¦b«æ©Ê¹ï¤A酰®ò°ò×ô»¤¾Éªº¨x·l¶Ë¼Ò«¬¤¤»¤¾É¨x²ÓM¼W´Þ¡¨ªº®ü³ø®i¥Ü¤¤¡A¼Æ¾Ú´£¨Ñ¤F¤ä«ùÃÒ¾Ú¡A§Y SZN-043 ¥i¥H»¤¾É¨x²ÓM¯S²§©Ê¦A¥Í¡C¹ï¤A酰®ò°ò×ô¹L¶q¡A¥i¥H§ïµ½¨x¥\¯à¡A¥i¥H´î¤ÖÃa¦º±¿n¡C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/7 ¤U¤È 06:59:26²Ä 1940 ½g¦^À³
|
½Ð±Ð¤j®a¡A§Ú¬Ý¨ìªººÃ°Ý¦p¤U 1.Áp¹©¸ê¥»§ë¸ê¦³¦X¹Ù¡G¬O§_¬°·s¸³¨Æ 2.¼W¸ê°h¤F4eµ¹»{¤£¨ìªºµL½tªÑªF¡H |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/7 ¤U¤È 06:19:32²Ä 1939 ½g¦^À³
|
R¤j ªYÄ£¦Û¤v®Ú¥»µL¦æ¾P¯à¤O µL½×¬O¡u§C¨x¬r¡v¡B¡u·P«_ÃÄ¡v ¨S¸ÕÃĮĹLÃö¡A±ÂÅv¤jÃļt¦æ¾Pªº¸Ü¡I ³£¬O§@¹Ú¶¥¬q¡I ÃĮĸըº麽¤[¤F¡AÁöÁÙ¨S¦³§¹¦¨¥Ø¼Ð¡A¦ý¤j¤è¦VÀ³¸Ó¦³ÃФF¡C ¤u·~§½¬°¦óã¤F¦P·N¨ç¡H¤½¥qÀ³¸Ó¦³¸q°È§i¶DªÑªF̤~¹ï¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤U¤È 12:23:54²Ä 1938 ½g¦^À³
|
¦pªG§Ú¬OIntercept¤½¥qCEO¡A¦b®³¨ì²Ä1±iNASHÃÄÃÒ«á¸êª÷¤ô¦ìº¡·¸¡AnµÛ¤âOcalivaªº¤U¤@¥N·sÃÄ(§ó¨ã¦w¥þ©Ê»PÀø®Ä)¡A¨º»òª½¨úSNP-630§@ÁpÃĶ}µo´N¬O³Ì¨Î³Ì§Ö³t¿ï¶µ¤§1 ! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 09:45:43²Ä 1934 ½g¦^À³ ²×§½¤§¾Ô¦³¤H©ã¤F 4.05»õ¬ü¤¸!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤U¤È 12:13:53²Ä 1937 ½g¦^À³
|
¤j¹Ú·Q®a¤jªº¹Ú·Q °_¯è! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/21 ¤U¤È 06:24:47²Ä 1230 ½g¦^À³ ¦pªG¤j¶O©P³¹¥u®³¾Ç¦WÃÄÃÒ§ð¦û1¦¨¥«¦û²v(¾Ç¦WÃÄÃÒ·Q10%¥«¦û¤]¤£¥i¯à)¡A«hSNP-810¤j¹Ú¸Ó¿ô!!! ÁÙ¦³¥xÆW¤H©R¤£«ÜÈ¿ú... ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 10:42:03²Ä 1936 ½g¦^À³ ....¤½¥q«áÄò¤´¦³³W¹º¹ï©ó¬ü°ê¥«°â 600ºØ§t¦³¤AñQÓi×ô¤§·P«_Ãĵ¥½Æ¤è¡AY¥Ñ SNP-810 ¨Ó´À´« |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 10:42:03²Ä 1936 ½g¦^À³
|
¤G) µL¨x¬r©Ê¤îµh·sÃÄ(OTC)¡G SNP-810 µ¦²¤¹B¥Î...¤§Äw½X¡C¦Ò¶qÅçÃÒ SNP-810 ¬°µL¨x¬r©Ê®É¶¡¸ûªø¡A§ÚÌpµe¤À¶¥¬q¨Ó§¹¦¨¡A²Ä¤@¶¥¬q¥ý¥H¡§§C¬r©Ê¤AñQÓi×ô¡¨¤W¥«¡A²Ä¤G¶¥¬q¦A¥H Phase IV¸ÕÅç¡A±À¼s¦Ü¡§µL¨x¬r©Ê¤AñQÓi×ô¡¨¡C (¤T) µL¨x¬r©Ê¤îµh½Æ¤è·sÃÄ(³B¤èÃÄ)¡G ...¤½¥q«áÄò¤´¦³³W¹º¹ï©ó¬ü°ê¥«°â 600ºØ§t¦³¤AñQÓi×ô¤§·P«_Ãĵ¥½Æ¤è¡AY¥Ñ SNP-810 ¨Ó´À´«¡A¥ç¥i¨ü°U¶i¦æÃİʤÎÃĮĸÕÅçÅçÃÒÀø®Ä¡C ------------------------------------------------------------------------------------------------ ¥þ±¶}¾Ô«Ü¯Ó®É¡A¯à¦¬Ã¬º¡º¡? «¥®a¡uÀY³£¬~¸¨¥h¨o¡AµL«c°L¨Ï±o¡C¡v¡A¬Ý¤U¥h... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 10:02:17²Ä 1935 ½g¦^À³
|
FDA¹ïOcalivaªººÃ¼{¦b¦w¥þ©Ê(¨x¬r)! Ocaliva +SNP-630ÁpÃĦ³ÅãµÛªº¨ó¦P§@¥Î¡AOcaliva ¾¯¶q°§C¡AÀø®Ä»P¦w¥þ©Ê§ó°ª§ó¨Î! SNP-610 / SNP-630 °Êª« PK/PD ¸ÕÅç ¦b SNP-630 ¨Ö¥Î¨ä¥L¤T´ÁÃĪ«ªº´ú¸Õ¤¤¡A§Ú̵o²{ SNP-630 »P¤T´ÁÃĪ« Ocaliva ¨Ö¥ÎªvÀø NASH ¤p¹«¡A¦b¦å¿}¡B¦åÁx©T¾J¡B¨xŦ¤T»Ä¥Ìªo¯×µ¥¶µ¥Øªº°§C®ÄªG¬ÒÀu©ó³æ¿W¨Ï¥Î Ocaliva ©Î SNP-630(p<0.05)¡A¦³ÅãµÛªº¨ó¦P§@¥Î¡AÅã¥Ü SNP-630 µo®i½Æ¤èÃĪ«ªº¼ç¤O¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/20 ¤W¤È 11:34:58²Ä 1477 ½g¦^À³ ²×§½¤§¾Ô! 2021.8.2 Intercept ø»sOcalivaÀò±oNASH §å㪺·s³~®|:¥un«O«ù¦w¥þ©Ê |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 09:45:43²Ä 1934 ½g¦^À³
|
²×§½¤§¾Ô¦³¤H©ã¤F 4.05»õ¬ü¤¸!!! 1/18 16.56¤¸ ; 5/6 19.27¤¸ 2022.5.5 :Intercept Pharmaceuticals ±N¦VÁ`³¡¦ì©ó^°êªº Advanz Pharma ¥X°â¨ä¦b¬ü°ê¥H¥~ªº¨x¯fÃĪ« Ocaliva ªºÅv§Q¡A«áªÌ¦P·N¦b¨â®a¤½¥q¶g¥|«Å¥¬ªº¥æ©ö¤¤ [¹w¥I] Intercept 4.05 »õ¬ü¤¸ ----------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/18 ¤W¤È 07:49:34²Ä 1600 ½g¦^À³ ·Q[½ä]¤@©]P´I?³o®aIntercept pharmaceuticalsªº[²×§½¤§¾Ô]¦³¼Éº¦10~20¿ªº¹ê¤O»P¾÷·|?! ì¦]: 1.ªÑ»ù¾ú¥v°ª 2014.1.6 $497¡A¾ú¥v§C:2021.8.16 $11.6 2.¬Q¤é¦¬½Lº¦7.96% ¦¬$17.76----¬ü°ê§ë¸êªÌ¶}©l©ãª`Ocalivaªº[²×§½¤§¾Ô] 2022.1.7---2022 ¦~¤£¥i¿ù¹Lªº 3¶µ....¹ï©ó³o¨Ç»sÃÄ°Ó¨Ó»¡¡A³o¥i¯à¬O«D±`¿E°Ê¤H¤ßªº¤@¦~¡C 3.¤@¾Ô¨M¥Í¦º®É¶¡:2022¦~¤W¥b¦~ 2021.12.20 Intercept ¥i¯à·|¦b 2022 ¦~¤W¥b¦~»P FDA «·s´£¥æ·|ij¡C 4.Ó¤H¤£·|©ãª`³o³õ½ä§½¡A°lÂÜFDA§å㪺²Ä1¤äNASHÃĪ«¥Î¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/20 ¤W¤È 11:34:58²Ä 1477 ½g¦^À³ ²×§½¤§¾Ô! 2021.8.2 Intercept ø»sOcalivaÀò±oNASH §å㪺·s³~®|:¥un«O«ù¦w¥þ©Ê www.fiercepharma.com/pharma/intercept-still-sees-fda-approval-pathway-for-nash-hopeful-ocaliva-as-long-as-safety-holds |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/7 ¤W¤È 06:55:37²Ä 1933 ½g¦^À³
|
5/6¤w¤W¶Çij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡A À³¸Ó´N¬O¦~³ø¤º®e¡C |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/5/5 ¤U¤È 03:19:41²Ä 1932 ½g¦^À³
|
¸ò¤j¼tñªº 810 confirmation study ¡AY¼Æ¾Ú²Å¦X¤j¼tªº¹w´Á¡A«áÄò±ÂÅv½Í§Pªº§ð¨¾¡A¨ä¹êº¡¯Ó®Éªº¡C Ó¤H¬Oı±o¡A¦b IPO «eÀ³¸Ó¤£·|¦³µ²ªG¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/5 ¤W¤È 10:01:10²Ä 1931 ½g¦^À³
|
¨xª¢°Ê°_¨Ó¤F?! ©ñ±ó¤F¤îµh?! ÁÙ¬O¤îµh¦¨¥\¤F¡A¦æ¦³¾l¤O¨Ó¬Ý¨xª¢ 104·s¾¯Ê ¬ã¨sÅ@²z®v(Á{§É¸ÕÅç¬ãµo³B) 1.¨ó§UÁ{§É¸ÕÅ禬®×»P°õ¦æ¸ÕÅç¬ÛÃö¨Æ©y¡C 2.»Ý¦³Å@¤h/Å@²z®v/ÂåÀË®v°õ·Ó(¯à°t¦X©â¦å)¡C |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/3 ¤U¤È 09:44:32²Ä 1930 ½g¦^À³
|
104·s¾¯Ê ¬ã¨sÅ@²z®v(Á{§É¸ÕÅç¬ãµo³B) 1.¨ó§UÁ{§É¸ÕÅ禬®×»P°õ¦æ¸ÕÅç¬ÛÃö¨Æ©y¡C 2.»Ý¦³Å@¤h/Å@²z®v/ÂåÀË®v°õ·Ó(¯à°t¦X©â¦å)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³
|
°ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting. 2022.5.2 Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today announced that the FDA has granted the Company a pre-Emergency Use Authorization (EUA) meeting on May 10, 2022, finance.yahoo.com/news/fda-granted-veru-pre-emergency-123000144.html ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤U¤È 03:04:48²Ä 1897 ½g¦^À³ ¬Q¤é¦A¼W1®a¤¤«×¦Ü««×¦í°|±wªÌ¤fªAÃÄ¥Ó½ÐEUA ¡A[°ß¿W°ê¹©¼B¸³«ÅºÙ¤£¥ÎPȹF¼Ð]!!! 2022.4.11 ¬ü°êÁÚªü±KVeru¤½¥q¤fªA§Ü¯f¬rÃĪ« sabizabulin¡A P3¤¤´Á¼Æ¾ÚÅã¥Ü¡A»P¦w¼¢¾¯¬Û¤ñ¡A¦b¤¤«×¦Ü««×¦í°|±wªÌ¤¤ªº¦º¤`²v°§C¤F 55%¡C¡]p=0.0029¡^µ²ªG³Q»{¬°¨ã¦³²Îp¾Ç·N¸q©M²Îp¾Ç·N¸q¡C -------------------------------------------------------------------------------------------- Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/30 ¤U¤È 09:09:24²Ä 1928 ½g¦^À³
|
2022.4.19 ¥[®³¤jªº¬ã¨sµ²ªG»P¬ü°ê¬Û¦P¡A¼W´T¸û¤p¦Ó¤w¡C §ó§ï¼ÐÅÒ»P¥[µù¨x¬rĵ»y¨Ã¤£¯à¨¾¤î¹ï¤A酰®ò°ò×ô¹L¶q·N¥~!(»Ýn±Ä¨úÃB¥~±¹¬I¨Ó´î»´·N¥~¹ï¤A酰®ò°ò×ô¹L¶q) www.cmaj.ca/content/194/15/E542 ¥[®³¤j©ó 2009 ¦~ 10 ¤ë¹ï²£«~¼ÐÅÒ¶i¦æ¤F§ó§ï¡A¥Hĵ§i¥i¯à¦s¦b¨x·l¶Ëªº·ÀI¡C2016 ¦~¡A¥Ļó·s¤F¦w¥þ¾¯¶qªºªþ¥[¼ÐÅÒ¡A¨ÃÃѧO§t¦³¹ï¤A酰®ò°ò×ôªº²£«~¡C µM¦Ó¡A¦b³o¶µ°w¹ï 2004 ¦~¦Ü 2020 ¦~¶¡¥[®³¤j 9 Ó¬Ù©M 3 Ó¦a°Ïªº 12000 ¦h¨Ò¹ï¤A酰®ò°ò×ô·N¥~¹L¶q¤J°|ªº¬ã¨s¤¤¡A¬ã¨s¤Hûµo²{§ó·sªº¼ÐÅÒ¹ï¤J°|¨S¦³¼vÅT.... Ų©ó¹ï¤A酰®ò°ò×ô·N¥~¹L¶q¹ï¤½¦@½Ã¥Í©M½Ã¥Í¨t²Îªº¼vÅT¡A¥H¤Î¥þ²y¬Fµ¦¨î©wªÌ¹ï«P¶i¦w¥þ¨Ï¥Î¹ï¤A酰®ò°ò×ôªº¿³½ì¡A§Ú̪º¬ã¨sµ²ªGªí©ú¡A»Ýn±Ä¨úÃB¥~±¹¬I¨Ó¹w¨¾³o¨Ç¨Æ¥ó¡C ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/23 ¤W¤È 10:18:43²Ä 1916 ½g¦^À³ §ó·s¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä...2022.4.21---FDA ...¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/26 ¤U¤È 10:55:44²Ä 1927 ½g¦^À³
|
¬üªÑ¤S±Y¤F~` ©ú¤Ñ¨«µÛÁ@¤F |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/26 ¤U¤È 12:01:34²Ä 1926 ½g¦^À³
|
«¢«¢ º¦¨S¥÷¡A¶^¦³¥÷ ³oªi¨S·f¤W¡A¶^µ¥¨ì¤W¥««e |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/25 ¤W¤È 10:54:17²Ä 1925 ½g¦^À³
|
¦ý¬O¸ô¸³§Ú¤£´±e¦P¤H®æ(¬ì¾Ç¤W¥i¥H»{¦P)¡Aµ}ÄÀ¤]Ä묹¤F¬u²±ªÑªFªºÅv¯q!·íµM¦ÑÁó¦û¤jªÑ¡A¤pªÑªF¤]¬O»¡¤£¥X¸Ü¡A A 2019¦~3¤ë7¤é ¡X ¬°§§¤j·sÃĬãµo¹ê¤O¡A´£¤É°ê»Ú¥«³õÄvª§¤O¡A¤¤¤Ñ B 2019¦~¾P°âÃB¤w¹F23.2»õ¬üª÷¡A©Ò¥H¥þ²y³£¦b¬Ý³oÓ¾AÀ³¯g¡C ¡u¦X¤@¸òLEO Pharma¬O¦b¼¯®Ú¤j³qÂåÀø²£·~¤j·|¤W°t¹ïªº¡C§Ú̦bu¬ü°Ñ¥[¤§«e´N¦³±µ¤f¤£¤Ö¼t°Ó¡C¼¯®Ú¤j³q«D±`¤Íµ½¡AÀ°§ÚÌ°t¹ï§ë¸ê¤H»P¼t°Ó¡C¤@¤ëªì¸òLEO Pharma½Í§¹¤§«á¡A¥L̦^¥h¬ã¨s§ÚÌ´£¨Ñªº¸ê®Æ¡C¨º®ÉÔ§Ú̪º¤@´ÁÁ{§É¸ÕÅç©M¤HÅé±´¯Á¸ÕÅçµ²ªGªºÃÒ¾Ú¤w¸g«D±`©ú½T¡A¦P®ÉÁÉ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/25 ¤W¤È 10:28:39²Ä 1924 ½g¦^À³
|
¥DnÁÙ¬O¤â¤W³¡¦ìªº°ÝÃD¡A¸êª÷°÷©ñªø·íµM¨S°ÝÃD¡C¸êª÷¤£¨¬´N~ ¤§«eÄ_0/¬u²±¨ì¦X¤@/¤O¿n¹q¡A¨ä¹êÁȨì¤jªiªº³£¬O©ñ¤[ªº¡C ¬Ý¨ìªÑ»ù¨Ó¨Ó¦^¦^¡A®e©ö§ìÀt¨«Å¾¡C §Æ±æ¦U¦ì«ù¦³¤H(¦³²´¥úªº¤H)¤jÁÈ¡C³o¼Ë¤~¦³¦¨´N·P¡C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/4/25 ¤W¤È 09:53:53²Ä 1923 ½g¦^À³
|
dk¤j¡A§JªA¤ßÅ]¤§«á¡A¥¼¨Ó§ë¸ê·|¤@¦|·¶¶ªº; ¦³¤@¥y¸Ü»P§A¦@«j¡A§ë¸ê¬O¥H¦~¬°³æ¦ìªº; ³o½g¸ô¸³ªº±M³X±z¤]¥i¥H°Ñ¦Ò:www.qtumic.com/insights/1427825968822616064 |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/25 ¤W¤È 09:43:05²Ä 1922 ½g¦^À³
|
R¤j ¨ü±Ð¤F ¤ßÅ]Ãø¹L ¥u¯à§¤µ¥ÃD§÷µo»Ã¡A¤T¤ÑªÑªF¥i¥H¼W¥[1w¥H¤W¡C ±q¸ê¥»ÃB/ªÑªF¤H¼Æ:ªYÄ£(6.9»õ/ 2271¤H) :Ä_ÄÖ(8.5»õ/ 29736¤H):°ê¹©(14.2»õ/ 18372¤H):¦X¤@(38.8»õ/ 45737¤H) ¥Ø«e©úÅã¤H®ð¤£¨¬¡A«§Q´N¦b½G¥ÐµL¤H¯Ñ¡A¯Ñ¶}¦³¤Hª§(¤H¨ú§Ú±ó)! ¤H±ó§Ú¨úªº§NªùªÑ§ë¸êõ¾Ç ¦pªG§ë¸ê³£¸òµÛ¤j³¡¤À¤H°µ¤@¼Ëªº¨Æ±¡¡A¨ºªÖ©w¥u¯à±o¨ì¥±eªºªí²{¡A¦]¬°¤j³¡¤À¤H¥Nªíªº´N¬O¥§¡ÁZ®Ä¡CY§Æ±æ¯à¨ú±oÀu©ó¥§¡ªº³ø¹S¡A¦ÛµM¥²¶·´±©ó©M²³¤H¤Ï¦V¾Þ§@¡A³o¤]´N¬O¤Úµá¯S©Ò»¡ªº¡A¦b§O¤H³g°ý®É®£Äß¡A¦b§O¤H®£Ä߮ɳg°ý¡C¦P®É¡A¤H±ó§Ú¨ú¤]¬Onªí¹F¤@ºØ¿W¥ß¦Û¥Dªº¬ã¨sºë¯«¡A¦Ó¤£¬O¯S¥ß¿W¦æ¡A¬°¤F¤Ï¹ï¦Ó¤Ï¹ïªº§¾«Äºë¯«¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/25 ¤W¤È 09:32:32²Ä 1921 ½g¦^À³
|
¦X¤@SNS812¬OªvÀø»P¹w¨¾®ÄªG¡A½÷·ç»PÆQ³¥¸qªº¤fªAÃĬOªvÀø! ¬Ý¬ÝÆQ³¥¸q¬O¦nÃÄ(Àu©ó½÷·ç)¡A¬ü°ê¤]¶R³æ¡C MoneyDJ·s»D 2022-04-22 11:17:58 °OªÌ ½²©Ó±Ò ³ø¾É ¤é¥»ÆQ³¥¸q»sÃÄ(Shionogi¡B4507.JP)¬ãµo¤¤ªº¤fªA¦¡·s«aªÍª¢(COVID-19)ªvÀøÃĶǥX¬ü°ê¬F©²·Q¶R¡B¥¿©MÆQ³¥¸q¶i¦æ¨ó°Ó¡C¦ÓÆQ³¥¸qÃÒ¹ê¡A¡u¥¿©M¬ü°ê´N¥Í²£Åé¨î¡B¨ÑÀ³µ¥¨Æ¶µ¶i¦æ¨óij¡v¡A¿EÀy¤µ¤éªÑ»ùÅw¼y°f½Ä¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 11:39:56²Ä 1882 ½g¦^À³ »´¤¤¯g¯à¤j´T´î¤Ö¯f¬r¶q´N¬O§Ö³t¨úÃÒ¤§¹D! 2022.4.6 ¡nÆQ³¥¸q»sÃĤfªAÁ{§ÉÀø®Ä§ó³Ó½÷·ç»PÀq§J¡I www.genetinfo.com/international-news/item/57850.html ...90%¥H¤Wªº¨ü¸ÕªÌ©ó²Ä4¤ÑÅ餺¤wÀË´ú¤£¥X¯f¬r¶q.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 06:13:46²Ä 1920 ½g¦^À³
|
§ÚÀ£¦X¤@[»ó]Ãú¼Q¾¯ªº²z½×°ò¦ (Omicron¶Ý»ó©Ê·¥¤Ö«¯g¡A Delta¶ÝªÍ©Ê«¯g¦h) 2020.11.26 www.nature.com/articles/s41385-020-00359-2 °w¹ï¤W©I§l¹D·P¬V¡A¨¾·P¬V³Ì¨Îªº¬Ì]¬O¡u»ó¤º¬Ì]¡v¡A¦Ó¥Ø«eªº¡uª`®g«¬¬Ì]¡vÁöµM¥i¥H¹w¨¾«¯g¡A¦ý¤´Ãøªý¤î¤W©I§l¹D¶Ç¼½¡A¤£ºÞ´X¾¯¥[±j¡A¤j¬ù¹L¤F¥|Ó¤ë«á¡A´N·|¥¢®Ä¡A¨Ã¥i¶Ç¼½¥L¤H¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:31:34²Ä 1853 ½g¦^À³ §ÚÀ£: 1.¥þ²yº¤ä[»óÃú¼Q¾¯] ¦X¤@SNS812¼s®Ä«¬§Ü·s«a¬y·P¤p®Ö»Ä·sÃÄ¡A¤wn¥Ó½ÐP1 2.¦A¯}¥xÆW·sÃıÂÅv¬ö¿ýªºON101 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 05:38:46²Ä 1919 ½g¦^À³
|
¤µ¤Ñ¤â¤W³o®a¥¼¤W¥«¤½¥q¦b¥²´Iºô¶R»ù128~129¡A½æ»ù150¡C(¹wp250¤¸¥H¤W¤H¨ú§Ú±ó) ³o®a¤½¥q¥h¦~µ|«áÁÈ6.8¤¸¡A¦¨ªø>100%¡A¶i¤JÀ禬Ãzµo´Á.... 9¦~«e«Ü¦h¤H¥ÎÁ«·l»ù½æ¥X¡A«Ü¦nij»ù¦b¤Q¶ôªì¦¨¥æ¡C ·|§ë¸ê³o®a¤½¥q¬Oª¾¹D¨ä²£«~ªùÂe·¥°ª(¥xÆW«ÜÃø¦A¦³²Ä2®a¥X²{)¡C (¿ù»~)ªº¨M©w---³o¬O±q¤µ¤ÑªºÀò§Q»PªÑ»ùµ²ªG¨Ó¬Ý¡A¦ý¦b·í®É¬O(¹ï)ªº¨M©w¡A¦]¬°¨S¦h¤[¶Ç¥XÁ`¸g²zµ¥¤HÂ÷¾... --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/20 ¤W¤È 10:58:06²Ä 1226 ½g¦^À³ ...²{¦b¤â¤W³o®a¥¼¤W¥«¤½¥q¦b¥²´Iºô¶R»ù65~70(§Ú±µ¹L2¦¸¹q¸Ü¥X~70¤¸¶R)¡A½æ»ù120~140¡C ¦pªG¤£¬O5¦~«e»P¤@¦ì¬ãµo¸g²z²á¤Ñ«á³B²z1¥b«ùªÑ(¿ù»~ªº¨M©w)¡A²{¦b¤â¤W>300±i¡C ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/5/10 ¤W¤È 06:53:42²Ä 2536 ½g¦^À³ [·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/11 ¤U¤È 04:33:19²Ä 1500 ½g¦^À³ ¥¢±Ñ¨Ã¤£¥i©È¡A¤ßºA¨M©w¤F§ÚÌ·|¦p¦ó¦^À³!§ë¸êµJÂI»P§ë¤J»ù¦ì¤£¦P¡A©Ò¯à©Ó¨üÀ£¤O´N¤£¤@P¡C .................................................................................... ´¿¸g¤â¤W«ù¦³3®a¥¼¤W¥«¤½¥q¡A¤@®a´ó·À(·l¥¢15¸U)¡C2019¦~¤@®a¤W¿³Âd(«ù¦³18¦~Åo¡A§ë¤J¦¨¥»¦®³¦^¡A»P´ó·À¨º®a¤½¥q¦P¤@²£·~)¡C²{¦b¤â¤WÁÙ«ù¦³1¤ä¥¼¤W¥«¤½¥q(«ù¦³6¦~¡A§ë¤J¦¨¥»¤]¦®³¦^)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 05:12:20²Ä 1918 ½g¦^À³
|
±q¸ê¥»ÃB/ªÑªF¤H¼Æ:ªYÄ£(6.9»õ/ 2271¤H) :Ä_ÄÖ(8.5»õ/ 29736¤H):°ê¹©(14.2»õ/ 18372¤H):¦X¤@(38.8»õ/ 45737¤H) ¥Ø«e©úÅã¤H®ð¤£¨¬¡A«§Q´N¦b½G¥ÐµL¤H¯Ñ¡A¯Ñ¶}¦³¤Hª§(¤H¨ú§Ú±ó)! ¤H±ó§Ú¨úªº§NªùªÑ§ë¸êõ¾Ç ¦pªG§ë¸ê³£¸òµÛ¤j³¡¤À¤H°µ¤@¼Ëªº¨Æ±¡¡A¨ºªÖ©w¥u¯à±o¨ì¥±eªºªí²{¡A¦]¬°¤j³¡¤À¤H¥Nªíªº´N¬O¥§¡ÁZ®Ä¡CY§Æ±æ¯à¨ú±oÀu©ó¥§¡ªº³ø¹S¡A¦ÛµM¥²¶·´±©ó©M²³¤H¤Ï¦V¾Þ§@¡A³o¤]´N¬O¤Úµá¯S©Ò»¡ªº¡A¦b§O¤H³g°ý®É®£Äß¡A¦b§O¤H®£Ä߮ɳg°ý¡C¦P®É¡A¤H±ó§Ú¨ú¤]¬Onªí¹F¤@ºØ¿W¥ß¦Û¥Dªº¬ã¨sºë¯«¡A¦Ó¤£¬O¯S¥ß¿W¦æ¡A¬°¤F¤Ï¹ï¦Ó¤Ï¹ïªº§¾«Äºë¯«¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/24 ¤U¤È 04:09:55²Ä 1917 ½g¦^À³
|
¤H®ð¤£¨¬´N¬O¤£¨¬ ÃD§÷³£¨Sµo´§¨ì ±µ¤U¨Ó¯}¸U«Üªñ¤F ²{¦b¤£º¦«Ý¦ó®É |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/23 ¤W¤È 10:18:43²Ä 1916 ½g¦^À³
|
§ó·s¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä!!! 2009¦~7¤ë¡A¬ü°êFDA«Å¥¬¹ï¤A酰®ò°ò×ô¥[µùĵ§i¼ÐÅÒ¡A¥H´î¤Ö¥i¯à³y¦¨¹L¶qªAÃĪº±¡§Î¡Aµ²ªG¤£¨}¨Æ¥ó±q2009~2021¤´²r¼W440%!!! ------------------------------------------------------------------------------------------------- 2022.4.21---FDA ĵ§i¯kµh¸É¥R¾¯§t¦³¥¼¥Ó³øªºÃĪ« ...¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä ...2009 ¦~¡AFDA ´N¹ï¤A酰®ò°ò×ô¾ÉP¨x·l¶Ëªº·ÀIĵ§i¬ü°ê®ø¶OªÌ...³o¨Ç¦æ°Ê¹ï¹w¨¾¹ï¤A酰®ò°ò×ôªº¤£¨}¤ÏÀ³§@¥Î¬Æ·L¡C®Ú¾ÚFDA ªº¤£¨}¨Æ¥ó³ø§i¨t²Î¡A2009 ¦~³ø§i¤Fªñ 2,800 °_¯A¤Î¹ï¤A酰®ò°ò×ôªº¤£¨}¨Æ¥ó¡C¨ì 2021 ¦~¡A¤£¨}¨Æ¥óªº¼Æ¶q¤w¼Wªø¨ì 15,000 ¦h°_¡A¼Wªø¤F 440%¡C±q 2009 ¦~¨ì 2021 ¦~¡A³ø§i¤F¶W¹L 27,000 ¨Ò¯A¤Î¹ï¤A酰®ò°ò×ôªºÃĪ«¦º¤`¡C www.painnewsnetwork.org/stories/category/Pain+Medication |
|
|
·|û¡Gonly10135877 µoªí®É¶¡:2022/4/21 ¤W¤È 10:49:02²Ä 1915 ½g¦^À³
|
¤îµhÃĪº¬G¨Æ www.youtube.com/watch?v=obRnwe68VR4 |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/4/21 ¤W¤È 09:46:49²Ä 1914 ½g¦^À³
|
ªYÄ£©|»Ý¤º³¡±±¨î±M®×¼f¬d³ø§i¤~¯à¥Ó½Ð¤WÂd¡A¤º±±Án©ú®Ñ¬O¨CÓ·|p¦~«×²×¤F®É³£n¥Ó³øªº¶µ¥Ø¡AY¥h¬d¸ß¨ä¥L®a¤½¥q¤]¯àµo²{¤j¦h¼Æ©ó4¤ë«e³£·|§ó·s¡ã©Ò¥H·Ç½T¤£¯à»¡¬O¤WÂd¦³·s¶i®i |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/20 ¤U¤È 10:55:46²Ä 1913 ½g¦^À³
|
¬Ý¨Ó¨S¤H¤F¸Ñ ¨S¤Hª£ ªYÄ£¤]ºâ¨¾¬Ì·§©ÀªÑ°Ú. µL½×¥´¬ÌÐt©Î¬V¬Ì³£·|¥Î¨ì¤îµhÃÄ |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/4/20 ¤U¤È 04:02:40²Ä 1912 ½g¦^À³
|
¤½¥q³£¦³¦b¤@¨B¤@¨B¬°¤WÂd°µ·Ç³Æ¡A¤j®a¦w¤ßµ¥«Ý; ˬO§Ú¤ñ¸û¦n©_630ªº¤G´ÁÁ{§É¦ó®É·|¶}©l?¦³¤H¦³¸ê°T¶Ü? ----------------------------------------------------------------------------- ¤½¥q¥N¸¹ ¤½¥q²ºÙ ¤½§i¤é´Á ¤º±±Án©ú®Ñ¤§Ãþ«¬ ¥D¦® 6634 ªYÄ£ 111/03/30 Án©ú¤º³¡±±¨î¨î«×³]p¤Î°õ¦æ§¡¦³®Ä-¿í´`ªk¥O³W³¹³¡¤À±Ä¥þ³¡ªk¥O³W³¹§¡Án©ú 110¦~«×¤º³¡±±¨î¨î«×Án©ú®Ñ¤½§i |
|
|
·|û¡Gonly10135877 µoªí®É¶¡:2022/4/20 ¤U¤È 03:07:52²Ä 1911 ½g¦^À³
|
ªYÄ£¤]ºâ¨¾¬Ì·§©ÀªÑ°Ú. µL½×¥´¬ÌÐt©Î¬V¬Ì³£·|¥Î¨ì¤îµhÃÄ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/20 ¤U¤È 02:00:54²Ä 1910 ½g¦^À³
|
¨¾¬Ì·§©À³£¤W¤Ñ¤F¡A·sÃÄÁÙ¦b¦aªO¨S·R ¯u·Ð§r~~~ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/4/19 ¤U¤È 11:26:39²Ä 1909 ½g¦^À³
|
°ò¥»¤W¤£¥Î¤Ó¾á¤ß¡A¬Û«H¦n®ø®§¦bªñ´XӤ뤺·|¨Ó¨ì¡IªYÄ£¥ú¥Ø«e²{¦³¨â±iÃÄÃÒ¢w¥x¬ü¡A±N¨Ó¦~Àò§Q¦Ü¤Ö10¢w60¤¸¤§¶¡¡i«ü¦Û¤v©e¥N¤u¦Û½æ¡j¡AªÑ»ù´N¦³300¢w1200¤¸¹ê¤O¡A±N¨ÓÁÙ¦³«Ü¦h¦n®ø®§¡CÁÙ¬OÃéê¦í©ñÓ10¦~¡A¤@©wµo¤j°]¡I¤£n¤Ó«æºCºC¨Ó¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/19 ¤U¤È 06:05:34²Ä 1908 ½g¦^À³
|
µL®øµL®§~~µ¥«Ý¬Oº©ªøªº §Æ±æ¦³¦nµ²ªG |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/16 ¤U¤È 04:14:17²Ä 1907 ½g¦^À³
|
ÁÙ¤£½Ä¤@ªi n§ä²Ä¥|¥xÁÙ¬Olineªº¥D¤O¨Ó©Ô¤@¤U --------------------------- »´¯g¦b®a¸Õ¿ì ¬_¤åõ¡G´¶®³¯k¸Ñ¨M |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/4/15 ¤U¤È 09:55:02²Ä 1906 ½g¦^À³
|
©_©Ç¡I «ç»ò¨ì²{¦bÁÙ¨S¦³¤½§i¡H ¨ú±o·|p®vªº¡u¤º±±³ø§i¡v ³o¤£¬O¤WÂdªº¥²nµ{§Ç¶Ü¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/15 ¤U¤È 07:14:55²Ä 1905 ½g¦^À³
|
ªk·½¨Ì¾Ú¡G¨Ì¾·~¦w¥þ½Ã¥ÍºÞ²z¿ìªk²Ä86±ø³W©w¡A勞¤u¤H數¦b¤T¤Q¤H¥H¤W¤§¨Æ·~³æ¦ì¡A¨Ì²Ä¤G±ø¤§¤@¦Ü²Ä¤T±ø¤§¤@¡B²Ä六±ø³W©w³]ºÞ理³æ¦ì©Î¸mºÞ理¤Hû®É¡AÀ³¶ñ¨ã¾·~¦w¥þ½Ã¥ÍºÞ理³æ¦ì¡]¤Hû¡^³]¸m¡]ÅÜ更¡^³ø³Æ®Ñ¡]¦pªþªí¤T¡^¡A³¯³ø勞°ÊÀˬd¾÷ºc³Æ¬d¡C |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/4/15 ¤U¤È 06:19:20²Ä 1904 ½g¦^À³
|
½Ð°Ý104¼x¤~¡A¤A¯Å¾·~¦w¥þ½Ã¥ÍºÞ²z¤Hû ¨S¦³¤u¼t¤]»Ýn¤u¦w?ÁÙ¬O¤WÂdªk³W³W©w |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/14 ¤W¤È 05:28:18²Ä 1903 ½g¦^À³
|
1.¦p¹w´Á¬FªvÀ£¤O¤j¹L¤@¤Á¤U¡Apublic health emergency¦A©µªø90¤Ñ¨ì7/15 2022.4.13 www.reuters.com/business/healthcare-pharmaceuticals/us-renews-covid-19-public-health-emergency-2022-04-13/ ...This could be the last time HHS Secretary Xavier Becerra extends it, policy experts have said. ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 03:25:28²Ä 1872 ½g¦^À³ 1.¹w´ú¤U¶g4/15¦A©µªø90¤Ñ¨ì7/15¡A«ôµn§Y·|«Å¥¬²×¤îpublic health emergency¡C 2.°ê¹©¼B¸³¦b1/5»¡¦a[¸Ñª¼¦¨¥\]¦A¹L21¤Ñ§Î¦¨±j¯P»ä·¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/13 ¤U¤È 01:50:33²Ä 1902 ½g¦^À³
|
§Ú¬O½¼¦Ì1°¦¡A¤£¬O³Û¤ô·|µ²á¡A³Û¦ÌÅܦ׺ꪺ¤H¡A§æ¤£°ÊªÑ»ù¤W¤U¡C ¦Û¤v¿W¥ß§PÂ_¼f·V§ë¸ê¡A¦Ût·ÀI¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/13 ¤U¤È 01:26:16²Ä 1901 ½g¦^À³
|
¯E¹©¸Ñª¼ª§Ä³PÈ×¥¿±ø´Ú??? 2016.2.22¡i¥»³ø¥x¥_°T¡j¥Í§ÞªÑªÑ¤ý¯E¹©¡A¬Q¤Ñ¤½¥¬¨ÅÀùªvÀø©Ê¬Ì]·sÃÄOBI-822Á{§É¸ÕÅç¸Ñª¼µ²ªG¡A¡u¥DnÀø®Ä«ü¼Ð¥¼§e²{²Îp¾Ç¤WÅãµÛ·N¸q¡v¡A¦ý¯E¹©±j½Õ¡A³o¬O¤@¦¸«D±`¦¨¥\ªº¸Ñª¼¡A¤ñ¹w´Á¦n¡A¨S¦³©Ò¿×®À±Ñ¡AÃÒ¹ê¡uÀù¯g§K¬ÌÀøªk¤w¸g¤£¬O¹Ú¡A¬O¥i¥H¹ê²{ªº·sÀøªk¡v¡C -------------------------------------------------------------------------------------------- ¥]¬A¦ý¤£©ó:©Ò¿×¡u¥]¬A¦ý¤£©ó¡v¡A¹ê¬°§t¡]¥]¬A¡^¡u¦CÁ|ªÌ¡v¡A¦ý¤£¥H¡u¦CÁ|ªÌ¡v¬°¦Ó¨¥¡C Âd¶R¤¤¤ß:¤W(¿³)Âd¤½¥q«¤j°T®§µo¥¬À³ª`·N¨Æ¶µ°Ñ¦Ò°Ýµª¶°¡v×¥¿¹ï·Óªí www.tpex.org.tw/storage/eb_data/10805/108005569311-1.pdf ...´¦¥Ü¥Dn¤Î¦¸nµû¦ô«ü¼Ð¤§²Îpµ²ªG(¥]§t¦ý¤£©ó P È)¤Î²Îp¤W¤§·N¸q(¥]§t¦ý¤£©ó¬O§_¹F¦¨²Îp¤WÅãµÛµ²ªG)¡CÕ«ª©ó¨ä¥L«nì¦]¾ÉP¤½¥qµLªk´¦¥Ü²Îp¸ê®Æ¡A«hÀ³±Ô©ú²z¥Ñ»¡©ú¤§¡A±©¦]¥¼¥R¤À´¦ÅSP·l¤ÎªÑªFÅv¯q©Î¤Þµoª§³^¨Æ¥ó¡A¤½¥qÀ³¦Ût¨ä³d¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/13 ¤W¤È 09:08:24²Ä 1900 ½g¦^À³
|
³Ìªñ½L¶Õ¤S¤£¦n¤F¡A¿\¥É¦ó®Éµo¥ú? |
|
|
·|û¡GSunny10149577 µoªí®É¶¡:2022/4/12 ¤U¤È 11:05:13²Ä 1899 ½g¦^À³
|
R¤j:¦n ! ¬J¬OªYÄ£°Q½×ª© ´Á«Ý¦h¸ÑŪªYÄ£ªº¸ÕÅç¶i«× ¦Ü©ó¨ä¥L¤½¥qªºµû½×´NÂI¨ì¬°¤î |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤U¤È 03:10:34²Ä 1898 ½g¦^À³
|
Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³ 1¤äÃĪ«ªºÁ{§É¹êÅç«ç»ò¸ÑŪ? 1.¦pªG©úÅãÀu©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA·|´£«e²×¤î 2021.07.28¥_·¥¬P - KY(6550-TE) ¤µ (28) ¤éªí¥Ü¡A¦¬¨ì¬ü°ê FDA ¨Ó¨ç³qª¾¡AªvÀø´c½èªÍ¶¡¥ÖÀù·sÃÄ ADI-PEG20 ¤T ´ÁÁ{§É¸ÕÅç¡A¥i°±¤î¦¬¨ú¯f±w¡B´£¦µ²§ô¸ÕÅç¨Ã¶i¦æ¸Ñª¼¡A«Ý§¹¦¨Á{§É¸Ñª¼«á¡A±N¥Ó½ÐÃÄÃÒ¡C 2.¦pªG©úÅã®t©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA¤]·|´£«e²×¤î 2017.7.6 ¸ÕÅçªÌ¦º¤` FDA ©R¥OÀq§J°±¤î¤T¶µ Keytruda ÃöÁä¬ã¨s read01.com/Q3Aogyk.html#.Ycvx0GhBzcs FDA «Øij¨ü¸ÕªÌ¥ß¨è©ñ±ó°Ñ»P Keytruda ªº¨â¶µ III ´Á¬ã¨s¡A¨Ã©R¥OÀq§J¥ß§Y°±¤î KEYNOTE-023 ¶¤¦C 1 ¤¤ªº±wªÌ¹ê Åç¡C 3.¤ð¶·×§ïÄ~ÄòÁ{§É¬O¥Ã 2021.8.31--¥ÍµØ¬ì·sÃÄSilmitasertib(CX-4945)¥Î©ó·s«aªÍª¢¤G´Á«¯g¤HÅé¡A¤µ(31)¤é«Å¥¬Á{§É¸ÕÅç´Á¤¤¼Æ¾Ú¡A¸g¿W ¥ßÁ{§É¼Æ¾ÚºÊ¹î©eû·|(Data Monitoring Committee¡ADMC)¼f¬d³q¹L¡A¤ð¶·×§ï¥ô¦óÁ{§É¸ÕÅç³]p¡A¥i«ùÄò¶i¦æ·s«a« ¯g±wªÌ¦¬®×¡C 4.¶·×§ï¤Ï˦³¤F¤£½T©w? (»´¤¤¯g¦º¤£¤F¤H¡A©Ò¥H¤£¥i¯à³Q²×¤î) °ê¹©:DMC«Øij¼W¥[¦¬ªv»Ýn®ñ®ð¤ä«ù¤§«¯g¦í°|¯f±w¡C(«D«I¤J©Ê³q®ð¡B°ª¬y¶q®ñ®ð©Î¸§J½¤) ³o®É¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J«¯g±wªÌÁ{§É¬Ý¬Ý¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤U¤È 03:04:48²Ä 1897 ½g¦^À³
|
¬Q¤é¦A¼W1®a¤¤«×¦Ü««×¦í°|±wªÌ¤fªAÃÄ¥Ó½ÐEUA ¡A[°ß¿W°ê¹©¼B¸³«ÅºÙ¤£¥ÎPȹF¼Ð]!!! 2022.4.11 ¬ü°êÁÚªü±KVeru¤½¥q¤fªA§Ü¯f¬rÃĪ« sabizabulin¡A P3¤¤´Á¼Æ¾ÚÅã¥Ü¡A»P¦w¼¢¾¯¬Û¤ñ¡A¦b¤¤«×¦Ü««×¦í°|±wªÌ¤¤ªº¦º¤`²v°§C¤F 55%¡C¡]p=0.0029¡^µ²ªG³Q»{¬°¨ã¦³²Îp¾Ç·N¸q©M²Îp¾Ç·N¸q¡C -------------------------------------------------------------------------------------------- Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤W¤È 07:44:08²Ä 1896 ½g¦^À³
|
¨S¦³Pre-EUAªºsubmission number¨ü²zÃÒ¸¹¡Aªí¥ÜFDA¤£¦P·N¥Ó½ÐEUA! ¦A¤T©IÆ~Âd¶Rn¨D°ê¹©¤½§i1¤ë¥÷»PFDA Pre-EUA·|ijµ²ªG¡A¦³¨S¦³¦¬¨ìFDA ªºpre-eua acknowledgment letter? »¡¥Õ¤Fn¬OFDA¦P·N¥Ó½ÐEUA¡A°ê¹©¦Ñ¦Ær¹ª³Ù¤Ñ³Û¥X¸¹½X¡C ±q¸Ñª¼¼Æ¾Ú¥ÎÃIJջP¹ï·Ó²Õ¨S¦³®t²§¡A§Ú±ÀÂ_°ê¹©¨S¦³Pre-eua meeting! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤W¤È 05:15:17²Ä 1895 ½g¦^À³
|
¬JµM±Nµ²§ôPHE¡AFDA·|Ä~Äò±ÂÅvEUA??? ¡§¤Z¤H¤§´¼¡A¯à¨£¤wµM¡A¤£¯à¨£±NµM¡C¡¨ ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/4 ¤W¤È 09:30:58²Ä 1862 ½g¦^À³ Adagio»PRevive¥Ó½ÐEUA¤]¦³¨Ç±ß¡A¦]¬°±q¦U¤è·s»D®ø®§¨Ó¬Ý¡A«ôµn¤£¤é´N·|«Å¥¬²×¤îpublic health emergency¡C ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤W¤È 06:25:02²Ä 1663 ½g¦^À³ ¬°¤°»òn¬ÝPHE©µªø©Îµ²§ô? ©³¤U˹L¨Ó¡A¤@¥¹HHS«Å¥¬ºò«æª¬ºA(PHE)µ²§ô¡AFDA§Y¨S¦³EUAÅv¤O¡C ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 05:28:06²Ä 1657 ½g¦^À³ µo¥¬EUAªºµ{§Ç¯A¤Î¤Ó¨BÆJ¡G¤@¬O½T©w¬O§_¶i¤Jºò«æª¬ºA¡A¥Ñ°ê¨¾³¡¡B°ê¤g¦w¥þ³¡©Î½Ã¥Í©MºÖ§Q³¡¡]Health and Human Services¡AHHS¡^½T©w¡F¤G¬OHHS«Å¥¬¶i¤Jºò«æª¬ºA¡F¤T¬OFDA¹ïEUA½Ð¨D¶i¦æ¼fµû¡F¥|¬OHHSµo¥¬¡]©Î©e°UFDA¥Nµo¡^EUA©Î©Úµ´EUA½Ð¨D¡F¤¬OHHS²×¤îEUA¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤W¤È 05:06:56²Ä 1894 ½g¦^À³
|
2022.4.11 HHS µo¥X¤F¤½¦@½Ã¥Íºò«æ¨Æ¥ó³vº¥µ²§ôªº©ú½T«H¸¹ www.healthcarefinancenews.com/news/hhs-giving-clear-signals-wind-down-public-health-emergency Áp¨¹¬F©²Ãö«Yt³d¤HMichael P. Strazzellaªí¥Ü..¡A·í«eªº¤½¦@½Ã¥Íºò«æª¬ºA±N©ó 4 ¤ë 16 ¤éµ²§ô¡AÁp¨¹¬F©²¤w¸gµ¹¥X¤F PHE §Y±Nµ²§ôªº©Ò¦³¸ñ¶H¡C...½Ã¥Í»P¤½²³ªA°È³¡³¡ªø¿Aºûº¸¡P¨©¶ë©Ô¦b¹wºâÅ¥ÃÒ·|¤W©ú½Tªí¥Ü¡A¸Ó°ê§Y±Nµ²§ô³o³õ¤½¦@½Ã¥Íºò«æ¨Æ¥ó¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 03:25:28²Ä 1872 ½g¦^À³ 1.¹w´ú¤U¶g4/15¦A©µªø90¤Ñ¨ì7/15¡A«ôµn§Y·|«Å¥¬²×¤îpublic health emergency¡C 2.°ê¹©¼B¸³¦b1/5»¡¦a[¸Ñª¼¦¨¥\]¦A¹L21¤Ñ§Î¦¨±j¯P»ä·¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/4 ¤W¤È 09:42:25²Ä 1863 ½g¦^À³ 2022.3.16 President Biden Signs Into Law Medicare Telehealth Coverage Extension Post-Public Health Emergency ... after the end of the designated public health emergency (¡§PHE¡¨) www.jdsupra.com/legalnews/president-biden-signs-into-law-medicare-580961 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/11 ¤U¤È 08:12:34²Ä 1893 ½g¦^À³
|
®×¨Ò:www.sohu.com/a/381736110_120554400 °ò³J¥Íª«¦b2020¦~3¤ë13¤é¡A¬ü国FDA¦P·N¨ü²zPre-EUA¡A¤]µ¹¤Fsubmission number:PEUA 200083FDA ¡A ³Ì«áFDA¼f§åµ²ªG¤£±ÂÅvEUA ! xueqiu.com/1468994395/152988279 °ò³J¥Íª«¤£¦A³QFDA¤¹许开®i·s«a¯f¬r检测 §Ú±ÀÂ_°ê¹©³sPre-eua meeting¤]¨S¦³!!! --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/11 ¤U¤È 04:35:10²Ä 1892 ½g¦^À³ ...¥ýn¦³1. FDA Pre-EUA [¦P·N]¨ü²z¸ê®æ¡A¤~¯à¦³2.¥Ó½ÐEUA¡AFDA±ÂÅv»P§_¸ê®æ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/11 ¤U¤È 04:35:10²Ä 1892 ½g¦^À³
|
1/5°ê¹©¸Ñª¼°OªÌ·|www.youtube.com/watch?v=R1Xs-SLfu8Q 20¤À05¬í~¼B¸³»¡1¤ë¥÷n¥Ó½ÐPre-EUAmeeting¡C ©IÆ~Âd¶Rn¨D°ê¹©¤½§i1¤ë¥÷»PFDA Pre-EUA·|ijµ²ªG¡A¦³¨S¦³¦¬¨ìFDA ªºpre-eua acknowledgment letter? ¥ýn¦³1. FDA Pre-EUA [¦P·N]¨ü²z¸ê®æ¡A¤~¯à¦³2.¥Ó½ÐEUA¡AFDA±ÂÅv»P§_¸ê®æ¡C 1. (Pre-EUA·|ij)FDA¦P·N¨ü²zPre-EUA¥ýµo±iPEUAÃÒ : PEUAÃÒªø³o¯ë¼Ò¼Ë: www.sohu.com/a/381736110_120554400 ( submission number:PEUA XXXXXX) 2. FDA¦P·N±ÂÅvEUA¦Aµo±iEUA ÃÒ®Ñ: EUAÃҮѪø³o¯ë¼Ò¼Ë: www.fda.gov/media/136522/download (EUA Number: EUA XXXXXX) -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/21 ¤W¤È 08:01:08²Ä 1807 ½g¦^À³ ¦pªG°ê¹©¦b2¤ë¦³¸òFDA¶}pre-EUA Meeting¡Aªì¨B¼f¬d¼Æ¾Ú«á¡A½Ð°ÝFDA¬Oµo[¦P·N]ÁÙ¬O[¤£¦P·N]¨«step 4³o¨B? ¨Ì3/16ªº¼Æ¾Ú¡A§Ú»{¬°¨S¦³step 3 ¡A¦]¬°¦³¦¬¨ìFDA ªºpre-eua acknowledgment letterÅK©w¬OºVÆr¥´¹ªªºµo¥¬!!! ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/19 ¤W¤È 11:56:49²Ä 1804 ½g¦^À³ ¡§³Õ¾Ç¤§¡A¼f°Ý¤§¡A·V«ä¤§¡A©ú¿ë¤§¡A¿w¦æ¤§¡¨ .. °ê¹©¥Í§ÞÁ`¸g²z Ĭ¸g¤Ñ¡G...µM«á¸òFDA´N¬O¥Ó½ÐPre-EUAªº·|ij¡C[¦P·N]¡A¨º§ÚÌ´N·|submit¡A´N¬O¶i¦æ¥Ó½ÐEUAªº°Ê§@¡C¡v |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/11 ¤U¤È 04:19:06²Ä 1891 ½g¦^À³
|
ÀH®É===>µ¥¤F¦n¤[§r~~³o¨Ç¤j¼t¦bµ¥¤°»ò©O?»°§Öñ¤@ñ¤F°Õ ¤j½L¤£¦n¡A¤£¹L¬Ý°_¨Ó¬O¦³¤HÅU¡C °£¥»¤½¥qSNP-810(¦w®õ®³ ¯k)¥~¡A¥Ø«e¥«³õ¤W©|µL¨ä¥¦Ãþ¦üµL¨x¬r©Ê¤§acetaminophen¤§¤îµhÄvª§²£«~¡C¥Ø«e¥»¤½ ¥qSNP-810·sÃĤw»P°ê»Ú¥Dn¤îµhÃĤj¼tñq¦³Àv¦X¬ù¡A¦³³Ì·s¶i®i¡A±NÀH®É¤½§i¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/11 ¤W¤È 08:13:19²Ä 1890 ½g¦^À³
|
ÃĪ«¦³¨S¦³Àø®Ä¦b¦X¦¨®É´Nª`©w¡AÁ{§É¸ÕÅç¥u¬OÅçÃÒ¨ä¦w¥þ»PÀø®Ä¡C ÂÔ·V°ª¼hªº¸gÀçºÞ²z¸Û«H!(13¦~¿³Âd¤¸¦Ñ) ...«e¥ô¸ê¸Û·|p®v©ó°õ¦æ[°]°È³øªí¬d®Ö¥~¶Ô]´Á¶¡.... ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/16 ¤U¤È 05:21:57²Ä 1522 ½g¦^À³ 3¨¥2»y»¡¤£²M¡A²Ä6·Pn«¥¯à¸ú¦h»·°{¦h»·! -------------------------------------------------------------------------------------------- ¤½¥q¦WºÙ¡G°ê¹© µo¨¥¤é´Á¡G2021/11/25 µo¨¥®É¶¡¡G16:29:53 µo¨¥¤H¡G´¿¤ì¼W 1.¸³¨Æ·|³q¹L¤é´Á(¨Æ¹êµo¥Í¤é):110/11/25 ... 8.Åܧó·|p®v¤§ì¦]:¥»¤½¥qÀç¹B¤ÎºÞ²zµ¥¾ãÅé¦Ò¶q 11.³Ìªñ¤G¦~«×¤w¥Ó³ø©Î§Y±N½s»s¤§°]°È³ø§i¬O§_´¿¸g·|p®v½Õ¾ã©Î´£¥X¤º ³¡±±¨î«¤j§ï¶i¨Æ¶µ¤§«Øij: ¬O¡C«e¥ô¸ê¸Û·|p®v©ó°õ¦æ109¦~¦~«×°]°È³øªí¬d®Ö¥~¶Ô´Á¶¡¡A«Øij¥»¤½¥qÀ³¸¨¹ê Ãö«Y¤H¿ëÃѤκ޲z¡BÀ³±j¤Æ¹ï¤l¤½¥q¤§ºÊ·þ»PºÞ²z§@·~¡B¥Ó½Ð¶U´Ú«e¨Ì¨î«×¹w¦ô¸ê ª÷»Ý¨D¡BÀ³¸¨¹ê¾P°âq³æ³B²z¤Î¥æ³f§@·~¡BÀ³¸¨¹ê§ë¸ê§@·~°lÂܤΦs³f¤§²¾°ÊÀ³¥ß §Y¥¿½T¬ö¿ý¡C¥t¨ä©ó¶i¦æ109¦~¦~«×¤º±±¨î«×¹ê¦a¬d®Ö§@·~¡A«Øij¥»¤½¥qÀ³¸¨¹ê¸³ ¨Æ·|¤Î¼fp©eû·|¤§¥l¶°µ{§Ç¤Î¤å¥ó»P¬ö¿ý§@·~¡BÀ³¸¨¹êÁ~¹SºÞ²z©eû·|§@·~¡BÀ³ ¸¨¹ê¹ï¤l¤½¥q¤§ºÊ·þ»PºÞ²z§@·~¡BÂç²M¦L¥§¤l¤½¥q¤§§ë¸ê¡BÀ³¸¨¹êÃö«Y¤H¥æ©öºÞ²z §@·~¡BÀ³¸¨¹ê¾P°â´`Àô§@·~¡B«Ø¥ß¦U¶µ¶O¥Î³ø¤ä¤§ºÞ²z§@·~¡BÀ³¥[±j¤º³¡½]®Ö¤§Â¾ ¯à(§t¤º±±¦Ûµû¤§¾É¤J)¤ÎÀ³¸¨¹ê¦LŲºÞ²z§@·~¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/20 ¤W¤È 07:06:12²Ä 533 ½g¦^À³ ...ªü¯÷®üÀq¯g³Ð·sÃĪ«¤j¼ú¦n§l¤Þ¤H!°÷¸Þ²§ªº....3¨¥2»y»¡¤£²M¡A«¥¦¥X²M¨SÁȨS½ß¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/11 ¤W¤È 07:42:23²Ä 1889 ½g¦^À³
|
开©Ý药业»P°ê¹©Á{§É³]p¦P¼Ë¥[SOC¡A开©Ý药业733¦W¨ü¸ÕªÌ¬O°ê¹©124¤Hªº5.9¿¡A733¦W¸Ñª¼¼Æ¾Ú§tPÈ(°ê¹©Ãø²£)! 开©Ý药业¥ÎÃIJÕ:GT0918+ SOC / ¹ï·Ó²Õ:¦w¼¢¾¯+ SOC °ê¹©¥ÎÃIJÕ:Antroquinonol+SOC / ¹ï·Ó²Õ:¦w¼¢¾¯+SOC clinicaltrials.gov/ct2/show/NCT04870606?term=NCT04870606&draw=2&rank=1 |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/10 ¤U¤È 09:55:52²Ä 1888 ½g¦^À³
|
§Ú²q·QR¤j¬O´£¿ô§ë¸ê¤H¹ï©ó¬ì¾Ç¤W¤ÀªR¦³¦³¾Ì¦³¾Ú¡A¦Ó¤£¬O¥Î¦ü¬O¦Ó«D¨Óª£ªÑ. ¤§«eªº¯E¹©¤¤¸Î¤Ó¶Ë¤F¡C¤Ï¥¿¤£³ßÅw´N§O¬Ý¡A¤£µM·sÄ£¤]¤Ó§N²M¤F §Úªº¬Ýªk¡A§Ú¥Î¤§«eªº·s»D¨Óµû©T¡A§â¤â¤W³Ñ¤Uªº¹©¤ý³£¥X¥ú¤F ¥Dnµû¦ô«ü¼Ð±d´_²v(recover ratio)¡A¸ÕÅçµ²ªG¦b²Ä14¤Ñ¥ÎÃIJժº±d´_²v¬O100%¡A¹ï·Ó²Õªº±d´_²v¬O96.0%¡C¦¸nµû¦ô«ü¼Ð¦³ICU«¯g¯f¤HªvÀø®É¶¡¡APȬ°0.5404)¡A¦í°|®É¶¡PÈ0.9951¡A§ïµ½®É¶¡PÈ0.7034¡A²M°£¯f¬rªº®É¶¡PÈ0.5422¡A©I§l§xÃøPÈ0.0327¡A¦Ù¦×µmµhPÈ0.0525¡A¨ý¶åı³à¥¢PÈ0.1059¡C ·|û¡G¶À±Ò½÷10152632 µoªí®É¶¡:2022/4/8 ¤U¤È 05:13:36²Ä 1873 ½g¦^À³ ¥ý©ñ¹L§O¤H¡A¤~¯à©ñ¹L¦Û¤v¡A§_«h¦p§A³o¯ë¥Ã»·³Q°ê¹©ªº¹ï¿ù¡A¸j¦í§Aªº¤H¥Í¡A¦óW¨Ó«v¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/10 ¤W¤È 09:22:54²Ä 1887 ½g¦^À³
|
°ê¹©¦¡ªº¸Ñª¼ PK 开©Ý药业¸Ñª¼PÈ -------------------------------------------------------------------------------------------------- 开©Ý药业¤è±还ªí¥Ü¡A´¶§J鲁Ói¥i¦³®Ä°§C·s«a±wªÌªº¦í°|/¦º¤`²v¡A¯S别¬O¦b§¹¦¨ªA药¤j¤_7¤Ñªº¨ü试ªÌ¤¤¡]N=693¡^¡A对·Ó组¤Î´¶§J鲁Ói组¦í°|¨Æ¥ó数¤À别为6¨Ò¡]§t¤@¨Ò¦º¤`¡^¤Î0¨Ò¡]p¡à0.02¡^¡A¬Û应«O护²v为100%¡C ´¶§J鲁Ói¦b¦ñ¦³°ª风险¦]¯Àªº¨ü试ªÌ¤¤¡]¯S别¬O¤¤°ª¦~龄组¡^¡A¯à显µÛ°§C¦í°|/¦º¤`²v¡C¦p¦~龄≥60岁¥B¦ñ¦³¦Ü¤Ö¤@个°ò础¯e¯f¡]¨Ò¦pªÎD¡B¿}§¿¯f¡B°ª¦å压µ¥¡^ªº¨ü试ªÌ¡A´¶§J鲁Ói¥i显µÛ°§C¦í°|/¦º¤`²v¡]p¡à0.02¡^¡A¬Û应«O护²v为100%¥BÆÓ¦í°|©Î¦º¤`¡C 开©Ý药业还ªí¥Ü¡A¬Û对¤_对·Ó组¡A´¶§J鲁Óiªv疗组从给药²Ä3¤Ñ¨ì²Ä28¤Ñ¡A¥i显µÛ«ù续°§C·s«a¯f¬r载¶q¡]²Ä3¤Ñ¤Î²Ä28¤Ñ¡Ap¡à0.01¡^¡C¦Ó¦b¯g状§ïµ½¤è±¡A´¶§J鲁Ói组较对·Ó组¥i§ó¦n¦a§ïµ½·s«aªÍª¢ªº³¡¤À¬Û关¯g状¦p发热¡BÉaµu¡B«y¹Â¡A¥B§ïµ½«ù续ɬ¤_对·Ó组¨ì¦Ü¤Ö²Ä28¤Ñ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/10 ¤W¤È 09:12:48²Ä 1886 ½g¦^À³
|
Delta¦b¬ü°ê¤wªñ¥Gµ´¸ñ(¥@¬É¦U¦a¦P¬O)¡AÁ{§É¨S¦³¦¬ªvOmicron±wªÌªº¼Æ¾Ú¡A§O¦b°µEUA¤j¹Ú¡C www.statista.com/chart/27076/coronavirus-variants-in-the-us/ ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤U¤È 01:50:12²Ä 1859 ½g¦^À³ ¬°¤°»ò²{¦b¥Ó½ÐEUA¼Æ¾Ú¤À¦¨Omicron[«e]»P[«á]¥Î·N???(³o´N¬O§Ú¦b1/22´£°Ý°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æªºì·N) ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 02:22:40²Ä 1614 ½g¦^À³ ¶K´X«h°T®§¡A§ë¸ê¤H[¿W¥ß«ä¦Ò]²´¤UFDA±ÂÅvEUA¦a±ø¥ó??? 1.°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æ? 2. ¬ü°ê¦b2021.11.27«eOmicron¯f¨Ò 0¡A ¬ü°êÁp¨¹¯e¯f¨¾ªv¤¤¤ß(CDC)ºI¦Ü2022.1.1¤é°ê¤º95.4%ªº·s¯f¨Ò¡ADeltaÅܺدf¬r«h³QÀ£ÁY³Ñ¤U4.6% |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/10 ¤W¤È 07:08:02²Ä 1885 ½g¦^À³
|
开©Ý药业´¶§J鲁Ói(Á{§É3´Á¼Æ¾Ú¨ã¦³ [统计学显µÛ©Ê] ) PK °ê¹©Antroquinonol(Á{§É2´Á ¼Æ¾ÚÃø²£!!!) ------------------------------------------------------------------------------------------------ 1. 733¦W¨ü试ªÌ¡A¨ä¤¤¦³727¦W(99.18%)¨t¦b [¬ü国] ¤J组 2.´¶§J鲁Ói¦³®Ä°§C·s«a±wªÌ¡]¥Dn¨üDelta©MOmicron变ÉÝ®è·P¬V¡^ªº¦í°|²v©M¦º¤`²v¡A¯S别¬O对¤_ªA药¶W过7¤Ñªº¥þ³¡±wªÌ¡A¥H¤Î¦ñ¦³°ª风险¦]¯Àªº¤¤°ª¦~龄·s«a±wªÌ达¨ì100%«O护²v¡A¨ã¦³ [统计学显µÛ©Ê] ¡C ¡@¡@ 数Õu显¥Ü¡A´¶§J鲁Ói对轻¤¤¯g¨k©Ê±wªÌªº¦í°|风险°§C100%¡A轻¤¤¯g¤k©Ê±wªÌªº¦í°|风险°§C90%¡F«¯g·s«a±wªÌªº¦º¤`风险°§C92%¡A¦í°|¤Ñ数缩µu9¤Ñ¡C 3.¥h¦~7¤ë16¤é¡A´¶§J鲁Ói³Q¤Ú©Ô¦c±Â¤©紧«æ¨Ï¥Î±Â权¡]EUA¡^¡A¥Î¤_·s«a¦í°|±wªÌªºªv疗¡C¥B´¶§J鲁Ói´¿¤@«×ÉO¤é¥»盐³¥ú媺S-217622³Q认为¬O¨ä疗®Ä¦³¥i¯à·B¬ü©ÎªÌ¶W¶V辉·çPaxlovidªº·s«a¤fªA药¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/9 ¤W¤È 06:50:39²Ä 1884 ½g¦^À³
|
¤£n§Q¥Î¸ê°T¤£¹ïµ¥¨Ó§|±þ¤@ª¾¥b¸Ñªº§ë¸ê¤H! ½Ð°Ý°ê¹©¦³¨S¦³¦¬ªvOmicron±wªÌªºÁ{§É¼Æ¾Ú¡AÅýFDA¨ü²zpre-EUA??? ¡§NCT04870606ªº临§É试从2021¦~4¤ë开©l¤J组¡A当时¡A¦b¬ü国¬y¦æªº¬O·s«a¼wûضð变ÉÝ®è¡F¨ì¤F2021¦~12¤ëªì¡A¬ü国¤S¥H奥±K§J¦¥变ÉÝ®è较为¬y¦æ¡C¡¨开©Ý药业创©l¤H¡B¸³¨Æ长ÝCEOµ£¤Í¤§³Õ¤h¦b§ë资ªÌ电话会议¤Wªí¥Ü¡A¦]¦¹¡A¡§´Á¤¤¦Ò¡¨Ê^现ªº¡A¥Dn¬O´¶§J鲁Ói对¼wûضð变ÉÝ®èÚÌ诊±wªÌªº®ÄªG¡F¦Ó¡§¥æ¨÷¡¨«eªº¦Z¤T©P¡A«ez临§É试验ªº¤J组¤H员则¤S¥H奥±K§J¦¥变Éݮ誺ÚÌ诊±wªÌ为¥D¡C ¡@¡@©Ò¥H¡§³Ì终ªº数Õu©Ò现§e现ªº结ªG¬O¼wûضð¡B奥±K§J¦¥¤@°_ªº结ªG ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤U¤È 01:50:12²Ä 1859 ½g¦^À³ ...¬°¤°»ò²{¦b¥Ó½ÐEUA¼Æ¾Ú¤À¦¨Omicron[«e]»P[«á]¥Î·N???(³o´N¬O§Ú¦b1/22´£°Ý°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æªºì·N) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/9 ¤W¤È 06:25:54²Ä 1883 ½g¦^À³
|
¦n¦n¾Ç¾Ç¹ï©¤´Á¤¤¦Ò¦¨绩¤£¦n¦ý«i´±±¹ï¡Aª¾¤v¥¢±Ñì¦]«á¡A¤O©é´Á¥½¦Ò½Âà(¤£n1±i¼L´N·|¸ò½÷·çPK¸ò·ç¼w¦è³PK)¡C 2022.4.7 ¥þ²y²Ä¤T´Ú·s«a¤fªA¯S®Ä药n来¤F¡H开©Ý药业´¶§J鲁Ói¤WºtÕa¤Ñ¤j¤Ï转 ¤½¥qªÑɲ¤@¤é½µf www.ce.cn/cysc/yy/hydt/202204/07/t20220407_37468284.shtml ¤½¥q将积Ìå¦V¤¤国¡B¬ü国¤Î¨ä¥L国®a©M¦a区ªº国®a药ª«监·þÉóÌÛ¥Ó请紧«æ¥Î药EUA许¥i¡C ...该试验¦@¤J组¤F733¦W¨ü试ªÌ¡A¨ä¤¤¦³727¦W(99.18%)¨t¦b¬ü国¤J组¡C开©Ý药业对¡m¬ì创ªO¤é报¡n记ªÌ进¤@¨Bªí¥Ü称¡A«ez试验´Á间¡A¬ü国¥ý¦Z¦³¼wûضð¡B奥±K§J¦¥两Ïú·s«a¯f¬r变ÉÝ®è¬y¦æ¡A¦]¦¹¡§该临§É试验关键数Õu¤]证实¤F¡A´¶§J鲁Ói对¼wûضð©M奥±K§J¦¥变Éݮ誺临§É疗®Ä¡C ...´¶§J鲁Ói还¥i显µÛ«ù续°§C·s«a¯f¬r载¶q ...´¶§J鲁Ói¥æ¥Xªº¡§´Á¥½¦Ò¡¨¦¨绩单¡A让«Ü¦h¤H·P¨ì·N¥~¡C为´N¦b2021¦~©³¡A开©Ý药业´¿¤½§i¤F«ez临§É试验ªº¡§´Á¤¤¦Ò¡¨¦¨绩¡]§Y¤¤´Á数Õu¡^¡A¤ÀªR结ªG为¡§该项临§É试验¦]为¨Æ¥ó数较¤Ö没¦³达¨ì统计学显µÛ©Ê¡¨..... -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/13 ¤U¤È 05:49:50²Ä 1697 ½g¦^À³ Á{§É¬O¬ì¾Ç¡A¬ì¾Ç¬O¬Ý¼Æ¾Úªº¡A¦Ó¤£¬O¤@¥y¡un¸ò½÷·çPK¡v! ÆQ³¥¸q»¡©ú·|ªº¼Æ¾Ú¡AS-217622¦b°§C¯f¬r¸ü¶q»PPaxlovid±µªñ¡A¥i¥H»¡¬O¤@ÓÅå³ß¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 11:39:56²Ä 1882 ½g¦^À³
|
»´¤¤¯g¯à¤j´T´î¤Ö¯f¬r¶q´N¬O§Ö³t¨úÃÒ¤§¹D! 2022.4.6 ¡nÆQ³¥¸q»sÃĤfªAÁ{§ÉÀø®Ä§ó³Ó½÷·ç»PÀq§J¡I www.genetinfo.com/international-news/item/57850.html ...90%¥H¤Wªº¨ü¸ÕªÌ©ó²Ä4¤ÑÅ餺¤wÀË´ú¤£¥X¯f¬r¶q.... ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 10:31:37²Ä 1858 ½g¦^À³ (²Ä¤@½uÃĪ«)»´¤¤¯gºnªvÀø¦b¤j´T´î¤Ö¯f¬r¶q¹w¨¾¶i®i¬°«¯g¡A¦Ó«¯gªÌªººnªvÀø¤£¦b´î¤Ö¯f¬r¶q! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:42:20²Ä 1854 ½g¦^À³ ¦X¤@SNS812:³q过ú£¤Ö¯f¬r°ò¦]组©M»E¦X酶mRNAªº«þ贝数¡A§í¨î¯f¬rÎ`¨î¦}ªý断¦Z续·P¬V¡C IC50 med.sina.cn/article_detail_100_2_113260.html --------------------------------------------------------------------------------------- ¤é¥»ÆQ³¥¸qS-217622(§í¨î·s«a¯f¬rªº¼W´Þ) EC50 xueqiu.com/3403713237/213884867 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 11:03:06²Ä 1881 ½g¦^À³
|
·sÃÄ»â°ì«Ü´Ý»Å¡A¥²¶·n¦³¤H¨«¦b«e±¶}¸ô¡A¨CÓ¤H³£§Æ±æ·sÃĶ}µo¦¨¥\ºÉ³t¶i¤J¥«³õ¡B¥[¤J®¾±Ï¥Í©Rªº¦æ¦C¡A¦ý¤½¥q¤£¯à§Q¥Î¸ê°T¤£¹ïµ¥¨Ó§|±þ¤@ª¾¥b¸Ñªº§ë¸ê¤H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 10:53:56²Ä 1880 ½g¦^À³
|
3/15 [¤½§i¡j¸É¥R¨ÌÂd¶R¤¤¤ß¨Ó¨çn¨D½Ã¥ÍºÖ§Q³¡¯e¯fºÞ¨î¸pÁܽа깩¥X®u ...(µù: 1.¹ï·Ó²Õ¬O±Ä¥Î¼Ð·ÇÀøªk¡A¥i¨Ï¥Î¤w®ÖãÃĪ«¡A¥]§t·ç¼w¦è³¡C --------------------------------------------------------------------------------------------------- 3/15¤½§iÃø¹D¤£¬O¬G·NÁô¿f¥ÎÃIJդ]¥Î¼Ð·ÇÀøªk??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 10:40:39²Ä 1879 ½g¦^À³
|
¼B¸³©úª¾¥ÎÃIJջP¹ï·Ó²Õ¤GªÌ¬Ò¥[¼Ð·ÇÀøªk(SOC:¥i¨Ï¥Î¤w®ÖãÃĪ«¡A¥]§t·ç¼w¦è³) ½Ð°Ý¼B¸³¬°¦ón»~¾É§ë¸êªÌ¥H¬°AntroquinonolÀø®Ä¨Î(4¤Ñ-»´¤¤¯g)¥i»P·ç¼w¦è³(10¤Ñ-«¯g)PK? ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 09:19:59²Ä 1856 ½g¦^À³ Ãø¹D°ê¹©Á{§É³]p¤£¬OÀu®Ä©Ê³]p??? 2022.3.15°ê¹©¤½§i§ó¥¿: ¥ÎÃIJÕ:Antroquinonol+¼Ð·ÇÀøªk(SOC) PK ¹ï·Ó²Õ:¦w¼¢¾¯+¼Ð·ÇÀøªk(SOC) ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/19 ¤U¤È 01:58:53²Ä 1806 ½g¦^À³ §Ú»¡1ÓÀ~§A1¸õªº[4¤ÑP-value=0.9951]»P[10¤ÑP<0.001]¯u¬Û!!! 1. www.businesstoday.com.tw/article/category/183029/post/202201260016/ ...¼B³Ó«iªí¥Ü¡A³o¥¿¬O°ê¹©ªº¾÷·|¡A¡u§Ú̪º¥ÎÃIJեX°|¤¤¦ì¼Æ¬O[4¤Ñ]¡A·ç¼w¦è³¬O[10¤Ñ] stock.pchome.com.tw/news/cat1/20220315/9700004132202203154.html (µù: 1.¹ï·Ó²Õ¬O±Ä¥Î¼Ð·ÇÀøªk¡A¥i¨Ï¥Î¤w®ÖãÃĪ«¡A¥]§t·ç¼w¦è³¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 07:50:51²Ä 1878 ½g¦^À³
|
¥h¦~12¤ë§Ú»¡¥[¦¬«¯gªÌ¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J«¯g±wªÌÁ{§É¬Ý¬Ý¡C ¤µ¤Ñ±q¸Ñª¼¼Æ¾Ú¨Ó¬Ý [¥h¦~ªº¥[¦¬«¯gªÌ] ´N¬O[»´¤¤¯g¦³®Ä©Ê«Ü¤£©úÅã¡A©Ò¥H¥[¤J«¯g±wªÌÁ{§É] ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/16 ¤W¤È 07:16:12²Ä 1799 ½g¦^À³ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³ 1¤äÃĪ«ªºÁ{§É¹êÅç«ç»ò¸ÑŪ? 1.¦pªG©úÅãÀu©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA·|´£«e²×¤î ... °ê¹©:DMC«Øij¼W¥[¦¬ªv»Ýn®ñ®ð¤ä«ù¤§«¯g¦í°|¯f±w¡C(«D«I¤J©Ê³q®ð¡B°ª¬y¶q®ñ®ð©Î¸§J½¤) ³o®É¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J«¯g±wªÌÁ{§É¬Ý¬Ý¡C ------------------------------------------------------------------------------------------------ ¥[¦¬«¯g±wªÌ? 2022.1.5: ¦b¦¸nµû¦ô«ü¼Ð¡]®É¶¡½d³ò¬°28¤Ñ¡^¡AICU«¯g¯f¤HªvÀø®É¶¡...¥ÎÃIJժºªvÀø®É¶¡ÁYµu¤F9.5¤Ñ (¨S¹ï·Ó²Õ¼Æ¾ÚPȬݰ_¨Ó´N¬Oº}«G) µ²ªG 2022.3.15:ICU«¯g¯f¤HªvÀø®É¶¡¡G¸ÕÅçµ²ªG: ¥ÎÃIJժº¯f¤H¤¤¦ì¼ÆªvÀø¤Ñ¼Æ¬°13.5¤Ñ¡A¹ï·Ó²Õ¬°23¤Ñ(P-value=0.5404)¡C Y¬O[¥Dn]µû¦ô«ü¼ÐPȺ}«G«ç¤£¤½¥¬? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 07:31:50²Ä 1877 ½g¦^À³
|
·s»D:°ê¹©·s«a·sÃÄ¥D«ü¼ÐPȿ𤣤½¥¬¡A¸Ñª¼ºâ¤£ºâ¹F¼Ð¥~¬ÉÃú¸Ì¬Ýªá --------------------------------------------------------------------------------------------- ¦¸nµû¦ô«ü¼ÐPÈ¥þ³£¤½¥¬¡AµL¿W¦³°¸´N¤Ö¥Dn«ü¼ÐPÈ¡A°ê¹©¦³¤°»òÃø¨¥¤§Áô? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 07:08:42²Ä 1876 ½g¦^À³
|
¥H¦w¼¢¾¯¬°¹ï·Ó¤§¸ûÀu©Ê(superiority)¸ÕÅç¡A¸ÕÅçÃÄ«~Y¯à¦¨¥\¦aÅã¥Ü»P¦w¼¢¾¯¨ã¦³ÅãµÛªº²Õ¶¡®t²§¡A¨äÀø®Ä¬O¥i¥Hª½±µ½T»{ªº¡C ------------------------------------------------------------------------------------------------- ½Ð°Ý¥Dnµû¦ô«ü¼Ð:¥ÎÃIJÕ100%¡A¹ï·Ó²Õ96.0% ©Ò¿×ªº¸Ñª¼¦¨¥\±q¦ó¦Ó±o?(°ò¨È»P¯E¹©¤]¨S§â¸Ñª¼·d¦¨³o¯ë¥Ð¦a) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 06:57:41²Ä 1875 ½g¦^À³
|
FDA [[[strongly]]] recommends that drugs to treat COVID-19 be evaluated in randomized, placebo-controlled, double-blind clinical trials using a [[[superiority design]]] -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/22 ¤W¤È 09:09:37²Ä 1809 ½g¦^À³ ...2020.5.11 FDA COVID-19ÃĪ««ü«n www.fda.gov/media/137926/download ...FDA ¡§±j¯P«Øij¨Ï¥ÎÀu®Ä©Ê³]pªºÀH¾÷¡B¦w¼¢¾¯¹ï·Ó¡BÂùª¼Á{§É¸ÕÅçµû¦ô¥Î©óªvÀø©Î¹w¨¾ COVID-19 ªºÃĪ«¡¨¡A¨ÃÀ³¦b©Ò¦³ªvÀø¤è®×¤¤¨Ï¥Î¼Ð·ÇÅ@²z¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 06:39:46²Ä 1874 ½g¦^À³
|
¤w¦^´_¹L¡A¦A¦^¤@¦¸. ³o¨Ç¤½¥q§â¼s¤j§ë¸êªÌªºÅv¯qÂ\¨º¸Ì? FDA COVID-19ÃĪ«Á{§É«ü«n²M²M·¡·¡¼gµÛ:±j¯P«Øij¨Ï¥Î[Àu®Ä©Ê]³]p¦aÁ{§É¡A¬°¦ó¤£´±»¡? ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤U¤È 02:43:31²Ä 1665 ½g¦^À³ ¦pªG¤£n¤ÓµeªêÄê«ç·|©Û¤H°v? ¥h¦~6¤ëNRX¤½¥q°ª¼h¤½¥¬ZYESAMI¼Æ¾Ú¥¿¦Vn¥Ó½ÐEUA¡Aµ²ªG³QFDA¥´ºj¡A2022.1¤ë¾D¨ü·l¥¢ªº§ë¸êªÌ´£§i:¸ê®Æ¦s¦b«¤jµê°²©M»~¾É©Ê... ............................................................................................ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 07:50:58²Ä 1611 ½g¦^À³ ¸g¹L°ò¨È»P¯E¹©¨Æ¥ó«á¡A§ë¸ê¤H¹ï¥Í§ÞªÑ¯d¤U¤£¦nªº¦L¶H¡A¤£§Æ±æ¾ú¥v¨Æ¥ó«ºt! 1. FDA©Úµ´NRxÃļtZyesami¥Î©óªvÀø¦M«¯f±w¤§EUA ....... 2. 2022.1.20ÃÒ¨é´Û¶B«ß®v¨Æ°È©Ò¥Nªí§ë¸êªÌ«Å¥¬¹ï NRx ¶i¦æ½Õ¬d2021 ¦~ 6 ¤ë¡ANRx «Å¥¬¦V¬ü°êFDA´£¥æ¥Ó½Ð¡An¨DÀò ±oZYESAMIªººò«æ¨Ï¥Î±ÂÅvEUA¡A¥HªvÀø±w¦³©I§l°IºÜªº¦M« COVID-19 ±wªÌ. 2021 ¦~ 11 ¤ë 4 ¤é¡A NRx «Å¥¬ FDA ©Úµ´¬° ZYESAMI µo¥¬ EUA ¡A¡§¦]¬°Ãö©ó¸ÓÃĪ«ªº¤wª¾©M¼ç¦b¯q³B¥H¤Î ZYESAMI ¦b±w¦³ÄY« COVID-19©I§l¨t²Î¯e¯fªº±wªÌ¤¤ªº¤wª¾©M¼ç¦b·ÀIªº¼Æ¾Ú¤£¨¬¥¢±Ñ¡C¡¨ |
|
|
·|û¡G¶À±Ò½÷10152632 µoªí®É¶¡:2022/4/8 ¤U¤È 05:13:36²Ä 1873 ½g¦^À³
|
¥ý©ñ¹L§O¤H¡A¤~¯à©ñ¹L¦Û¤v¡A§_«h¦p§A³o¯ë¥Ã»·³Q°ê¹©ªº¹ï¿ù¡A¸j¦í§Aªº¤H¥Í¡A¦óW¨Ó«v¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 03:25:28²Ä 1872 ½g¦^À³
|
1.¹w´ú¤U¶g4/15¦A©µªø90¤Ñ¨ì7/15¡A«ôµn§Y·|«Å¥¬²×¤îpublic health emergency¡C 2.°ê¹©¼B¸³¦b1/5»¡¦a[¸Ñª¼¦¨¥\]¦A¹L21¤Ñ§Î¦¨±j¯P»ä·¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 05:28:06²Ä 1657 ½g¦^À³ ¦Û2020.3¤ë¬ü°êHHSµo¥¬COVID-19ºò«æª¬ºA°_¤w³sÄò8©u§ó·s©µªø8¦¸(¨C¦¸©µªø90¤Ñ)¡A¤U¤@¦¸(2022.4¤ë)·|«Å¥¬©µªø©Î²×¤îEUA??? |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/4/8 ¤U¤È 12:06:17²Ä 1871 ½g¦^À³
|
³o¦¸Áö¤£¬O±ÂÅv®ø®§¡A¦ý¦b±M§Q¤å«á±¦LÃÒ±M®aµû¦ô¦Ê»õ¬ü¤¸Äݯu¡I2020¦~¤AñQÓi×ô¾P°â91»õ¬ü¤¸¡A¥H¦Ê¤À¤§4¼Wªø¡A¤µ¦~è¦n¤@¦Ê»õ¬ü¤¸¡C¦]¬°µL¬r¡A±N¨Ó¼W¥[´T«×·|§ó¤j¡C¨âÃÄÅé¨t¦U¤@¦Ê»õ¬ü¤¸¡A¥ú¤À¼íª÷¤@¦¨¡A´N¹F600»õ¥x¹ô¡C¥HªYÄ£¤pªÑ¥»¨CªÑ¹F850¤¸Àò§Q¡A¯uªº¦³¥i¯à¶Ü¡H¦]¬°§Ú¤]¤£À´¡A½Ð±M·~¤j¤j¶}¥Ü¡AÁÂÁ¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/7 ¤U¤È 11:17:51²Ä 1870 ½g¦^À³
|
À~§Ú¤@¸õ¡A²r¤@¬Ý¥H¬°¬O±ÂÅv¤F |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/4/7 ¤U¤È 07:27:28²Ä 1869 ½g¦^À³
|
1.¨Æ¹êµo¥Í¤é:111/04/07 2.¤½¥q¦WºÙ:ªYÄ£¥ÍÂåªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q¡C 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î¡C 5.µo¥Í½t¥Ñ: ¥»¤½¥q±µÀò©e¥ô±M§Q¨Æ°È©Ò³qª¾¡A¥»¤½¥qµL¨x¬r¤AñQÓi×ô¤îµh·sÃÄSNP-810(¦w®õ®³¯k) ¨ú±o¼Ú¬w±M§Q¡A±M§Q¦WºÙ:¡uNEW ACETAMINOPHEN COMPOUND COMPOSITION WITHOUT SIDE EFFECT TO LIVER¡v¡C 6.¦]À³±¹¬I:¤£¾A¥Î¡C 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ: ¤@.¥»¤½¥qµL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810(¦w®õ®³¯k)¥ý«e¤wÀò±o¬ü°ê¡B¤é¥»¡BÁú°ê ¡B¤¤°ê¡B¼Ú¨È±M§Q²Õ´(«Xù´µ¡B¥Õ«Xù´µ¡B«¢ÂħJ¡B¨È¬ü¥§¨È¡B¨È¶ë«ôµM¡B¦Nº¸¦N´µ ¡B¶ð¦N§J¤Î¤g®w°Ò¦@¤K°ê)¡B¤¤µØ¥Á°êµ¥±M§Q¡A¤µ¤SÀò±o¼Ú¬w±M§Q(¼Ú¬w±M§Q§t^°ê¡B ¼w°ê¡Bªk°ê¡B·ç¤h¡B·ç¨å¡B¤ñ§Q®É¡B±¶§J¡B¤¦³Á¡B¦è¯Z¤ú¡BªâÄõ¡B·Rº¸Äõ¡B¸q¤j§Q¡B ²üÄõ¡B®¿«Â¡BªiÄõ¡B¸²µå¤ú¡Kµ¥38Ó·|û°ê)¡A¨ä¥¦¥@¬É¦U°ê±M§Q¥ç¿n·¥¼f®Ö¤¤¡C ¤G.¥»±M§Q¦³®Ä´Á³Ì¦h¥i©µªø¦Ü¦è¤¸2038¦~¡C ¤T.SNP-810(¦w®õ®³¯k)¥Ø«e¤w¦V¬ü°êFDA´£¥X¼Ï¯Ã¸ÕÅç¥Ó½Ð¡AFDA¿n·¥¼f²z¤¤¡C ¥|.®Ú¾ÚFuture Market Insights 2021¦~¥«³õ²Îp³ø§i«ü¥X¡A¥þ²yAcetaminophen(¤AñQ Ói×ô)¤îµhÃÄ¥«³õ³W¼Ò©ó2020¦~¹ê»Ú¬ù¬°91.5»õ¬ü¤¸¡A¦Ó¥Dn¥«³õ¦p¥_¬ü¦û¤ñ¬ù33.0%¡B ¼Ú¬w¬ù26.3% ©M¨È¬w(¥]§tªF¨È©M«n¨È°ê®a)¬ù31.7%¡CY¥H¨C¦~¦~§¡½Æ¦X¼Wªø²v(CAGR) 4.1% pºâ¡A©ó2031¦~¥þ²y¤îµhÃÄ¥«³õ³W¼Ò¥i¹F140.7»õ¬ü¤¸¡C°£¥»¤½¥qSNP-810(¦w®õ®³ ¯k)¥~¡A¥Ø«e¥«³õ¤W©|µL¨ä¥¦Ãþ¦üµL¨x¬r©Ê¤§acetaminophen¤§¤îµhÄvª§²£«~¡C¥Ø«e¥»¤½ ¥qSNP-810·sÃĤw»P°ê»Ú¥Dn¤îµhÃĤj¼tñq¦³Àv¦X¬ù¡A¦³³Ì·s¶i®i¡A±NÀH®É¤½§i¡C ¤.·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2022/4/6 ¤U¤È 06:56:14²Ä 1868 ½g¦^À³
|
3¤ëÀ禬¬O0,ªí¥Ü¸ÕÅç¤w§¹¦¨¡H! |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/4/5 ¤U¤È 08:04:35²Ä 1867 ½g¦^À³
|
¥HªYªY¤pªÑ¥»¡A¬y³qªÑ²¼¤£¦h¡A¦³°í±j¥B©úÅã¥|ÁûÃĹê¤O¡B¤j¼t±ÂÅv¡A¬Û«H¨göt°_¨Óª½©b200¤¸¡A®É¶¡¤£¥²3Ó¤ë¡A¤j·§2Ó¤ë¡F§Æ±æ¤j®a¯à¤jÁÈ¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/5 ¤U¤È 03:05:47²Ä 1866 ½g¦^À³
|
¦pªG¬O¦P°¦¯T?(¥»©ÊÃø²¾) ©R¤¤ª`©w§Ú±N³B©ó©t¿W¡A¯î²D»P±I¹æ¤¤§Ú¾Ç·|¤F§Ô@¡A§Ú½L½õ©ó¯î쪺¤@¨¤¡A¾iºë»W¾U¡B«Ì®§¥H«Ý¡A²×¦³¤@¨è¡A¿E±¡»PÅé¯à·|¥þ±Ãzµo¡A¤ä¼µ§Ú¨º«i²rªº¤@À»¡C¡m¯T¹D¡n ©¹©¹¨ú±o¦¨¥\ªº´I¤H¡A¥L̳£¦³µÛ³oºØ¯T¹Dºë¯«¡C´I¤H¤§©Ò¥H¯à°÷¨ú±o¦¨¥\¡A°£¤F¦³Áæ¦Ó¤£±Ë¡B¥Ã¤£¨¥±Ñªº¯T¹Dºë¯«¡A©¹©¹ÁÙ¦³³o¤ºØ¯T©Ê«äºû¡I ¯T©Ê«äºû¤@¡B¦¨¥\¤§¹D¡A¶Q¦b°í«ù...¯T©Ê«äºû¤¡B¤£°Ê«h¤w¡A¤@»ïÅå¤H¡I ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:25:31²Ä 1852 ½g¦^À³ ¦³¤H»¡240¬O·sÃĪº³Ì¤j©@¦b¥~³ò¾Þ§@...¡A±À´ú»P[²ö¼w¯Ç¨Ó¥x³]¤l¤½¥q ¦¸¥@¥N¬Ì]¹wp¤U¥b¦~±À¥X]µ´¹ï¦³Ãö«Y? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/5 ¤U¤È 01:08:01²Ä 1865 ½g¦^À³
|
¬Ý¤pªYªY¶W°ê³»¡B¥_·¥¡C¾Ç¤@¤UÁÞg¡A¬°¤W¥«·Ç³Æ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/5 ¤W¤È 10:46:00²Ä 1864 ½g¦^À³
|
°ê¹©¥i¥H®³¥XFDA¯Sã¼Æ¾Ú¤£¥Î»P¦w¼¢¾¯PK¤å¥ó¶Ü?(¬JµM§¹¥þ²Å¦X¬ü°êFDA µo¥¬©ó2020¦~5¤ëªº·s«aªÍª¢Á{§É«ü¾É³W©w) °ê¹©ºô¶: goldenbiotech.com/news-tw/%E5%8F%B0%E7%81%A3%E9%A6%96%E7%99%BC%E5%9C%8B%E9%BC%8E%E7%94%9F%E6%8A%80%E7%BE%8E%E5%9C%8B%E6%96%B0%E5%86%A0%E8%82%BA%E7%82%8E%E4%BA%8C%E6%9C%9F%E8%87%A8%E5%BA%8A%E5%B7%B2%E5%AE%8C%E6%88%90%E7%AC%AC/ °ê¹©¥Í§ÞÁ{§ÉÂå¾Ç³¡³¯¨Ø©gÂå®v«ü¥X...§¹¥þ²Å¦X¬ü°êFDA µo¥¬©ó2020¦~5¤ëªº·s«aªÍª¢Á{§É«ü¾É³W©w¡A°w¹ïÃļt¶}µo·s«aªÍª¢ªºªvÀø©M¹w¨¾ÃĪ«¤Î¥Íª«»s¾¯ªº«ü¾É¡A³W©w¶·±Ä¥Î³Ì°ª¯Åªº³]p¡A¤]´N¬OÁ{§É¸ÕÅ窺³]p¥²¶·¬°ÀH¾÷¡BÂùª¼¡B¦Ó¥B¦³¦w¼¢¾¯¹ï·Ó(randomized, placebo-controlled, double-blind clinical trials)ªº¸ÕÅç¡A¤~¬O¥\®Ä©ÊÅçÃҳ̥i«HªºÃÒ¾Ú ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/23 ¤W¤È 07:59:18²Ä 1810 ½g¦^À³ ¤C¤ë¥bÀn¡X¡X¤ðª¾¦º¬¡! 2020.5.11 FDA COVID-19ÃĪ«Á{§É«ü«n¤w©ú©ú¥Õ¥Õ¼gµÛ:±j¯P«Øij¨Ï¥Î[Àu®Ä©Ê]³]p¦aÁ{§É!!! FDA¤£¬Onµ¥®Ä©Ê»P¤£¦H©Ê¡A¬On[Àu®Ä©Ê]!!! P2¸Ñª¼ªº¼Æ¾Ú¹L¤£¤Fpre-EUAªùÂe:2¤ëpre-EUA meeting¡AFDA¦Ñ¦¦³¦^ÂСA¤½¥q¤£»¡¦Ó¤w¡AÁÙ°ø±æ4¤ë¥Ó½ÐEUA¡AÁÙ¦³¼Æ¾Ú¤£È°µP3ªº |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/4 ¤W¤È 09:42:25²Ä 1863 ½g¦^À³
|
2022.3.16 President Biden Signs Into Law Medicare Telehealth Coverage Extension Post-Public Health Emergency ... after the end of the designated public health emergency (¡§PHE¡¨) www.jdsupra.com/legalnews/president-biden-signs-into-law-medicare-5809616/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/4 ¤W¤È 09:30:58²Ä 1862 ½g¦^À³
|
Adagio»PRevive¥Ó½ÐEUA¤]¦³¨Ç±ß¡A¦]¬°±q¦U¤è·s»D®ø®§¨Ó¬Ý¡A«ôµn¤£¤é´N·|«Å¥¬²×¤îpublic health emergency¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/4 ¤W¤È 09:06:46²Ä 1861 ½g¦^À³
|
FDA¯S㪽±µ§@P3Á{§Éªºbucillamine ¡A¹wp2022.Q2¥Ó½ÐEUA ¡C 2022.3.29 finance.yahoo.com/news/revive-therapeutics-provides-phase-3-124500504.html ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/14 ¤U¤È 11:28:48²Ä 1590 ½g¦^À³ µL¤H¯à¥X¨ä¥k¤F!? »´¤¤¯g¤fªAÃļƾں}«G¡AFDAn¨DRevive¤½¥q¸õ¹LP1»PP2¡A¯Sã±qP3Á{§É¹êÅç¡C¦A¥HP3ªº´Á¤¤¼Æ¾Ú¥Ó½ÐEUA. www.clinicalleader.com/doc/can-revive-overcome-long-odds-with-a-small-molecule-covid-treatment-0001 ...In June 2020, we approached the FDA with an IND for COVID. We hoped to move into a Phase 2 study and were surprised when the FDA looked at the data and fast-tracked our request to a Phase 3 study. Being able to skip the Phase 1 and Phase 2 studies was a huge win for our small company.¡¨ --------------------------------------------------------------------------------------------------- Benjamin A. Smith¡G¦b±z¬Ý¨Ó¡ARevive ¬O§_¦³¾÷·|Àò±o EUA¡A±z»{¬°³oºØ¾÷·|¦³¦h¤j¡H Biomedical_trader¡G¶â¡A¦b¤U¤@¦¸¤¤´Á¤ÀªR¤¤¡]600 ¦W±wªÌ¡A¹wp±N«Ü§Ö´£¥æ¡^¡A§Ú»{¬°¾÷·|¤£¤j¡C¦ý¬O¡A§Aª¾¹D¡A§Ú³Ì¦nªº²q´ú¬O¡A¤j¬ù»Ýn 700 ¨ì 900 ¦W±wªÌ¤~¯àÃÒ©ú¥L̪ºÃĪ«¦³©Ò¤£¦P¡C¦Ó¥B¡A±zª¾¹D¡A§Ú̪¾¹D¥¬¦è©Ô©úªº¬Y¨Ç¾÷¨î¥i¥H¸Ñ¨M¬Y¨Ç°ÝÃD¡A³o¨Ç°ÝÃD¨Ï¬Y¨Ç±wªÌ¡]¨Ò¦p¿}§¿¯f±wªÌ©M¦Ñ¦~¤H¡^¥X²{ COVID ÄY«¯gª¬ªº·ÀI§ó°ª¡C©Ò¥H§Ú½T¹ê»{¬°¥L̦³¤j¬ù 60% ªº¾÷·|¦b 800¡]±wªÌ¡^¼Ð°O³Bªí²{¥X®t²§¡C |
|
|
·|û¡Gmeetav10144056 µoªí®É¶¡:2022/4/4 ¤W¤È 03:10:07²Ä 1860 ½g¦^À³
|
R¤j¼g¨º»ò¦h¨S¥Îªº¡A¨º¬OºØ«H¥õ¡I Let it go! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤U¤È 01:50:12²Ä 1859 ½g¦^À³
|
°ê¹©¤½¥¬ªº¼Æ¾Ú»P§ó¥¿¼Æ¦¸¤£¬O¦b©IÄV§ë¸ê¤H¶Ü? ®t²§¦h¤j¦Û¤v¥h¬Ý¬ü°êÃļt¬O¦p¦ó¤½¥¬¼Æ¾Ú¹F¼Ð¡AÁÙ¦³¬°¤°»ò²{¦b¥Ó½ÐEUA¼Æ¾Ú¤À¦¨Omicron[«e]»P[«á]¥Î·N???(³o´N¬O§Ú¦b1/22´£°Ý°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æªºì·N) 2022.3.30 Adagio «Å§G ADG20¡]adintrevimab )Àø®Ä¹F¼Ð¡A²Ä2©u¦VFDA´£¥æEUA¥Ó请! www.thepharmaletter.com/article/strong-showing-for-adagio-s-adg20-in-pre-and-post-exposure-settings-for-covid-19 ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 02:22:40²Ä 1614 ½g¦^À³ ¶K´X«h°T®§¡A§ë¸ê¤H[¿W¥ß«ä¦Ò]²´¤UFDA±ÂÅvEUA¦a±ø¥ó??? 1.°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æ? 2. ¬ü°ê¦b2021.11.27«eOmicron¯f¨Ò 0¡A ¬ü°êÁp¨¹¯e¯f¨¾ªv¤¤¤ß(CDC)ºI¦Ü2022.1.1¤é°ê¤º95.4%ªº·s¯f¨Ò¡ADeltaÅܺدf¬r«h³QÀ£ÁY³Ñ¤U4.6% |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 10:31:37²Ä 1858 ½g¦^À³
|
(²Ä¤@½uÃĪ«)»´¤¤¯gºnªvÀø¦b¤j´T´î¤Ö¯f¬r¶q¹w¨¾¶i®i¬°«¯g¡A¦Ó«¯gªÌªººnªvÀø¤£¦b´î¤Ö¯f¬r¶q! S-217622©ó2¤ë25¤é¥Ó½ÐÀò§å¡A¦b2/3´ÁÁ{§É¸ÕÅ礤°w¹ï»´«×©M¤¤«×±wªÌ¶i¦æªº2b´ÁÁ{§É¸ÕÅ礤¡A°ª¾¯¶q©M§C¾¯¶q²Õ¯f¬rºw«×ÅܤƩúÅã¸û°ª»P¦w¼¢¾¯²Õ¬Û¤ñ¡A¹F¨ì¥DnÀø®Äµû¦ô«ü¼Ð»ù¡C ¥t¤@¤è±¡A»P¦w¼¢¾¯²Õ¬Û¤ñ¡ACOVID-19 ¯gª¬ªºÁ`¤ÀÅã¥Ü¡A¦bº¦¸µ¹ÃÄ«á¦Ü 120 ¤p®É¡]²Ä 6 ¤Ñ¡^ªº³æ¦ì®É¶¡Åܤƶq¦³©Ò§ïµ½¡A¦ý¨S¦³²Îp¾Ç·N¸qªº®t²§¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:42:20²Ä 1854 ½g¦^À³ ¦X¤@SNS812:³q过ú£¤Ö¯f¬r°ò¦]组©M»E¦X酶mRNAªº«þ贝数¡A§í¨î¯f¬rÎ`¨î¦}ªý断¦Z续·P¬V¡C IC50 med.sina.cn/article_detail_100_2_113260.html --------------------------------------------------------------------------------------- ¤é¥»ÆQ³¥¸qS-217622(§í¨î·s«a¯f¬rªº¼W´Þ) EC50 xueqiu.com/3403713237/213884867 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 09:29:43²Ä 1857 ½g¦^À³
|
¼w°ê¨k¤l¦b1¦~¤º±µ¿æ87¦¸·s«a¬Ì]!(³Q§ì¥h°µ¬ì¬ã¤F) www.dw.com/en/german-man-got-covid-jab-87-times-report/a-61338245 ...¨C¤Ñ³Ì¦h±µºØ 3 ¦¸¬Ì] |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 09:19:59²Ä 1856 ½g¦^À³
|
Ãø¹D°ê¹©Á{§É³]p¤£¬OÀu®Ä©Ê³]p??? 2022.3.15°ê¹©¤½§i§ó¥¿: ¥ÎÃIJÕ:Antroquinonol+¼Ð·ÇÀøªk(SOC) ¹ï·Ó²Õ:¬°¦w¼¢¾¯+¼Ð·ÇÀøªk(SOC) -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/22 ¤W¤È 09:09:37²Ä 1809 ½g¦^À³ FDA ¡§±j¯P«Øij¨Ï¥ÎÀu®Ä©Ê³]pªºÀH¾÷¡B¦w¼¢¾¯¹ï·Ó¡BÂùª¼Á{§É¸ÕÅçµû¦ô¥Î©óªvÀø©Î¹w¨¾ COVID-19 ªºÃĪ«¡¨¡A¨ÃÀ³¦b©Ò¦³ªvÀø¤è®×¤¤¨Ï¥Î¼Ð·ÇÅ@²z¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:58:19²Ä 1855 ½g¦^À³
|
¤£À´¤°»ò¬OÀu®Ä©Ê Á{§É³]p?(¤£»P¦w¼¢¾¯PK¡A²ª½¬O¤Ñ¤è©]ÃÓ¤@¤d¹s¤@©]ªº¨Æ) ¬ü°êª©¬Ý¤£À´¡A¤¤°êª©Á`¸Ó¬Ý±oÀ´! 2022.2.17¤¤°ê¯e±±³¡µo¥¬: ·s«¬«a状¯f¬rªÍª¢§Ü¯f¬r·s药临§É试验§Þ术«ü导ì则 (»PFDA 2020.5.11 COVID-19ÃĪ««ü«n¬Û¦ü) ¦P¼Ë [±j¯P] «Øij¨Ï¥Î[Àu®Ä©Ê³]p] [Àu®Ä©Ê³]p] [Àu®Ä©Ê³]p]!!! suntrap.com/newsinfo/621198.html?templateId=174030 --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/22 ¤W¤È 09:09:37²Ä 1809 ½g¦^À³ FDA ¡§ [±j¯P] «Øij¨Ï¥Î[Àu®Ä©Ê³]p] [Àu®Ä©Ê³]p] [Àu®Ä©Ê³]p]!!! °ê¹©ªº¼Æ¾Ú¬O«D¦H®Ä©Ê©ÎÀu®Ä©Ê©Îµ¥®Ä©Ê? 3´ÁÁ{§ÉÃø¨o! 2020.5.11 FDA COVID-19ÃĪ««ü«n www.fda.gov/media/137926/download ...FDA ¡§±j¯P«Øij¨Ï¥ÎÀu®Ä©Ê³]pªºÀH¾÷¡B¦w¼¢¾¯¹ï·Ó¡BÂùª¼Á{§É¸ÕÅçµû¦ô¥Î©óªvÀø©Î¹w¨¾ COVID-19 ªºÃĪ«¡¨¡A¨ÃÀ³¦b©Ò¦³ªvÀø¤è®×¤¤¨Ï¥Î¼Ð·ÇÅ@²z¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:42:20²Ä 1854 ½g¦^À³
|
¦X¤@SNS812:³q过ú£¤Ö¯f¬r°ò¦]组©M»E¦X酶mRNAªº«þ贝数¡A§í¨î¯f¬rÎ`¨î¦}ªý断¦Z续·P¬V¡C IC50 med.sina.cn/article_detail_100_2_113260.html --------------------------------------------------------------------------------------- ¤é¥»ÆQ³¥¸qS-217622(§í¨î·s«a¯f¬rªº¼W´Þ) EC50 xueqiu.com/3403713237/213884867 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:31:34²Ä 1853 ½g¦^À³
|
§ÚÀ£: 1.¥þ²yº¤ä[»óÃú¼Q¾¯] ¦X¤@SNS812¼s®Ä«¬§Ü·s«a¬y·P¤p®Ö»Ä·sÃÄ¡A¤wn¥Ó½ÐP1 2.¦A¯}¥xÆW·sÃıÂÅv¬ö¿ýªºON101 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:25:31²Ä 1852 ½g¦^À³
|
¦³¤H»¡240¬O·sÃĪº³Ì¤j©@¦b¥~³ò¾Þ§@...¡A±À´ú»P[²ö¼w¯Ç¨Ó¥x³]¤l¤½¥q ¦¸¥@¥N¬Ì]¹wp¤U¥b¦~±À¥X]µ´¹ï¦³Ãö«Y? ¤@²¼¤HÁÙ¾K¥Í¹Ú¦º¦b156¨º®a!!! |
|
|
·|û¡Gmeetav10144056 µoªí®É¶¡:2022/4/1 ¤U¤È 07:29:52²Ä 1851 ½g¦^À³
|
¨S®ø®§´N240¤F¡A¦³®t¶Ü¡I»¡¦nªº¤WÂd¬ü¬üªº¡I¥_·¥¥«È³£ºÙ¤ý¤F¡In¤£n¦Ó¤w¡I |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/4/1 ¤U¤È 02:07:23²Ä 1850 ½g¦^À³
|
news.cnyes.com/news/id/4844700 ¬ü°ê¦ò¦{»PCVSµ¥ÃÄ°Ó´N¾~¤ùÃþÃĪ«©M¸Ñ ª÷ÃB¹F8.78»õ¬ü¤¸ ¬ü°ê¦òù¨½¹F¦{¤w»P CVS Health Corp (CVS-US) ©M¥t¥~ 3 ®a»sÃĤ½¥q¹F¦¨¶W¹L 8.78 »õ¬ü¤¸ªº©M¸Ñ¨óij¡A¥H¸Ñ¨M¦³Ãö¦b¸Ó¦{§Uªø¾~¤ùÃþÃĪ«ÀݥΤ¤©Ò§êºt¨¤¦âªº¯Á½ß¡C ¦ò¦{Á`À˹îªø¿p} (Ashley Moody) µo¥¬Án©úªí¥Ü¡ACVS ±N¤ä¥I 4.84 »õ¬ü¤¸¡ATeva Pharmaceutical Industries Ltd (TEVA-US) ±N¤ä¥I 1.948 »õ¬ü¤¸¡AAbbvie Inc (ABBV-US) ©ÒÄݪº¦ãº¸«Ø (Allergan) ³¡ªù±N¤ä¥I 1.342 »õ¬ü¤¸¡AEndo International Plc (ENDP-US) ±N¤ä¥I 6500 ¸U¬ü¤¸¡C ¤j³¡¤À¸êª÷±N¥Î©ó´î¤Ö¾~¤ùÃþÃĪ«¡CTeva ÁÙ±N´£¨Ñ 8400 ¸U¬ü¤¸ªº¾Ç¦WÃÄ Narcan »ó¼QÃú¾¯¡A³o´Ú¼QÃú¾¯¥i¥H¼È®É½w¸Ñ¾~¤ùÃþÃĪ«¹L¶q¨Ï¥Îªº¼vÅT¡C ©Ò¦³¤½¥q¦b¦P·N©M¸Ñ¤§»Ú³£§_»{´¿¦³¤£·í¦æ¬°¡C ù¼w®q¦{»P Teva ©M¦ãº¸«Ø 9 ¤Ñ¹F¦¨Ãþ¦üªº©M¸Ñ¨óij¡A»ùȬ° 1.07 »õ¬ü¤¸¡C CVS ªí¥Ü¡A©M¸Ñ²Å¦X¦U¤è³Ì¤j§Q¯q¡A¨Ã¥B±N¤j¤O®Â½Ã»P¾~¤ùÃþÃĪ«¦³Ãöªº¨ä¥L¶D³^¡CTeva ªí¥Ü¡A¥¦¡uÄ~Äò¿n·¥¨ó°Ó¸Ñ¨MÃþ¦ü¯Á½ßªº¥þ°ê¸Ñ¨M¤è®×¡v¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/3/30 ¤U¤È 06:47:09²Ä 1849 ½g¦^À³
|
ÁÞ°òÄ_Ä_ªÑ»ù¦b¤TӤ뤺±q80¤¸º¦¨ì210¤¸ªñ¤T¿¡F±q¥Í§ÞªÑ¤ñ»ùÃö«Y¡A¬Û¹ï¤ñ»ùªYÄ£¬O«K©yªº¡B¬O¦nªº¡Aµ¥µo¥¬±ÂÅv®ø®§¡A¦³¤W½Ä200¤¸¦X²z¹w´Á¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/3/28 ¤U¤È 09:51:40²Ä 1848 ½g¦^À³
|
©_©Ç¤F¡A¿}°ò³£½Ä¤F¡A¦ó®É½ü¨ì·sÃħr? |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/3/28 ¤U¤È 01:54:05²Ä 1847 ½g¦^À³
|
²{¦bªYÄ£ªÑ»ù¦ì¶¥¨ä¹ê¬O«Ü§Cªº¡A±N¨Ó¥|ÁûÃÄÁ`±ÂÅv¥un0¡E4»õ¬ü¤¸´N¬O²{¦b¦æ±¡¡F²Ê¦ô¥|ÁûÃÄ¥[Á`20»õ¬ü¤¸±ÂÅv¤£Ãø¡A©Ò¥H¡AªÑ»ù¦³50¿¤Wº¦ªÅ¶¡¡C¦]¦¹¡AªYÄ£ªÑ²¼È±o¬ÃÂáA¤]¤£¼Ö¨£³Q¨ÖÁÊ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/26 ¤U¤È 09:41:24²Ä 1846 ½g¦^À³
|
1. 2021.5.6 Tylenol to arrive in Australia www.facebook.com/watch/?v=842161146647362 ¬[¤W¥þ¬OGSK´¶®³¯k 2.2020.6.25 www.smh.com.au/business/companies/us-painkiller-to-be-sold-in-australian-pharmacies-to-shore-up-supply-20200624-p555kx.html ¥þ²y»sÃÄ¥¨ÀY±j¥Í¤½¥q¤wÀòã¦b¿D¤j§Q¨ÈÃÄ©±¾P°â¨ä¬ü°ê¤îµhÃÄ«~µP Tylenol ..¥Ñ©ó¨ÑÀ³µu¯Ê¡A¥]¬A¿ÕµØ©M½÷·ç¦b¤ºªº³\¦h¨ä¥L¤j«¬»sÃĨÑÀ³°Ó¤]Àòã¶i¤f¤@¨t¦CÃÄ«~¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/26 ¤U¤È 09:27:43²Ä 1845 ½g¦^À³
|
§Ú¤§«e¤]¥H¬°¬Ý½Ö®a¥X»ù°ª´Nµ¹½Ö®a¡Aª½¨ì³o«h·s»D:2021¦~5¤ëTylenol¦b¿D¬w¤W¬[¶}½æ!(¨º2021.5¤ë«e?) ¼Ú¬w^°ê...¥i¥H¦n¦n«ä¦Ò¤@¤U! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:44:54²Ä 1216 ½g¦^À³ GSKªº´¶®³¯k¦P¼Ë½æ¨ìÀ~À~¥s! ¦]¬°¯Ê³f¡A¨Ï±oJ&J¶X¶Õ¶i¤J¿D¬w¥«³õ(¥h¦~¥Ó½Ð¡A¤µ¦~5¤ë¥¿¦¡¤W¬[) 2020.6.25 www.smh.com.au/business/companies/us-painkiller-to-be-sold-in-australian-pharmacies-to- shore-up-supply-20200624-p555kx.html .... J&Jªº¤@¦ì¤kµo¨¥¤Hªí¥Ü¡A¸Ó¤½¥q«Ü°ª¿³¦b«D³B¤èÃÄ¡§«e©Ò¥¼¦³ªº»Ý¨D¡¨®É´Á¬°¿D¤j§Q¨È¤H´£¨Ñ³o¨Ç²£«~¡C¡§·í§ÚÌ·NÃѨ켳¼ö®§µhµu¯Ê®É¡A§Ú̬°¤F¤½¦@°·±dªº§Q¯q¦V TGA ´£¥X¤F¥Ó½Ð¡A¡¨ -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:13:39²Ä 1215 ½g¦^À³ ...¤µ¦~5¤ëTylenol¦b¿D¬w¤W¬[¶}½æ¡A³Ì«Ü¤j¦]¯À´N¬OGSKªº´¶®³¯k¨ÑÀ³µu¯Ê |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/3/26 ¤U¤È 03:30:28²Ä 1844 ½g¦^À³
|
«Ü¦n©_¡A¼Ú¬w©M¬ü°ê¤j¼t©Î¬O¤é¥»¡A¤À°Ï±ÂÅvÁÙn¦Ò¶q¤°»ò¤½²³§Q¯q¡C¥ý¤½§i³¡¥÷°Ï°ì«á³Ñ¤Uªº°Ï°ì¬O¤£¬O´N¤£¦n½Í¤F¡AY¬O³o¼Ë°®¯Üµ¹¤@®a³Ì¦nªº±ÂÅvª÷¤£´N¦n¤F |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/26 ¤W¤È 09:36:37²Ä 1843 ½g¦^À³
|
¦X¤@¦~³ø²Ä73¶ 800±i¡A±b±¡B¤½¤¹»ùȳ£¬O65296¤d¤¸ ¤@¯ë¨Ó»¡¡A±b±»ùȬ°ªì¦¸¨ú±o®Éªº»ù®æ¡C ¤½¤¹»ùȬ°¥iÃÒ©úªº»ùÈ¡A¦p¤W¥«Âd¦³¤½¶}»ù®æ¡C ¤½¤¹»ùÈÀH®É·|»P±b±»ùȤ£¦P¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/26 ¤W¤È 08:57:12²Ä 1842 ½g¦^À³
|
www.onenessbio.com/download/Financial/110_Q3_Financial_Report_TC.pdf 800±i ±b±ª÷ÃB53,640 ¤½¤¹»ùÈ53,640 ¨S¬Ý¨ìì©l§ë¸êª÷ÃB? |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/3/26 ¤W¤È 07:30:32²Ä 1841 ½g¦^À³
|
·PÁÂR¤j°]³ø»¡©ú¡A °£¤F³o¨â®a°ê»Ú¤jÃļt¡AªYÄ£¤]¥¿¦b¬¢½Í¥]¬A¤é°Ó¦b¤ºªº¦h®a¦X§@¤½¥q¡C §Æ±æ¤À°Ï°ì¦X§@±ÂÅv¯à³v¨B¶}ªá¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/26 ¤W¤È 07:24:31²Ä 1840 ½g¦^À³
|
800±i¡A±b±»ùÈ¡A¤½¤¹»ùȳ£¬O65296¤d¤¸ ©Ò¥H§¡»ù81.62¤¸¡A¬O»{ÁÊ¡HÁÙ¬O¶R¶i¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/25 ¤U¤È 10:38:59²Ä 1839 ½g¦^À³
|
¼W¸ê»ù75¤¸¡A¦X¤@³o81.6¤¸??? ----------------------------------------------------------------------------------------------- ·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/3/14 ¤W¤È 11:19:07²Ä 1788 ½g¦^À³ ·PÁÂdk¤j¦^À³¡A§Ú¬Ý¦X¤@°Ýµª¨ºÃä¬O¼g»{80¸UªÑ = 800±i |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/25 ¤U¤È 02:38:41²Ä 1838 ½g¦^À³
|
¦X¤@¦~³ø¤½§G «ùªYÄ£800±i¡A¨CªÑ¥§¡81.6¤¸¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/25 ¤W¤È 11:16:20²Ä 1837 ½g¦^À³
|
Ó¤H¬Ýªk¡A¶È¨Ñ°Ñ¦Ò¡I ³o2¤H»{ÁʤF75¤¸ªº²{ª÷¼W¸ê1¸U±i »Ýn7.5»õ¥x¹ô ¦pªG¨S¦³¹ï¤½¥q¥Ø«eªºª¬ªp¬Û·í¤F¸Ñ ¥B²`¨ã«H¤ßªº¸Ü¡]©Ò¿×ªº¸ê°T¤½¶}¤£¹ïºÙ¡^ ¤£¤Ó¥i¯àªá¤j§â¶r²¼»{ÁÊ ¥H¥Ø«eªº¦¨¥æ¶q¡A1¸U±in½æ¨ì¥Á°ê´X¦~¡H ©Ò¥H©wn«ùªÑ£¸¬q´Á¶¡¡A¥B»Ýn¦³°ò¥»±°µ¤ä¼µ¡C »P¨ä»{ÁÊ»ùn¦³¤j´T«×¶ZÂ÷¡A¥B»Ý¦³¤j¦¨¥æ¶q¤~¯à¾_Àú¥X²æ¡C ·íµM¡A³Q¨ÖÁʤ]¦³¥i¯àµo¥Í¡C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/3/25 ¤W¤È 09:41:10²Ä 1836 ½g¦^À³
|
§Ú«ä¦Ò¤F¤@¤U;¥i¯à¤¤ë¦hªº110ªÑªF·|¦~³ø·|¦³¨ÇºÝÙ§a? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 11:37:52²Ä 1835 ½g¦^À³
|
ªYÄ£³oºØ¤p¤½¥q¡A¤jÃļt¬O¥Î¦¬ÁÊÂX¤j²£«~½uÅý¦Û¤vÅܧó¤j¡A¦Ó¤£¬O¤JªÑ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 10:59:16²Ä 1834 ½g¦^À³
|
¤H¤§«ä¼{¦³¡A¥H¤U½×z©Î¦³»~! ----------------------------------------------------------------------------------------------- ¤G¡BP34. ©Ó¿Õ¨Æ¶µ ©e°U¬ã¨s¦X¬ù©|»Ý¤ä¥I$33,752¤Î$29,024 ¬O»Ý¤ä¥I¬ì§Þ³¡±ÂÅvª÷¶Ü? P24.¤U±¦³»¡©ú±M§Q§Þ³N¶O(¤ä¥I¬ì§Þ³¡±ÂÅvª÷À³¸Ó¬O¦C¦b³o¸Ì) ³o2µ§°U¬ã¨s¦X¬ù¶O¥Î:§ÚÓ¤H°¾¦V¬OSNP-810¬ãµo¨½µ{¸O¸Ì±--¤GӾdzN«¬Á{§É¹êÅç³q¹L¤TÁ`Á{§É¹êÅçÛ²z©eû·|¼f¬dªºÁ{§É¶O ¤T¡BP39. ¥xÆW¥Ò«È¤á109¦~¦¬¤J$462---¦b109°]³ø:«È¤á¦X¬ù¤§¦¬¤J°Ó«~¾P³f¦¬¤J¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 10:36:34²Ä 1833 ½g¦^À³
|
¤@¡BP21 ¸Õ²£¶O$4,012 ³o¬O¸Õ²£¤°»ò²£«~? --§Ú¤]»{¬°¬O6¨t¦C¸Õ²£¶O. ------------------------------------------------------------------------------------------- ·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2021/8/21 ¤U¤È 02:35:48²Ä 1371 ½g¦^À³ §Ú§Æ±æ¬O6¨t¦C 3.°ê»ÚÃļt¦X§@ÂX¤jì®Æ¥Í²£¶i¦æ¤¤ ---------------------------- P17¹w¥I¸Õ²£¶O346¸U ---------------------------- ªÑªF·|¤º®e¬ù²¤¦p¤U 1.¬°¤F¤WÂd·Ç³Æ¦Ó¼W¸ê,ìªÑªF©M¯S©w¤H³£«Ü¤ä«ù 2.630©ú¤Ñ¶}©l¤TÁ`¶i¦æ¤@´ÁÁ{§É 3.°ê»ÚÃļt¦X§@ÂX¤jì®Æ¥Í²£¶i¦æ¤¤ |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/24 ¤U¤È 08:59:28²Ä 1832 ½g¦^À³
|
R¤j «¢«¢«¢ ì¨Ó§Ú¤]·Q¬O¤£¬O¸ò¦X§@ªº¨â¤jÃļt¦³Ã±«O±K¨óij »{Áʲ{¼W«ùªÑ¡A¦ý¤£¯à¤½¶}¡C «á¨Ó·Q·Q¡A¬O¦Û¤v½M²q¡I ¦¶¸³¤£®e©ö°Ý¨ì¡I ¥t¥~¡A¦p¤£¯u¹ê¤½§i¡A®£¹H³W©w¡C |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/3/24 ¤U¤È 06:50:14²Ä 1831 ½g¦^À³
|
½Ð°Ý110 Q4°]³ø¤º®e: ¤@¡BP21 ¸Õ²£¶O$4,012 ³o¬O¸Õ²£¤°»ò²£«~? ¤G¡BP34. ©Ó¿Õ¨Æ¶µ ©e°U¬ã¨s¦X¬ù©|»Ý¤ä¥I$33,752¤Î$29,024 ¬O»Ý¤ä¥I¬ì§Þ³¡±ÂÅvª÷¶Ü? ¤T¡BP39. ¥xÆW¥Ò«È¤á109¦~¦¬¤J$462 ¬O½æ¤°»òÃÄ?ÁÙ¬O³Ò°È¦¬¤J? ¤A«È¤á¦b¬ü°ê¡A¤þ«È¤á¬°¼Ú¬w ·PÁ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 05:43:50²Ä 1830 ½g¦^À³
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/24 ¤U¤È 05:03:38²Ä 1829 ½g¦^À³ ¨Î¯C³¡¤À¥Ø«eÁÙ¬O7¤d¦h±i¡A¨Ã¨S¦³§ï¤½§i¦¨9¤d¦h±i¡C ---------------------------------------------------------------------------------------------- ¨º¬O¤£¬O³o2¦W¤]¦b«e10¤j¤§¦C¡A¤@¼ËÁÙ¨S¦³§ï¤½§i? §Ú¤]§Æ±æ¬O¬Y¤j¼t»{ªÑ¡A¦ý³oºØ¦n¨Æ«ç¥i¯à¤£¤½§i. »P¨ä²q¨Ó²q¥h¤£¦p°Ý°Ý¦¶¸³! |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/24 ¤U¤È 05:03:38²Ä 1829 ½g¦^À³
|
³o¬O¥h¦~²{¼W»{Áʳ¡¤À ªL¥ý¥Íªì¦¸¨ú±o¡A¨ä«ùªÑ¤½§i¸Ì¦³¡AÄÝ©ó¤jªÑªF¡C ¨Î¯C³¡¤À¥Ø«eÁÙ¬O7¤d¦h±i¡A¨Ã¨S¦³§ï¤½§i¦¨9¤d¦h±i¡C ¦Ó³o¨â¦ì³£ÁÙ¬O¦b¤½§i¤ºªº10¤H¡A§Y¨Ï¦A¦©±¼¨Î¯C»{Áʪº1970±i¡C ¨º¶°«O¤¤ªº12¤H¤¤ªº¥t2¦ì¡A¦©°£1970±i«á¡A¤]ÁÙ¦³8¤d±i®tÃB¡C ¬O½Ö©O¡H¬°¤°»ò¤£¤½§i¡H ¬O§_À³¸Ó½Ð¤½¥q»¡©ú¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 03:17:29²Ä 1828 ½g¦^À³
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2021/7/28 ¤U¤È 01:58:34²Ä 1341 ½g¦^À³ ì¨Ó¨Î®m¥þ»{¤F -------------------------- 1.³Q¨ú±oªÑ¥÷¤§¤½¥q¡GªYÄ£¥ÍÂåªÑ¥÷¦³¤½¥q¡A¤wµo¦æªÑ¥÷Á`ÃB¡G68 ,592,500ªÑ¡C 2.¨ú±o¤H¸ê®Æ¡G A.¨ú±o¤H¡G¨Î®m§ë¸êªÑ¥÷¦³¤½¥q (1) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¡G7,202,165ªÑ (2) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ ¡G13.87% (3) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¡G7,196,165ªÑ (4) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ¡G 10.49% B.¨ú±o¤H¡GªL®a§» (1) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¡Gªì¦¸¨ú±o¤£¾A¥Î (2) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ ¡Gªì¦¸¨ú±o¤£¾A¥Î (3) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¡G1,970,331ªÑ (4) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ¡G 2.87% C.¦Xp¡G (1) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¡G7,202,165ªÑ (2) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ ¡G13.87% (3) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¡G9,166,496ªÑ (4) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ¡G 13.36% 3.¨ú±o©Î¼W´î¤§ªÑ¼Æ¡B¤é´Á¤Î¤è¦¡¡G©ó109¦~12¤ë29¤é¸g¥ÑÂd¶R¥«³õ ¥æ©ö½æ¥X¤è¦¡´î¤Ö6,000ªÑ¤Î110¦~7¤ë26¤é¸g¥Ñ²{ª÷¼W¸ê¤è¦¡¼W¥[1,9 70,331ªÑ¡C 4.·s¼W©Î´î¤Ö¤§¦@¦P¨ú±o¤H¡G·s¼WªL®a§»¬°¦@¦P¨ú±o¤H¡C5.¨ú±oªÑ¥÷ ¤§¥Øªº¡G§ë¸ê ¡C 6.¹wp©ó1¦~¤º¦A¨ú±oªÑ¥÷¤§¼ÆÃB¤Î¤è¦¡¡G±N¦ÛÂd¶R¥«³õ¨Ì¦X²z¤§ªÑ »ù«ùÄò¶i¦æµû¦ô¡C 7.¸êª÷¨Ó·½©ú²Ó¡G¦Û¦³¸êª÷¡C 8.¨ú±oªÑ¥÷¤§ªÑÅv¦æ¨Ïpµe¡G µL¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/24 ¤U¤È 03:12:07²Ä 1827 ½g¦^À³
|
R¤j»¡ªº¬O ²{¦æ³W©w¬O§_n¿í¦u¡H 6.9¸U±iªºªÑ¥»¡A³o¨â¤H«ùªÑ°ª¹F¸U±i¡C 10%¬O6¤d9¦Ê±i¡AÅãµM¦Ü¤Ö¦³1¦ì«ùªÑ¶W¹L¡H ©Î¬Oè¦n¨â¦ì³£¥¼¹F10%¡H ¦ý³o¤S»P¤½¥q¤½§iªº¤jªÑªF«ùªÑ³Ì§CªÌ¥u¦³1¤d¦h±i¬Û½Ä¬ð¡C ¦Ü¤Ö³o¨â¦ì«ùªÑ³£¤ñ¥LÌÁÙn°ª«Ü¦h¡A²z½×¤WÀ³¸Ó¬On¤½§i³o¨â¦ì¤~¬O¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 02:59:34²Ä 1826 ½g¦^À³
|
³q±`³£¬O¸³ºÊ¨Æ©ñ±ó»{ÁʦӥѯS©w¤H»{ÁÊ¡A³o¤£µ¥¦P¨ä¥L¤jªÑªF¤]±o«Å§i©ñ±ó»{ÁÊ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 02:49:47²Ä 1825 ½g¦^À³
|
ªÑ¥»6.91»õ=6.91¸U±i¡A·í«e¤Q¤jªÑªF»{ÁÊ>419±i¡A³o2¤H´N¦³¸ó¹L<10%ªº¤½§iªùÂe¡A¨ä¹ê¤£Ãø¡C ¤£¹L2023¦~°_ªùÂe±N°¬°5%! 2022.01.12 udn.com/news/story/7239/6026768 ªÑªF«ùªÑ5%¶·¥ß§Y¥Ó³ø¡Kª÷ºÞ·|´ª¥X¤W¥«ÂdÂÃÃè¤H ¨Ì²{¦æ³W©w¡A«ùªÑ10%¥H¤W¤jªÑªF¡A±o¦Û¦æ¦V³Q§ë¸ê¤½¥q¥Ó³ø¡A¥Ñ³Q§ë¸ê¤½¥q¹ï¥~¤½§i¡F2023¦~°_«h¬O«ùªÑ5%¥H¤W´N±o¥Ó³ø¡AY¥¼¥Ó³ø¡B«h·|³B¥÷¸ÓªÑªF¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/9/25 ¤W¤È 08:37:18²Ä 1424 ½g¦^À³ 1000±i¥H¤W¤H¼Æ¼W2¦W¡A±i¼Æ¼W¥[14219.715±i/¼W¸ê16000±i=¥e¤ñ88.87%¡A¤£¥X·N¥~¤j¦h¼Æ¤pªÑªF©ñ±ó¤F! |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/24 ¤U¤È 01:54:07²Ä 1824 ½g¦^À³
|
N¤j ¤£ºÞ¬O¦P¶°¹Î ©Î¬O¤º³¡Ãö«Y¤H ¥H2¤H«ùªÑ°ª¹F¸U±i ³£À³¸Ón¤½§i Ãø¹D¬O¶°«O¤½¥q²Îp¿ù»~¶Ü¡H |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/3/24 ¤U¤È 01:24:07²Ä 1823 ½g¦^À³
|
¤£¦P¤H¡A¦P¤@³æ¦ì~ |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/24 ¤U¤È 01:20:58²Ä 1822 ½g¦^À³
|
N¤j ³o¨â®a³£¦³¦b3¸U1¤d±iªº¤½§i¦W³æ¤W¡A¤jªÑªF¤d±i³Ì§C¤]¤~1¤d¦h±i¡C ¥u¬O©_©Ç¡I ¥t¥~¨º2¤H¦³¸U±i¡A¦Ó¥B¬O¦b¥h¦~75¤¸¼W¸ê«á¤~¥X²{¡C ¥H«ùªÑ¤ñ²vºâ¡AÀ³¸Ó¬OÄÝ©ó¤jªÑªF¡A«ç¥i¤£¤½§i¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 12:04:49²Ä 1821 ½g¦^À³
|
²³¤H¬Òª¾[©ñªø½u³¨¤j³½]ªº¹D²z¡A¦ý¦³´X¤H¯àªø´Á«ù¦³? ²bªÅªk®v¡G¡i¯B°Êªº¤ß¥Í·Ð´o¡A¯u¤ß¤£°Ê¥Í´¼¼z¡j ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/27 ¤W¤È 09:46:03²Ä 879 ½g¦^À³ ·sÃħë¸ê¤£n¤Ó¦b·NÄw½X¨Ó¨Ó¥h¥h(µu½uªÌ«äºû)¡A¯u·Qµo¤j°]»Ýnªº¬Oºë½T¬Ý·Ç¦³µo®i¼ç¤O»PÄvª§¤OªÌ! ¥hÆ[¹î¥_·¥¬P2020.03.6~2021.02.26Äw½XÅÜ°Ê,ªÑ»ù10¤¸¦h¡A¦Ê±i¤d±i¤j¤á«ùªÑ´î¡A2021.3.3°_ªºµo®i¤w¥i·Q¦Óª¾! |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/3/24 ¤W¤È 11:44:55²Ä 1820 ½g¦^À³
|
´N¬OÆp¥Û¥Í§Þ¸ò¨Î®m¡A¤£¥Î·Q¤Ó¦h |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/24 ¤W¤È 11:29:31²Ä 1819 ½g¦^À³
|
½Ð±ÐR¤j ¸³ºÊ¨Æ¤Î¤jªÑªF«ùªÑÀ³¤½§i¡I ªYÄ£¤½§iªº¤d±i«ùªÑªÌ¥u¦³10¤H¡A¦@3¸U1¤d¦h±i¡C ¶°«Oªº´¦¥Ü¤d±i¦³12¤H¡A¦@4¸U1¤d¦h±i¡C ªí¥Ü¦³2¤H«ù¦³1¸U±i¡A¦Ó³o2¤Hªº«ùªÑ¤ñ¨ä¥L¤jªÑªFªº«ùªÑÁÙ¦h¡C ¬°¤°»ò³o2¤H«ùªÑ¥i¥H¤£»Ý¤½§i¡H¬O¦ó¤è¯«¸t¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤W¤È 08:19:23²Ä 1818 ½g¦^À³
|
©úÅãÁ׫´N»´!!! add-on:Á{§É¹êÅç¥ÎÃIJլ°Antroquinonol+¼Ð·ÇÀøªk(SoC)¡A¹ï·Ó²Õ«h¬°¦w¼¢¾¯+¼Ð·ÇÀøªk(SoC)¡C «¤¤¤§«¬O³o¬q:FDA strongly recommends that drugs to treat COVID-19 be evaluated in randomized, placebo-controlled, double-blind clinical trials using a superiority design |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤W¤È 08:03:54²Ä 1817 ½g¦^À³
|
3/23°ê¹©§ó¥¿¤½§i:(3)¥»¤½¥q¤§Á{§É¹êÅç¥ÎÃIJլ°Antroquinonol+¼Ð·ÇÀøªk(SoC)¡A¹ï·Ó²Õ«h¬°¦w¼¢¾¯+¼Ð·Ç Àøªk¡A²Å¦X¬ü°êFDA©Òn¨Dªº [ªþ¥[©Ê(add-on)¸ÕÅç³]p]... ªþ¥[©Ê(add-on)¸ÕÅç³]p¬O¤°»ò? ´N¬Onsuperiority studies[Àu®Ä©Ê]! FDA strongly recommends that drugs to treat COVID-19 be evaluated in randomized, placebo-controlled, double-blind clinical trials using a superiority design [trials in these populations should generally be designed as placebo-controlled superiority studies with an add-on design ] [trials in these populations should generally be designed as placebo-controlled superiority studies with an add-on design ] ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/23 ¤W¤È 07:59:18²Ä 1810 ½g¦^À³ ¤C¤ë¥bÀn¡X¡X¤ðª¾¦º¬¡! 2020.5.11 FDA COVID-19ÃĪ«Á{§É«ü«n¤w©ú©ú¥Õ¥Õ¼gµÛ:±j¯P«Øij¨Ï¥Î[Àu®Ä©Ê]³]p¦aÁ{§É!!! FDA¤£¬Onµ¥®Ä©Ê»P¤£¦H©Ê¡A¬On[Àu®Ä©Ê]!!! P2¸Ñª¼ªº¼Æ¾Ú¹L¤£¤Fpre-EUAªùÂe:2¤ëpre-EUA meeting¡AFDA¦Ñ¦¦³¦^ÂСA¤½¥q¤£»¡¦Ó¤w¡AÁÙ°ø±æ4¤ë¥Ó½ÐEUA¡AÁÙ¦³¼Æ¾Ú¤£È°µP3ªº¡C |
|
|
|